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SUMMARY 
 
 Alzheimer's disease (AD), as one of the most common neurodegenerative 
diseases, is characterized by the loss of neuronal dysfunction and death resulting in 
progressive cognitive impairment. The main histopathological hallmark of AD is the 
accumulation and deposition of misfolded Aβ peptide as amyloid plaques, however 
the precise role of Aβ toxicity in the disease pathogenesis is still unclear. Moreover, 
at early stages of the disease the important clinical features of the disorder, in addition 
to memory loss, are the disruptions of circadian rhythms and spatial disorientation.  
 In the present work I first studied the role of Aβ toxicity by comparing the 
findings of genome-wide association studies in sporadic AD with the results of an 
RNAi screen in a transgenic C. elegans model of Aβ toxicity. The initial finding was 
that none of the human orthologues of these worm genes are associated with risk for 
sporadic Alzheimer’s disease, indicating that Aβ toxicity in the worm model may not 
be equivalent to sporadic AD. Nevertheless, comparing the first degree physical 
interactors (+1 interactome) of the GWAS and worm screen-derived gene products 
have uncovered 4 worm genes that have a +1 interactome overlap with the GWAS 
genes that is larger than one would expect by chance. Three of these genes form a 
chaperonin complex and the fourth gene codes for actin, a major substrate of the same 
chaperonin.  
Next I have evaluated the circadian disruptions in AD by developing a new 
system to simultaneously monitor the oscillations of the peripheral molecular clock 
and behavioural rhythms in single Drosophila. Experiments were undertaken on wild-
type and Aβ-expressing flies. The results indicate the robustness of the peripheral 
clock is not correlated with the robustness of the circadian sleep and locomotor 
behaviours, indicating that the molecular clock does not directly drive behaviour.  
This is despite period length correlations that indicate that the underlying molecular 
mechanisms that generate both molecular and behavioural rhythms are the same.  
Rhythmicity in Aβ-expressing flies is worse than in controls. I further investigated the 
mechanism of spatial orientation in Drosophila. It was established that in the absence 
of visual stimuli the flies use self-motion cues to orientate themselves within the tubes 
and that in a Drosophila model of Aβ toxicity this control function is disrupted. 
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CHAPTER 1:  INTRODUCTION 
 
Neurodegenerative disease is a general term for a range of disorders related to 
the progressive loss of function or structure of neurons in the human brain resulting in 
cognitive decline. They are a major threat to public health, with Alzheimer’s disease 
(AD) being the most common disorder in adults. Other examples of such disorders 
include Parkinson’s and Huntington’s diseases (Forman, Trojanowski et al. 2004, 
Chiti and Dobson 2006). AD is thought to be caused by the self-association of at least 
two proteins, the amyloid beta peptide (Aβ) and tau, resulting in a spectrum of 
aggregates that may have features of amyloid. Furthermore, the aggregation of 
misfolded proteins characterizes other neurodegenerative diseases, meaning that they 
might have similar mechanism of pathogenesis. This chapter will give an overview of 
neurodegenerative diseases, focusing on Alzheimer’s disease and amyloid beta 
toxicity. 
 
1.1 NEURODEGENERATIVE DISEASES 
 
Neurodegenerative diseases can be hereditary or sporadic, or in the case of 
prion disease they may rarely be infectious.  They are characterized by progressive 
nervous system dysfunction, often associated with neuronal loss in the central nervous 
system, caused by accumulation of intracellular or extracellular protein aggregates 
(Forman, Trojanowski et al. 2004). 
 
1.1.1 MECHANISMS OF NEURODEGENERATION 
Recent studies of familial forms of these neurodegenerative diseases have led to the 
development of model systems, providing new insights into disease pathogenesis. 
One of the conclusions of such studies was that the misfolding, in case of 
neurodegenerative diseases, is caused by genetic mutations, most of which are located 
in completely unrelated genes. In many cases, these mutations lead to the 
overproduction of misfolded proteins, which have high aggregation propensity 
resulting in the deposition of protein aggregates in extra- and intracellular space 
(Forman, Trojanowski et al. 2004). For example, AD is characterized by the 
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extracellular aggregation and deposition of amyloid-beta (Aβ) peptide, particularly 
isoforms that are longer than normal - for example the Aβ42 isoform, with a length of 
42 amino acids, is more aggregation prone than the Aβ40 isoform that is 40 amino 
acids residues in length. Similarly, aggregation prone variants of alpha-synuclein are 
believed to be linked to Parkinson’s disease (PD) pathogenesis, while mutations in 
microtubule-associated protein tau are thought to be a cause of frontotemporal 
dementia (Soto 2003). Mutations identified in the familial cases can also provide 
insights into the pathogenesis of sporadic forms as the aggregates of the same proteins 
are found in the majority of the cases. In particular, all mutations in amyloid precursor 
protein, presenilin-1 and presenilin-2, as identified in the cases of familiar form of 
AD, lead to the overproduction of aggregation-prone isoforms of Aβ peptides, 
resulting in plaque deposition, which is the major pathological hallmark of the disease 
in both familial and sporadic forms (Weggen and Beher 2012). In the same way, 
mutations in the alpha-synuclein gene SNCA cause the accumulation of alpha-
synuclein proteins in the brain, a major neuropathological feature of familial and 
sporadic PD (Bertram and Tanzi 2005). Therefore, the study of these mutations can 
lead to further understanding of how and why some normally soluble proteins convert 
into insoluble, fibrillar aggregates.  
 Familial forms of neurodegenerative diseases only account to the small 
percentage of total number of cases, specifically 5-10% cases of AD, ~10% of PD 
(Bertram and Tanzi 2005). In contrast, the vast majority of the cases occur as sporadic 
forms, most likely resulting from a combination of genetic and environmental factors 
that are not yet fully understood (Tillement, Lecanu et al. 2010). 
 As mentioned before, the deposits of protein aggregates in the nervous system 
are a characteristic of most adult-onset neurodegenerative diseases and therefore this 
suggests that they share a common pathogenic mechanism. One explanation of this 
phenomenon could be age-related degradation of proteostasis network, a protein 
quality control system, leading to the progressive accumulation of protein damage and 
formation of misfolded protein aggregates (Douglas and Dillin 2010).  Furthermore, it 
has been suggested that accumulation of misfolded proteins associated with many of 
these diseases may be age-related and not necessarily a disease-related process 
(Lindner and Demarez 2009). Aging is thought to be a stochastic process combining 
the genetic and environmental factors and leading to the progressive physiological 
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decline (Hindle 2010). One of the main molecular phenotypes associated with aging is 
the non-linear accumulation of molecular and cellular damage which consequently 
leads to the time-dependent accumulation of protein aggregates (Lindner and 
Demarez 2009).  Moreover, frailty of old age, or this age-related accumulation of 
health deficits, is characterized by the combined effect of many health related factors 
and leads to the increased likelihood of death over time. The mortality rate grows 
exponentially with age, which however slows down at very advanced age (Partridge 
and Mangel 1999). 
In health however the correct conformation of the protein products, including 
neuronal proteins, is achieved by the protein quality system with the help of 
chaperone proteins, which inhibit formation of aggregates, and protein-clearance 
machinery that are in charge of degrading the damaged proteins by proteasomes and 
autophagy (Labbadia and Morimoto 2014). With age, the damage inflicted on these 
control mechanism progressively increases and consequently this leads to the 
accumulation of misfolded proteins and their aggregation (Hartl and Hayer-Hartl 
2009).  Moreover, although most of the proteins associated with neurodegeneration 
are expressed systemically, the resulting toxicity has been identified only in the 
neuronal cells. This might be due to the increased susceptibility of the brain structure, 
especially the neuronal cells, to the impairment of the protein quality system (Soto 
2003).  
As global life expectancy is progressively increasing, the prevalence and 
incidence of most neurodegenerative diseases will also rise dramatically in the 
elderly. The pathogenesis of many of these diseases is still unknown and they pose a 
threat to the economic and social wellbeing of current and future generations 
(Forman, Trojanowski et al. 2004). Therefore, it is important to understand the 
mechanisms of toxicity in order to develop the therapeutic solutions to treat and 
prevent these disorders. 
 
1.1.2 NEURODEGENERATIVE DISEASE CLASSIFICATIONS 
Several neurodegenerative diseases are classified as “proteopathies”, where protein 
misfolding causes toxicity. In these cases, DNA mutations in the encoding genes have 
been associated with the hereditary forms of neurodegenerative diseases. For 
example, in many different diseases the mutated gene has a repeat of CAG nucleotide 
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triplet that encodes the glutamine amino acid. These disorders with many repeats of 
glutamine are known as polyglutamine (polyQ) diseases, one example of which is 
Huntington’s disease (MacDonald, Ambrose et al. 1993). As a result, extra glutamine 
residues have toxic effects, such as impaired protein folding and aggregation that 
deposits itself as intranuclear inclusions (Figure 1.1).  
In some of the cases the proteins aggregate and deposit in the intracytoplasmic 
space. One example of such a disorder is Parkinson’s disease that is caused by the 
mutation in alpha-synuclein gene. The disease is characterized, in most cases, by 
aggregation of alpha-synuclein that forms insoluble fibrils in dopaminergic neurons of 
Lewy bodies (Shulman, De Jager et al. 2011). On the other hand, mutated protein can 
also be secreted extracellularly, for example amyloid-beta in Alzheimer’s disease 
(Querfurth and LaFerla 2010). Some evidence suggests that the inclusion bodies, 
consisting of abnormal aggregated proteins, are not the main cause of toxicity and 
whether soluble monomers, oligomers or larger aggregates have the most toxic effect 
in many of these conditions is uncertain. Moreover, it has been shown that in some 
Figure 1.2 Overview of protein misfolding and aggregation (adapted from (Forman, 
Trojanowski et al. 2004). Genetic and environmental factors can accelerate the 
process of protein misfolding and aggregation, while cellular quality-control systems, 
such as molecular chaperones, regulate the correct folding or refolding of the proteins. 
If the native state of proteins is unattainable, misfolded proteins are selectively 
removed through proteolysis or autophagy. However, failure to eliminate misfolded 
proteins leads to the aggregation and accumulation of toxic aggregates which can 
deposit themselves in the nucleus (for example polyQ deposits in Huntington’s 
disease), cytoplasm (alpha-synuclein in Parkinson’s disease) or in the extracellular 
space (Aβ in Alzheimer’s disease). 
Figure 1.1 Overview of protein misfolding and aggregation. Genetic and 
environmental factors can accelerate the process of protein misfolding and 
aggregation, while cellular quality-control systems, such as molecular chaperones, 
regulate the correct folding or refolding of the proteins. If the native state of proteins 
is unattainable, misfolded proteins are selectively removed through proteolysis or 
autophagy. However, failure to eliminate misfolded proteins leads to the aggregation 
and accumulation of toxic aggregates which can deposit themselves in the nucleus 
(for example polyQ deposits in Huntington’s disease), cytoplasm (alpha-synuclein in 
Parkinson’s disease) or in the extracellular space (Aβ in Alzheimer’s disease). 
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circumstances inclusions can serve a protective role (Soto 2003). However, in general 
the tendency of mutated protein to aggregate into oligomeric amyloid species is 
correlated with toxicity (Forman, Trojanowski et al. 2004). Alzheimer’s disease, as 
one of the most common neurodegenerative disease, is an excellent candidate disorder 
to study the mechanism of protein aggregation and its role in disease pathogenesis as 
it characterized by the presence of both intra and extracellular protein deposits. 
 
1.2 ALZHEIMER’S DISEASE 
 
Alzheimer’s disease (AD) accounts for more than 60% of dementia cases and 
affects approximately 46 million people worldwide (Alzheimer's 2014). AD is 
characterized by the progressive dysfunction and then loss of neurons and synapses 
especially in the cerebral cortex and by the presence of two neuropathological lesions: 
extracellular plaques, mainly composed of beta-amyloid peptide, and intracellular 
tangles, made up largely of cytoskeletal protein tau (Querfurth and LaFerla 2010). 
 
1.2.1 TAU PROTEIN 
Tau is a highly soluble microtubule-associated protein (MAP). One of the 
main functions of tau protein is to bind to the microtubule and promote their assembly 
and stability. Other functions include tubulin polymerization, maintaining neuronal 
integrity, axonal transport and axonal polarity.  These proteins are mostly found in 
neurons of central nervous system as compared to non-neuronal cells. However, tau is 
not present in dendrites, being confined normally to the axons where it provides 
microtubule stabilization (Ballatore, Lee et al. 2007). In adult human brain tau 
proteins are produced as a result of alternative splicing from a single gene labelled as 
a microtubule-associated tau protein (MAPT) and located on chromosome 17q21, 
composed of 16 exons. There are six tau isoforms in human brain tissue that are 
classified according to the number of binding domains. Each of the tau isoforms has 
certain physiological functions and appears to be differentially expressed during 
development of the brain (Goedert, Ghetti et al. 2000). 
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 The binding of tau to tubulin is regulated by its phosphorylation state. The 
longest isoform of tau protein has 79 potential Serine or Threonine phosphorylation 
sites. Notable, phosphorylation of tau is also developmentally regulated, when it is 
substantially higher in foetal brain than in adult brain. Phosphorylation of tau is 
regulated by coordinated action of a number of kinases and phosphatases (Ingram and 
Spillantini 2002). Under pathological conditions, such as in case of AD, the 
equilibrium of tau binding to tubulin is disrupted, resulting in microtubule 
disorganization and abnormal increase of unbound tau molecules (Figure 1.2). 
Consequently, hyperphosphorylation of tau is associated with misfolding and 
conformational changes in the normal structure of tau and leads to the aggregation 
into fibrillar structures, such as straight or paired helical filaments (SFs and PHFs 
respectively), inside the affected neurons. The PHFs is further self-assembly and 
forms neurofibrillary tangles (NFTs), which is one of the major hallmarks of AD 
(Brandt, Hundelt et al. 2005). At the cellular level, abnormal phosphorylation of tau 
introduces alterations in the binding abilities to tubulin and microtubule assembling, 
causing the interruption of axonal transport and consequently synapse dysfunction 
(Roy, Zhang et al. 2005).  
Previous findings show that the tau-mediated toxicity appears to be caused by 
the mutations in tau genes. In fact, the abundance of NTFs consisted mainly of 
hyperphosphorylated tau, correlates well with familial forms of frontotemporal 
Figure 1.2 Microtubule disintegration as a result of hyperphosphorylated tau. In 
healthy neurons tau binds to microtubules and stabilizes them, while in diseased 
neurons tau, as a result of hyperphosphorylation, detaches from the microtubules and 
aggregates into neurofibrillary tangles. 
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dementia and AD. Even though the presence of neurofibrillary tangles is associated 
with neuronal loss in AD, their role in pathology of AD is not yet clear (Goedert, 
Ghetti et al. 2000, Ingram and Spillantini 2002). 
 
1.2.2 AMYLOID-BETA 
Familial form of AD is associated with the mutation in one of the genes 
encoding amyloid precursor protein (APP) and Presenilins 1 and 2. Many disease-
linked mutations have been identified and each results in either an increased 
production of total Aβ protein or else a change in the balance of Aβ isoforms 
resulting in more aggregation-prone species predominating. Aβ denotes the peptides 
that consist of 36-43 amino acids and are generated as a cleavage product from the 
membrane protein APP. The gene coding the APP is located on chromosome 21 
which may explain why individuals with Down’s syndrome, who have three copies of 
that chromosome, have a high incidence of AD (Querfurth and LaFerla 2010). This 
suggests that the overexpression of APP can be a cause of AD. 
As a transmembrane protein, APP is metabolized by sequential proteolysis by 
enzymes including α−, β− and γ-secretase (Hardy 2006). APP can undergo 
proteolytic processing by two alternative pathways (LaFerla, Green et al. 2007), one 
of which leads to the generation of Aβ peptide (amyloidogenic) and the second one 
does not (non-amyloidogenic) as shown in Figure 1.3.  
Figure 1.3 Sequential cleavage of amyloid precursor protein. APP is processed by α− 
or β-secretases. The processing by α-secretase precludes Aβ formation, whereas 
processing by β-secretase and sequentially by γ-secretase lead to the production of Aβ 
peptide. Depending on the site of cleavage Aβ can be 36-43 amino acids long. 
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Crucial steps in APP processing happen at the cell surface, where APP can be 
transported to the cell surface or to endosomal compartment. On the cell surface APP 
undergoes non-amyloidogenic processing, where it is cleaved directly by α-secretase 
and then γ-secretase, a process that involves the alternative cleavage of Aβ into 
shorter fragments and therefore precludes amyloid-beta formation.  Amyloidogenic 
processing of APP occurs in the endosomal compartments and involves sequential 
enzymatic actions of β- and γ-secretases (De Strooper, Vassar et al. 2010). 
Extracellular cleavage by β-secretase creates soluble extracellular fragments (sAPP-β) 
and membrane-bound fragments labelled as C99. Following the release of sAPP-
β ectodomain, γ-secretase cleaves the transmembrane region of APP and generates 
amyloid-beta (Aβ) fragments of 30-51 amino acids residues in length (LaFerla, Green 
et al. 2007).  
 Monomers of Aβ40 and Aβ42 are the most common, with the longer isoform 
being more toxic due to the higher level of aggregation. It is yet unclear why some 
surface APP is cleaved directly by α-secretase while the others being internalized into 
endosomes to produce Aβ fragments (De Strooper, Vassar et al. 2010). 
 
1.2.3 GENETICS OF ALZHEIMER’S DISEASE 
The cause of Alzheimer’s disease is still unclear, except for around 5-10% of 
the cases where genetic mutations have been identified. Familial cases of AD (FAD), 
based on the reviews of twins and families studies, are characterized by the early 
onset (before the age of 65) and inherited in dominant autosomal manner. While most 
cases of AD do not show dominant inheritance and are termed sporadic, pathological 
and clinical studies of these forms of AD suggest that these two types have similar 
pathologically and clinically features (Hardy 2006, Querfurth and LaFerla 2010). 
Therefore, the genetic study of FAD can shed the light on the mechanism of the 
pathogenesis of this disease. 
Genetic analysis of FAD has revealed that mutations in several genes disrupt 
the equilibrium of Aβ production. These identified genes encode for amyloid 
precursor protein (APP) and presenilin 1 and 2 (PSEN1 and PSEN2 accordingly). 
Most of the mutations within APP cluster around the γ-secretase cleavage site, β-
secretase cleavage site or cause the changes to the sequence of Aβ peptides. The 
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mutations around the β-secretase cleavage site increase the production of Aβ, while 
the mutations in γ-secretase cleavage site promote the production of longer, less 
soluble and more toxic Aβ42 (LaFerla, Green et al. 2007, Querfurth and LaFerla 
2010). Furthermore, the mutation in the APP gene related to the Aβ sequence 
accelerates the self-aggregation of Aβ into amyloid fibrils and is highly toxic, as 
described in the case of Arctic mutations (Chiti and Dobson 2006).  
On the other hand, sporadic cases of AD, which do not exhibit autosomal 
dominant inheritance, have a complex aetiology and multiple studies suggest that they 
can be caused by a combination of environmental and genetic factors (Sleegers, 
Lambert et al. 2010). Currently, several potential risk genes have been identified. The 
most important risk gene is ApoE, discovered in 1993 by genetic linkage analysis; it 
is linked to a threefold increase in the risk of AD. Further analysis showed that only 
one of three alleles (namely the E4 allele) was a risk factor for this disease (Bu 2009). 
However, the exact mechanism behind such an association is still unclear. A number 
of studies suggest a role of ApoE in amyloid binding and deposition (Bu 2009, 
Bettens, Sleegers et al. 2010, Querfurth and LaFerla 2010). Some evidence suggests 
that while under the normal conditions ApoE enhances proteolytic clearance of Aβ; 
the E4 allele isoform is not as effective at promoting the breakdown as other alleles 
and thus increases susceptibility to the disease in individuals with that gene variant 
(Fuentealba, Liu et al. 2010). Furthermore, recent genome-wide association studies 
(GWAS) have suggested a number of new genetic risk factors associated with AD 
(Bertram and Tanzi 2005, Lambert, Heath et al. 2009). These studies are based on the 
assumption that if one type of genetic variant (or alleles) is more frequent in people 
with disease, then that particular single-nucleotide polymorphism is associated with 
disease and individuals carrying that polymorphism are at increased risk of disease. 
Interestingly, the genes involved in FAD (APP, PSEN1 and PSEN2) are absent from 
the list of the candidate genes associated with sporadic form of AD as identified by 
GWAS studies, while all of the studies confirmed the association of ApoE4 allele 
with the disease.  On the one hand, this finding might suggest the lack of sufficient 
power to detect the alleles with low frequency but high penetrance, but on the other 
hand it might suggest that sporadic and familial forms of AD have different 
mechanism of pathogenesis (Gandhi and Wood 2010). 
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1.2.4 Aβ  MEDIATED TOXICITY 
 According to the amyloid hypothesis, accumulation and aggregation of Aβ 
peptide in the brain is the primary neuropathological event that triggers other 
pathological aspects of AD including synaptic dysfunction, inflammation, 
neurofibrillary tangles and consequently neuronal death. Consequently, the amyloid 
cascade hypothesis also proposes that the changes in tau and formation of 
neurofibrillary tangles results from the imbalance between Aβ formation and Aβ 
clearance (Hardy and Selkoe 2002).  
The support for this hypothesis comes from various experimental 
observations. For example, transgenic mice overexpressing both mutant APP and 
mutant tau are characterized by the accelerated neuronal loss and show higher level of 
neurofibrillary tangle formation (as compared to transgenic mice model for tau alone), 
while the structure and amount of amyloid plaques remain on the same level (Lewis, 
Dickson et al. 2001). Moreover, it has been shown that in triple transgenic mice with 
APP, PS1 and tau mutations the Aβ deposition is developed prior to the NFTs (Oddo, 
Caccamo et al. 2003). This finding imply that the APP processing occurs upstream of 
tau and this assumption has been supported by the recent experimental results that 
demonstrate tau-dependent Aβ toxicity in mouse neuronal culture. Finally, APP 
transgenic mouse model with reduced level of endogenous tau show less cognitive 
impairment (Roberson, Scearce-Levie et al. 2007). 
 
1.3 SYNAPTIC DYSFUNCTION 
 
Recent studies suggest that toxic Aβ aggregates bind to the neurons and 
change their structure so that they disrupt synaptic communications. Moreover, 
persistent synaptic dysfunction may account for the evident neuronal loss on later 
stages of disease (Shankar and Walsh 2009). Similarly, it has been proposed that Aβ 
peptide also plays a crucial role in synaptic physiology and regulation of synaptic 
vesicle release (O'Brien and Wong 2011). Several lines of evidence have shown that 
Aβ impairs synaptic plasticity by inhibiting long-term potentiation (LTP), responsible 
for the learning and memory formation in synapses, and at the same time facilitating 
long-term depression (LTD), which reduces the efficacy of neuronal synapses (Walsh, 
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Klyubin et al. 2002). Aβ aggregates disrupt the release of presynaptic 
neurotransmitters and postsynaptic glutamatergic transmission by inducing the 
endocytosis of surface receptors, such as the N-methyl-D-aspartate (NDMA) receptor 
(Snyder, Nong et al. 2005). Similar effects have been observed during normal aging, 
when the balance between LTP and LTD is altered. However Aβ seems to be able to 
trigger such synaptic deficits even earlier (Querfurth and LaFerla 2010). In addition, 
experimental studies have shown that Aβ binds to neurotropic receptors essential for 
cognitive processing, such as brain derived neurotrophic factor (BDNF), impair the 
maintenance of LTP and consequently reduce the neurotrophic support (Dechant and 
Barde 2002).  
 Exposure to Aβ during disease progression inhibits key mitochondrial 
enzymes, causing the damage to ATP production, oxygen consumption and electron 
transport. In Alzheimer’s disease, as well as during normal aging, mitochondrial DNA 
(mtDNA) undergoes high levels of oxidative stress (Querfurth and LaFerla 2010). 
  
1.4 COGNITIVE DYSFUNCTIONS IN AD  
 
Several meta-analyses of risk factors for Alzheimer’s disease have reported 
that lifestyle factors can reduce the risk of developing the disease, specifically higher 
levels of education, social engagement, regular physical activity and cognitive 
stimulation can lower the risk of cognitive decline and AD (Buschert, Bokde et al. 
2010). By comparison, cerebrovascular and cardiovascular factors, which include 
smoking, obesity, alcohol intake, high blood pressure and diabetes, increase the risks 
of developing AD (Citron 2010). 
While the risk factors described for AD are well characterized they are 
unfortunately so wide-spread within the population that they are not sufficient to 
assist with early diagnosis of disease.  The timely diagnosis of AD therefore rests on 
detecting the early clinical features.  For many patients memory problems are the 
initial complaints however they may well already have deficits in other domains, in 
particular sleep/wake biology and spatial orientation. 
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1.4.1 MEMORY PROBLEMS 
Alzheimer’s disease is clinically characterized by cognitive and functional 
dysfunctions manifested by the memory problems and impairment in other cognitive 
domains such as language, perceptual thinking, orientation, attention and functional 
abilities (Burns and Iliffe 2009). At the early stage of the disease, the loss of short-
term memory is the most noticeable deterioration, which presents as difficulties in 
acquiring new memories or remembering recent facts. Depending on the progression 
of the disease, the impairment of memory and other intellectual functions, including 
long-term and implicit memory, become more prominent and can be accompanied by 
psychotic episodes, when patient have delusional symptoms, exhibit unpremeditated 
aggression or fails to recognize close relatives (Mayeux 2010). 
 
1.4.2 SLEEP PROBLEMS 
In addition, Alzheimer’s disease is accompanied by non-cognitive 
disturbances. As discussed previously, progression of AD leads to the loss of brain 
tissue and impaired mental abilities that may also disrupt the sleep/wake cycle. As a 
consequence, as a disease progress patients with AD lose their ability to maintain a 
full night’s sleep and have more fragmented sleep (Hatfield, Herbert et al. 2004, 
Musiek, Xiong et al. 2015, Peter-Derex, Yammine et al. 2015). Biological and 
physiological processes, including sleeping, body temperature, heart rate and others 
characteristics, are controlled by circadian rhythms that are driven by circadian 
clocks. In mammals central circadian clock is located in suprachiasmatic nucleus 
(SCN) in hypothalamus. In AD the normal functioning of circadian clocks are 
supposedly disrupted as a result of the progressive degeneration and loss of neuronal 
connections in hypothalamus, which includes the damage to SCN, however no 
conclusive evidence has been presented so far proving that the SCN is particularly 
affected by AD pathology (Volicer, Harper et al. 2001). On the other hand, the 
disturbance of sleep pattern may aggravate the cognitive impairment due to the 
impairment of sleep-dependent memory consolidation process (Peter-Derex, 
Yammine et al. 2015). Overall, circadian rhythms disturbances experienced by the 
patients with AD are more severe that those seen in healthy elderly individuals, 
characterized by the higher percentage of nocturnal activity, reduced amplitude of 
circadian rhythm and delayed body temperature rhythms (Volicer, Harper et al. 2001). 
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Recent anatomical studies have shown that there is convective flow between 
cerebrospinal fluid and the lymphatic vessels, called glymphatic system, which can 
help to remove toxic metabolites (Iliff, Wang et al. 2012). Moreover, it has been 
suggested that glymphatic clearance is regulated by sleep-wake cycle and this system 
is strongly stimulated by sleep. Interestingly, during sleep the Aβ clearance activity in 
mice is twice as fast as during waking hours (Xie, Kang et al. 2013). According to the 
clinical studies, the quality and duration of sleep may be early indicative symptom or 
AD and predict the onset of this disease (Mendelsohn and Larrick 2013). 
 
1.4.3 SPATIAL DISORIENTATION 
 Among the various behavioural and cognitive dysfunction, experienced by 
patients with AD, is spatial disorientation, or tendency to get lost in a familiar 
environment. The orientation involves the ability to extract the selective spatial 
information and consequently generate the mental representation of the environment. 
Failure to do so could result in the situation when patients with AD are unable to find 
their way from one room to another even in their own houses (Henderson, Mack et al. 
1989, Monacelli, Cushman et al. 2003). Therefore, the spatial navigation impairment, 
that usually occurs at the early stage of AD, together with the disruption of sleep-
wake cycle can interfere with the independent living of people with AD and is 
particularly burdensome to caregivers. 
 
1.5 ANIMAL MODELS OF AD 
 
 In humans, the study of neuropathological changes that occur during AD 
progression is limited because the data can only be acquired post mortem (Spires and 
Hyman 2005). For this reason animal models of the disease can facilitate our 
understanding of underlying pathogenic mechanisms and provide new insights into 
the disease (Gotz and Ittner 2008). Even though the role of particular cellular 
pathways can be studied in vitro (Cleary, Walsh et al. 2005), the use of animal models 
of the disease is preferred as it provides the opportunity to study complex biological 
interactions within the whole living organism (Spires and Hyman 2005). As a result, 
animal models of AD have proven to be an excellent tool to study the disease-related 
progression of Aβ and tau pathology, to examine synaptic abnormalities and 
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behavioural dysfunctions over time (Gotz and Ittner 2008). Eventually, the animal 
models can be used to develop and test a new therapeutic agents and validate 
diagnostic tests (Crowther, Kinghorn et al. 2004). 
 Transgenic models of AD have been developed in several organisms including 
vertebrates (specifically mouse, rats and monkeys) and invertebrates (fruit flies and 
worms) (Gotz and Ittner 2008). 
 
1.5.1 MOUSE MODELS OF AD 
 The mouse has been the mammalian model system of choice for genetic 
research and allowed to study the role of Aβ toxicity in the amyloid cascade 
hypothesis (Hall and Roberson 2012). Transgenic mice with mutations in APP, a gene 
associated with familial AD, have developed Alzheimer-like neuropathology, 
including the induced Aβ deposition, memory deficits and in some cases the 
neurofibrillary tangles (Games, Adams et al. 1995, Lewis, Dickson et al. 2001). 
Similarly, transgenic presenilin mutant mice are characterized by the increased levels 
of Aβ42 but they do not develop AD pathology (Huang, Yee et al. 2003). To enhance 
Aβ pathology, double transgenic models have been developed, expressing both APP 
and presenilin (Hall and Roberson 2012). They are characterized by the increased 
levels of cognitive dysfunctions occurred before the appearance of Aβ deposits, 
suggesting the causal role of Aβ toxicity in disease pathogenesis. In addition, 
transgenic mouse models of tau were developed to emulate the tau-related 
pathologies. Tau transgenic mouse model has been shown to be characterized by the 
enhanced neurofibrillary pathology, but in absence of Aβ deposits (Lee, Kenyon et al. 
2005). At present, more complex mouse models have been developed to recapitulate 
the complete set of AD-like features. In these triple transgenic mouse models three 
mutant genes were simultaneously expressed: of APP, tau and presenilin 1. These 
triple transgenic mice showed the progressive development of Aβ and tau pathology, 
but interestingly the Aβ deposition developed prior to the tau tangles (Oddo, Caccamo 
et al. 2003) confirming the amyloid cascade hypothesis. 
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 1.5.2 INVERTEBRATE MODELS OF AD 
 Invertebrate models of AD have emerged as a powerful tool to study the 
disease-related neurodegeneration. Both the nematode Caenorhabditis elegans (C. 
elegans) and the fruit fly, Drosophila melanogaster (Drosophila), are the most 
commonly used invertebrate models organisms. Invertebrate models offer many 
advantages over vertebrates, including their short lifespan, comprehensively studied 
genomics, variety of representing phenotypes and availability of genetic tools to 
express the human genes of interest. In particular, C. elegans was the first 
multicellular organisms of which the genome was fully sequenced (Hillier, Coulson et 
al. 2005). Moreover, the basic forms of learning and memory, as well as circadian 
rhythms, can be evaluated in Drosophila providing the functionally relevant 
neuroanatomy for human disorders. Generally, the fundamental aspects of cell 
biology are highly conserved in both humans and fruit flies (Crowther, Kinghorn et al. 
2004, Spires and Hyman 2005, Crowther, Page et al. 2006, Gotz and Ittner 2008). 
Most of the genes involved in familial AD have homologues in Drosophila 
and C. elegans. For example, the orthologue of APP has been identified in Drosophila 
(amyloid precursor protein-like protein APPL) as well as in C. elegans (amyloid 
precursor-like protein 1 APL-1) (Rosen, Martin-Morris et al. 1989, Daigle and Li 
1993). Both of these orthologues resemble the human counterpart throughout their 
length, but Aβ expressing region lacks the similarity to human APP. Despite this 
dissimilarity, overexpression of APPL in Drosophila leads to the axonal transport 
defects and increased neuronal loss in the developmental stage, suggesting the role of 
APP in axonal transport (Spires and Hyman 2005). In a similar manner, it has been 
reported that, in C. elegans, expression of Aβ in bodywall muscle results in the 
progressive paralysis and decreased lifespan (Dostal and Link 2010). The double 
transgenic models of AD in Drosophila with the coexpression of APPL and tau have 
been shown to induce the neuronal dysfunction and disrupt axonal transport (Torroja, 
Chu et al. 1999). In C. elegans, the overexpression of tau results in neurodegenerative 
changes and behavioural and synaptic dysfunctions (Kraemer, Zhang et al. 2003). In 
addition, the expression of human Aβ42 peptide have been reported to lead to 
accumulation of toxic amyloid aggregates and neurodegeneration, while the 
Drosophila model of less aggregation prone variant of Aβ40 developed the age-
dependent defects but no neurodegeneration (Crowther, Kinghorn et al. 2004, 
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Crowther, Page et al. 2006, Lu and Vogel 2009). The presence of the 
neurodegeneration, which can be evaluated histologically for Aβ42, can be observed 
and quantified by longevity assays and behavioural tests (Crowther, Kinghorn et al. 
2004, Crowther, Page et al. 2006).  
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CHAPTER 2: PROJECT AIMS 
 
Neurodegenerative diseases are currently incurable disorders associated with 
progressive loss of neuronal cells and supposedly caused by the accumulation of 
misfolded proteins. Alzheimer’s disease, one of the most common types of 
neurodegeneration, is assumed to be a result of disrupted balance between production 
and clearance of amyloid beta peptide. Elevated levels of Aβ aggregates in the brain 
tissue have been implicated in both familial and sporadic AD. Excessive amount of 
extracellular Aβ tend to self-aggregates into insoluble fibrils, which not only induce 
the oxidative stress to neuronal cells but also impairs synaptic function, leading to the 
progressive memory loss and cognitive deterioration associated with AD.  
The study of underlying pathogenic mechanisms of the disease in patients with 
AD is limited; nevertheless the animal models of AD can be used to investigate the 
molecular and behavioural dysfunctions associated with the disease. The invertebrate 
models, such as C. elegans and Drosophila, provide the opportunities to investigate 
the disease-related neurodegeneration and behavioural characteristics, as well as to 
perform the necessary genetic manipulations. 
Better understanding of disease pathogenesis and finding effective treatment 
for Alzheimer’s disease relies on the discovering the potential risk genes identified by 
genome-wide association studies and further studies of additional mechanisms of 
neurotoxicity, in particular the circadian rhythms disruption and underlying 
mechanisms of spatial disorientation, commonly associated with AD.  
Therefore, in this thesis three main research questions were addressed: 
1. Can we use an animal model of Aβ  toxicity to provide further insights into the 
human genetics by cross validating worm modifier genes with GWAS candidate 
genes? Taking into account the amyloid cascade hypothesis, that suggests the central 
role of Aβ toxicity in AD pathology (Hardy and Selkoe 2002), and on the other hand 
the absence of genes associated with familial AD from the GWAS findings brings 
into question the importance of Aβ in disease pathogenesis. In chapter 3, I evaluate 
the role of Aβ in AD by comparing the findings of GWAS in sporadic AD with the 
results of knockdown screen in a C. elegans model system that exclusively reports Aβ 
toxicity. 
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2. To what extent are the circadian disruptions associated with AD governed by 
dysfunction of the central clock? Several lines of evidence suggested that circadian 
disruptions contribute to the pathology of AD (Coogan, Schutova et al. 2013, Chen, 
Possidente et al. 2014), however it is still unclear whether the neurodegeneration 
damages the central clock itself or the communication pathways leading to the 
peripheral tissues. In chapter 4, I will describe the method developed to 
simultaneously monitor oscillations of peripheral clocks and behavioural rhythms in 
Drosophila model of AD. 
3. How does the fruit fly orientate itself in space and how is this disrupted 
in a model of AD? It has been previously shown that most animals have periodic 
positional preferences, namely they prefer to sleep and move in the certain locations 
(Campbell and Tobler 1984), indicative of highly developed mechanisms of spatial 
orientation, however the underlying control of such behaviour is yet to be determined. 
Moreover, in patients with AD, the similar ability to navigate within the familiar 
environment is disrupted at the early stage of the disease. In chapter 5, I will 
investigate the control of spatial orientation in fruit flies and note its disruption in a 
Drosophila model of AD. 
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CHAPTER 3: USING A  WORM MODEL OF Aβ  
TOXICITY TO DERIVE MORE INFORMATION FROM 
HUMAN GWAS IN ALZHEIMER’S DISEASE 
 
Finding potential candidate genes associated with an increased risk of a 
disease can contribute to improving our understanding of its pathogenesis; ultimately, 
leading to the discovery of possible pathological pathways involved in its 
development. This chapter describes methods to compare the findings of genome-
wide association studies in sporadic AD with the results of a genome-scale screen in a 
model organism.  The transgenic C. elegans model system used in this study allows 
the detection of RNAi constructs that suppress the Aβ-induced paralysis phenotype.  
By inferring which worm genes are knocked down by each RNAi construct we can 
gain information about which worm genes are essential for Aβ toxicity. The 
interactome network of the modifier genes was then compared to the interactome 
network for human AD GWAS hits and the degree of similarity was assessed. 
 
3.1 INTRODUCTION 
  
 According to a growing body of evidence, aging is the greatest risk factor in 
developing Alzheimer’s disease (AD). Genetics, however, plays an important role in 
the likelihood of developing AD as genetic inheritance has proven to be a major 
aetiological risk factor; indeed the heritability of so-called sporadic Alzheimer’s 
disease is estimated to be 58-79% (Gatz, Reynolds et al. 2006). The vast majority of 
AD is sporadic and exhibits heterogeneous, multifactorial inheritance. The most 
common assumption is that sporadic AD is likely to be regulated by a set of low-
penetrance risk genes across a variety of undetermined loci. These genetic variants are 
believed to be involved in a number of pathways, many of which are likely to alter the 
production, aggregation and clearance of Aβ. Other pathways that have been 
implicated include inflammatory pathways, particularly innate immunity. Although a 
comprehensive genetic characterization of AD has yet to be completed, there is a 
substantial evidence that the combination of these risk genes have a strong impact on 
the susceptibility to sporadic AD (Bertram and Tanzi 2009). Under these
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circumstances, recent progress in GWAS has furthered our understanding of the 
genetic influence on the aetiology of sporadic AD.  
 
3.1.1 THE PRINCIPLES OF GENOME WIDE ASSOCIATION STUDIES  
Genome-wide association studies (GWAS) simultaneously analyse a large 
number of genetic variants across the entire genome in unbiased hypothesis-free 
manner. GWASs are based on the assumption that particular genetic variants that 
occur in diseased individuals more frequently than in healthy controls contribute to 
the heritability of the disease. The sequence variants may have a direct effect on gene 
function but more commonly they are simply a marker for some other nearby 
pathogenic variant that itself may not be included in the screen. The most common 
type of DNA sequence variation within a population is single-nucleotide 
polymorphisms (SNP), therefore, in GWAS the markers for genetic variants are read 
using an SNP array.  
GWAS usually compares SNPs of two large groups of individuals: people 
diagnosed with disease and similar people without disease. Each of the SNPs is then 
thoroughly examined to determine if the allele frequency is significantly different 
between these two groups. The result is usually reported as an odds ratio: a ratio of 
odds of having disease for individual with a specific allele against the odds of having 
disease for individual without the same allele. The significance of the result is 
measured in terms of p-value that is normally calculated using a chi-squared test. The 
final results of genetic association studies are normally presented in a form of 
Manhattan plot (Figure 3.1); it shows the negative logarithm of p-values against the 
corresponding genomic locations. Each point on the Manhattan plot represents the 
individual SNP with its genomic positions plotted along the X-axis and significance 
level (negative logarithm of p-value) along the Y-axis. The SNPs with the most 
significant association will stand out on the plot as the smallest p-values will be 
plotted as a greatest number on Y-axis (due to the negative logarithm conversion). 
However, as GWAS compares thousands, sometimes, millions of SNPs, the analysis 
is prone to both false positives and false-negatives resulting in false associations. 
Therefore, the p-value threshold for GWAS is adjusted for multiple comparisons 
using the Bonferroni correction method. Note that although this stringent analysis 
reduces false positives, it can also increase the number of false negatives because in a 
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multigenic sporadic disorder most genetic associations are likely to have low odds 
ratios (Pearson and Manolio 2008).  
To make more use of the GWAS data we have I have used complementary 
data from a worm genetic modifier screen along with further analysis to reveal some 
previously unidentified associations. 
 
3.1.2 GWAS IN AD 
The various genome-wide association studies of AD completed to date have so 
far proved to be less consistent (Bertram and Tanzi 2009), with the exception that all 
studies coherently reported the strong association of ApoE4 locus with disease. The 
first generation of high-resolution, collaborative GWAS in AD was published in 2009 
and reported four genes (ApoE, CLU, CR1 and PICALM) with significant association 
with AD (Harold, Abraham et al. 2009, Lambert, Heath et al. 2009). Finding of three 
previously undiscovered genes demonstrates the potential of GWAS to identify new 
genetic variants that may play a role in the pathogenesis of sporadic AD. 
Additionally, a growing body of evidence has suggested that these genes may be 
involved in amyloid cascade and alter the clearance, trafficking or production of 
Aβ peptide. The second generation of GWAS in AD identified a further 17 risk genes; 
Figure 3.1 Manhattan plot (adapted from (Harold, Abraham et al. 2009). The 
significance of GWAS findings is displayed as a collection of points, each represented 
by chromosomal position on x-axis and –log10 GWAS p-value on y-axis. 
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therefore, at the time of this research there are a total 21 of risk genes associated with 
AD (Hollingworth, Harold et al. 2011, Lambert, Ibrahim-Verbaas et al. 2013).  
It is important to note that the genes that are known to be involved in FAD 
were absent from the GWAS findings; this may undermine the role of Aβ in 
pathogenesis of sporadic AD. The absence of these genes may be due to the fact that 
GWAS lacks sufficient sensitivity to detect rare variants, which might have low 
frequency of occurrence but in turn have higher penetrance. Obviously, one way to 
overcome this issue is to increase the size of samples by recruiting more subjects or 
by using higher resolution SNPs array.  However, in this work a different approach is 
used and is described below. 
In order to evaluate the importance of Aβ in the aetiology of sporadic AD, we 
intend to compare the findings of GWAS in AD with the results of a genome-wide 
knockdown screen in an animal model organism that reports solely Aβ toxicity, such 
as the nematode worm Caenorhabditis elegans. There are many advantages of using 
C. elegans as a model system of AD. For example, transgenic worms can have easily 
observable phenotypes caused by Aβ toxicity. Like mammals, they have complex 
biochemical pathways, most of which are well conserved. Worms are inexpensive to 
maintain and have a short lifespan, thereby facilitating large-scale laboratory studies. 
C. elegans was the first eukaryote with a nervous system to have its genome 
sequenced (Consortium 1998) and is the only organism for which we have a complete 
nervous system wiring diagram (White, Southgate et al. 1986). Moreover, the genetic 
characteristics of C. elegans have been well studied (Hillier, Coulson et al. 2005)  and 
the utility of RNA interference in C. elegans discovered in 1998 (Fire, Xu et al. 1998) 
has been extensively applied affording the opportunity to silence expression of target 
genes (Kamath and Ahringer 2003).  
 Additionally, with purpose of identifying new potential risk genes, we 
propose to include the GWAS findings of borderline significance (GWAS “grey 
zone”, p-values threshold below 10-5) together with the genes with conventional 
GWAS significance (p-value<10-7, GWAS “white zone”). Although this extended list 
of candidate genes will contain false positive results, it might additionally include 
previously unidentified risk genes that may contribute to the pathogenesis of sporadic 
AD. We hypothesize that if Aβ toxicity is indeed involved in sporadic AD, then we 
expect to see a statistically significant overlap between the list of genes identified by 
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GWAS and the list of genes derived from the genome-wide knockdown screen. 
However, if the leading cause of sporadic AD were distinct from the accumulation of 
Aβ peptide, we would expect the overlap between those two lists to occur due to 
chance. 
 
3.2 MATERIALS AND METHODS 
  
 The effect of Aβ toxicity on neurodegeneration in AD was studied using C. 
elegans model organism, which can be genetically modified to express human 
Aβ peptide. 
 
3.2.1 DESIGN OF THE EXPERIMENT (WORM SCREEN) 
In order to study the aggregation of Aβ, C. elegans transgenic lines have been 
generated expressing human β-amyloid (Aβ). In the C. elegans transgenic line 
CL4176 Aβ is expressed in muscle cells using the myosin promoter (Drake, Link et 
al. 2003). The identification of the pathways that are involved in the mechanism of 
Aβ toxicity in C. elegans can be achieved by employing genome-wide RNA-mediated 
interference (RNAi) as part of a genetic modifier screen. 
 
3.2.1.1 C. ELEGANS  STRAINS 
The C. elegans strain CL4176 [smg-1(cc546ts) dvIs27(pAF29 Pmyo-
3::Aβ42+pRF4)], expressing Aβ in the body-wall muscle, was used as a model of Aβ 
toxicity (Link 1995). Briefly, in order to create the temperature-dependent induction 
of Aβ, mRNA-surveillance system of the C. elegans (the smg system) was used to 
generate transgenic constructs. At non-permissive temperatures (23 oC) this system is 
inactive and allows the induction of transgene mRNA for human Aβ42. The inducible 
Aβ-expressing transgene was introduced to the strain CL4176 by inserting an Aβ 
minigene fragment into expression vector pPD118.60. The non-Aβ expressing strain 
CL802 [smg-1(cc546ts) rol-6(su1006)] was used as a background strain. Both 
CL4176 and matched transgenic control CL802 were cultured at permissive 
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temperature for smg mutation of 16 oC (Link, Taft et al. 2003) on solid peptone 
nematode growth media (NGM) as described in (Brenner 1974). 
 
3.2.1.2 RNA INTERFERENCE (RNAi) SCREEN FOR C. ELEGANS 
In the genome-wide RNAi screen, the worms were fed bacteria Escherichia 
coli (E. coli) carrying RNAi-expressing plasmids that target a particular gene of 
interest; typically the specific destruction of the target gene’s mRNA results in 
reduced expression of the gene product. 
The genome-wide RNAi modifier screen in C. elegans was performed by Dr. 
Aileen Moloney, working in the laboratory of Professor David Sattelle in the MRC 
Functional Genomics Unit in The University of Oxford. The screen was undertaken 
using the RNAi library generated in E. coli and obtained from Source BioScience 
(formerly GeneService, Nottingham, UK). The library was first generated by Dr. Julie 
Ahringer laboratory in Cambridge (Kamath and Ahringer 2003).  
Briefly, the construction of bacterial RNAi library first involves the PCR 
amplification of genomic DNA fragments from the target genes, then cloning those 
PCR products into the L4440 RNAi feeding vector and consequently transforming 
them into bacterial strain HT115 (Fraser, Kamath et al. 2000). Separate clones of the 
HT115 E.coli strain generated in this way were cultured overnight at 37 oC in 500 µl 
LB medium with 50 µg/ml ampicillin. Similarly, control E.coli containing empty 
plasmids (without an RNAi insert) were cultured simultaneously and under the same 
conditions. Those bacterial strains were transferred drop-wise onto solid NGM agar 
plates, containing 25 µg/ml carbencillin and 1 mM IPTG, and incubated overnight at 
room temperature. Worm embryos collected from synchronized worm cultures 
(Strange, Christensen et al. 2007) were transferred onto the NGM agar plates with 
either RNAi-expressing bacteria or control bacteria, and left for 48 h until they reach 
the third larval stage. The expression of Aβ in CL4176 C. elegans strain was induced 
by upshifting the surrounding temperature to 23 oC for 24 h and subsequently the 
worms were observed under the microscope and scored for the paralysis phenotype. 
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3.2.1.3 PRIMARY AND SECONDARY SCREEN TO DETECT RNAI MODIFIERS 
After the induction of Aβ expression by temperature uplift, the effect of 
RNAi-expressing clone on the severity of resulting paralysis phenotype in C. elegans 
strains was evaluated in triplicate and compared with triplicate wells containing 
worms fed control bacteria with empty plasmid. Additionally, as a positive control for 
RNAi activity, each plate included a well with RNAi-expressing bacteria that targeted 
the unc-22 gene, a regulator of muscle contraction; unc-22 RNAi normally resulted in 
uncoordinated twitching behaviour. Therefore, any plate with worms that were fed 
unc-22 RNAi bacteria, but nevertheless failed to twitch, was discarded and similar 
experiment repeated again. 
The locomotor behaviour of worms was analysed in triplicate at two distinct 
time points. The first experiment, performed 22 hours post-induction, was aimed at 
identifying the enhancers of Aβ toxicity by checking if worms, assessed in each 
triplicate for each RNAi clone, were still paralysed under the conditions when they 
would otherwise be moving normally, for example when Aβ-expressing worms were 
fed control bacterial cultures. Moreover, only Aβ-expressing worms have displayed 
such a phenotypic modification, and none of the worms from control strain CL802, 
without the expression of Aβ, have demonstrated a similar paralysis. Therefore, 
clones that induce a non-specific paralysis phenotype in worms were not considered. 
At the later time point, at 32 hours, the Aβ-expressing worms were expected to be 
paralysed so any RNAi clones that protected the locomotor function of worms, in 
triplicate wells, were defined as suppressors of Aβ toxicity. 
 Secondary screen have been repeated three times for each modifier from the 
primary screen, each repeat was undertaken in triplicate wells. Hourly observations of 
locomotor behaviour were used to generate the paralysis curves, where at each time 
point the percentage of worms that have not yet been paralysed in each plate is plotted 
against time from temperature upshift initiation. These paralysis curves were later 
analysed using the Kaplan-Meier estimator, a non-parametric maximum likelihood 
estimator of the probability that a particular worm in a given population of worms 
will have not be paralysed after a particular time point. The statistical significance of 
the estimation was calculated using Mantel-Cox Log Rank test based on p-value cut-
off of 0.05. 
 
CHAPTER 3: USING A WORM MODEL OF Aβ TOXICITY TO DERIVE MORE INFORMATION FROM HUMAN GWAS IN 
ALZHEIMER’S DISEASE 
 26 
3.2.2 LIST OF GWAS FINDINGS IN AD 
 The list of GWAS findings in AD was obtained from the Database of 
Genotype and Phenotypes (dbGaP) of the National Center for Biotechnology 
Information (Mailman, Feolo et al. 2007); dbGaP is a public repository of phenotype, 
genotype and association data as identified by the published studies. The data were 
accessed in June 2013 using the keywords “Alzheimer disease” for the disease and the 
results were displayed only with p-values <10-5 
(http://www.ncbi.nlm.nih.gov/projects/gapplusprev/sgap_plus.htm).  
 
3.2.3 HUMAN ORTHOLOGUES OF WORM GENES 
In order to compare the list of genes from the worm screen with GWAS 
findings, the first step of the analysis was to assign a human orthologue to each worm 
gene that modified the paralysis phenotype in the screen. In general, orthologues are 
the genes in a different organism that have evolved from a common ancestral gene by 
a specification event and they normally maintain the same function (Koonin 2005). 
As mentioned before, the worm genes are highly conserved on molecular and cellular 
levels with mammalian genes.  
The human orthologues of worm screen hits were identified using 
EnsemblCompara (http://www.ensembl.org), a phylogeny based orthology prediction 
method that collects the genomic information from external biological resources 
(Flicek, Ahmed et al. 2013). Only results with more than 25% of identity with respect 
to worm genes sequence were chosen (Lechner, Findeiss et al. 2011). Due to the 
definition of orthology in principal, evolutionary development of a certain gene can 
lead to the gene in one organism having multiple orthologues in another organism. So 
in a case when there was more than one human orthologue for a given worm gene, 
only the gene with highest percentage identity was chosen. However, in nearly 15% 
of cases there were multiple human orthologues with the same percent identity for a 
particular worm gene; in these cases a single orthologue was selected using 
MetaPhylogenyBasedOrthologs (MetaPhOrs) (Pryszcz, Huerta-Cepas et al. 2011) 
based on the consistency score. MetaPhOrs is a global public repository of 
phylogeny-based orthology predictions that calculates a consistency score based on 
the combined seven popular homology prediction sources of phylogenetic 
information. In MetaPhOrs, consistency score is a ratio of number of methods 
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confirming given relationship between particular protein pair and ranges from 0 to 1. 
This score is equal to 0 if none of the databases predict a particular orthology 
relationship and approaches 1 if predicted orthology is consistent among all the 
available data sources. Therefore, as a rule preferred orthologue out of multiple 
human orthologues for a given worm gene was chosen based on the highest 
consistency score. 
 
3.2.4 GENE ONTOLOGY ENRICHMENT ANALYSIS 
Gene ontology (GO), which consists of species-neutral terms representing 
gene product properties, is routinely used to describe gene product function or 
location. In order to interpret the functional profile of the worm screen hits, gene 
ontology enrichment analysis was implemented using the clueGO plugin for 
Cytoscape that analyses and visualizes a functionally organized biological term 
network for the list of genes (Bindea, Mlecnik et al. 2009). 
 
3.2.5 GENERATION OF GENE NETWORK 
The straighforward comparison between list of genes in GWAS white+grey 
zone and list of human orthologues of worm screen hits have demonstrated the lack of 
similarity, although we have discovered that 6 of the human orthologues of worm 
screen hits interact directly with genes in GWAS list. The comparison was performed  
using the BioGrid database (http://thebiogrid.org, v. 3.2.96) that contains the genetic 
and protein interaction data compiled from various studies and manually curated 
(Stark, Breitkreutz et al. 2006). The lists of genes in GWAS white+grey zone and the 
human orthologues of worm screen hits were analysed using data from the BioGrid 
database (v.3.2.96); specifically the primary lists of genes have been supplemented 
with genes encoding the first-degree physical interactors (+1 interactome) of the 
protein products of genes. 
 
3.2.6 STATISTICAL SIGNIFICANCE OF OVERLAP 
The statistical significance of the overlap between GWAS +1 interactomes 
and worm +1 interactome was determined by generating random lists of genes and 
comparing the experimental overlap with randomly generated. To do so, for each 
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worm screen gene we have randomly generated many +1 interactomes of the same 
size as the interactome of the gene being tested (Figure 3.2). 
Furthermore, in order to obtain a statistically significant result we have 
generated 1000 random worm +1 interactomes of the equivalent size for each gene in 
the worm screen list. Then, for each gene in the worm list the p-value was calculated 
based on the number of times that the overlap of the GWAS +1 interactome with a 
random worm +1 interactome was bigger or smaller than the overlap with an 
interactome of the appropriate size for that particular gene. To estimate the 
significance of our findings, we have also repeated this analysis 100 times for 60 
randomly generated worm genes (Figure 3.3).  
Overall, the computational algorithm to estimate the statistical significance of 
the overlap between +1 interactome for any particular worm screen hit “g” and 
GWAS +1 interactome is depicted on Figure 3.3 and follows the steps below: 
Algorithm 1: Estimating the statistical significance of the +1 interactome overlap 
1. For each human orthologue of the hits from the worm screen, “g”, the size of its 
+1 interactome “N” was evaluated. 
2. Using a Monte Carlo approach, we have randomly generated the +1 interactome 
of size “N” (Figure 3.2). This goal was accomplished by repeatedly concatenating 
the +1 interactome lists of randomly-chosen human orthologues of worm genes 
until the accumulated random interactome reached “N” entries. If the +1 
interactome of the first randomly selected worm gene exceed the size 
requirements, then only the first “N” genes in its +1 interactome were considered. 
Figure 3.2 Generation of equivalent random +1 interactomes (Khabirova, Moloney et 
al. 2014). Random +1 interactome (right) was generated in a way that it contains the 
same number of genes (in this example, N=11). Human orthologue of worm-screen 
hits is labeled with “1” (left). Random human genes with a worm orthologue are 
labeled with “2” (right). The +1 interactors are represented by small green dots. 
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3. The overlap (number of identical entries in both lists) between +1 interactomes of 
randomly generated worm list and GWAS list was quantified.  
4. Step 2 and 3 repeated N = 1000 times, producing 1000 Monte Carlo overlap 
scores “MCi,g”, where i ∈ 1,2…N.  
5. The random overlap score derived from this Monte Carlo approach “MCi,g” is 
compared with the experimental overlap score “Exp.scoreg” between +1 
interactomes of worm modifier gene g and GWAS. The number of times that 
MCi,g ≥  Exp.scoreg is counted as “nright,g” (Figure 3.4, panel A). Likewise, 
number of times when MCi,g ≤ Exp.scoreg is counted as “nleft,g” (Figure 3.4, panel 
B). 
Figure 3.3 Computational pipeline for determining the significance of the overlap 
between the +1 interactomes of worm modifier genes and GWAS white+grey zone 
genes (Khabirova, Moloney et al. 2014).   
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6. The p-value of the +1 interactome overlap for experimental gene “g” was 
calculated as a ratio of either “nright,g” or “nleft,g”, whichever is smaller, to the total 
number of simulations N, thus simulating the one-tailed test. 
 
3.3 RESULTS 
 
The expression of human Aβ in C. elegans, some but not all of which is 
secreted out of the muscle cells, leads to the aggregation of Aβ in muscles and results 
in progressive paralysis. Similarly, several studies have shown that Aβ is also 
deposited intramuscularly in Inclusion Body Myositis, a progressive human muscular 
disorder (Dostal and Link 2010). Moreover, the line that we used was designed to 
exhibit temperature-inducible expression of Aβ allowing toxic peptide expression to 
be initiated at specified times. The age-specific and synchronised expression of Aβ 
through temperature uplift results in a reproducible paralysis phenotype. Overall, 
exhaustive primary and secondary screens have been implemented to identify RNAi 
clones that significantly suppress or induce the paralysis phenotype in C. elegans. 
 
3.3.1 RNAI WORM SCREEN 
The identification of the pathways that are involved in the mechanism of 
Aβ toxicity in C. elegans can be achieved by employing genome-wide RNA-mediated 
Figure 3.4 Estimating the significance of highly overlapping/poorly overlapping +1 
interactomes (Khabirova, Moloney et al. 2014). The +1 interactome of human 
orthologues of worm genes can overlap more than expected by chance (panel A, 
contributing to nright) or less than expected (panel B, contributing to nleft). The p-value 
of overlap can be derived by generating 1000 random +1 interactomes.  
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interference (RNAi) as part of a genetic modifier screen. In the genome-wide RNAi 
screen, the worms are fed bacteria (Escherichia coli) that carry RNAi-expressing 
plasmids which target a particular gene of interest; typically the specific destruction 
of the target gene’s mRNA results in reduced expression of the gene products. Genes 
that modify the severity of the worm locomotor phenotype when knocked-down were 
considered “hits” in this screen.  
It was determined that 7970 human protein-encoding genes had orthologues in 
C. elegans. The transcription level of each of those genes was systematically knock 
down by using the Ahringer C. elegans RNAi feeding library (Kamath and Ahringer 
2003). After the induction of Aβ expression by temperature uplift, the resulting 
paralysis phenotype was evaluated in the presence of each genetic knockdown in 
triplicate and at two distinct time points. Identical C. elegans transgenic strains that 
did not express Aβ expression were used as controls.  
It has been identified from the Kaplan Meier estimator plot that induction of 
Aβ expression in worms of 48 h old (in their third larval stage) results in 50% of the 
worm population being paralysed 30 h post induction. Thorough primary and 
secondary screens were used to identify the RNAi clones that either significantly 
suppress or enhance the Aβ-induced paralysis phenotype (p-value<0.05, 4 biological 
replicates). The modifier clones were subsequently positively identified by DNA 
sequencing. Out of the initial 7970 worm genes, 78 have been identified as 
significantly suppressing the Aβ-induced paralysis and only three genes specifically 
enhanced the Aβ-induced paralysis (Appendix A.1).  
Furthermore, when we analysed the data looking for gene ontology 
enrichment (using the clueGO plugin for Cytoscape) we found a number of labels that 
were over-represented in the list of the worm screen hits, such as ATP synthesis, 
purine metabolism, protein binding and chaperone activity, and components of the 
translational machinery (Appendix A.2). 
 
3.3.2 PREPARING THE LIST OF GENES FOR COMPARISON 
Using the pipeline of identifying the human orthologues for worm genes 
described in 3.2.3, corresponding human orthologues were found for 61 out of 78 
worm modifier genes.  
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The list of GWAS findings in AD with p-value<10-5 was obtained from 
dbGaP as described in 3.2.2; it consists of 63 genes (Appendix A.3) and will be 
referred below as “GWAS white+grey zone”.  
 
 
3.3.3 GENE INTERCONNECTIVITY (NETWORK ANALYSIS) 
 Given the list of 61 human orthologues of worm screen hits and comparing it 
with 63 genes in GWAS white+grey zone, we expect significant overlap between 
these two gene lists as the worm screen reports exclusively on Aβ toxicity and GWAS 
findings account for the genes involved in the pathogenesis of sporadic AD. However, 
we found no overlap between these two gene lists.  As a matter of fact, the gene 
ontology annotations linked to the GWAS white+grey zone genes and to the human 
orthologues of worm modifier genes do not show any significant resemblance (gene 
enrichment analysis was performed using WEB-based GEne SeT AnaLysis Toolkit 
(Zhang, Kirov et al. 2005)).  
 However, if we consider the hypothesis that the GWAS finding in AD and 
worm screen hits might be related to each other on a higher level and act in the same 
pathways, we can gain some valuable insights into the role of Aβ in sporadic AD. 
Indeed, when we compared the direct physical interactors of genes in GWAS 
white+grey zone and human orthologues of worm screen hits, we have discovered 
that 6 of the human orthogues interact directly with genes in GWAS list. The 
comparison was performed  using the BioGrid database (v. 3.2.96) that contain the 
genetic and protein interaction data compiled from various studies and manually 
curated (Stark, Breitkreutz et al. 2006). 
 In order to find the genes in the worm modifier list that interact with the genes 
in GWAS list in a statistically significant manner, we have combined the candidate 
gene lists with the corresponding genes encoding the first-degree physical interactors 
(+1 interactome) using BioGrid database as described in 3.2.4. Whereas not every 
gene was annotated in BioGrid database, 60 out of 61 worm genes and 52 out of 63 of 
GWAS gene lists were present. As a result, GWAS +1 interactome (Figure 3.5) 
contains genes in GWAS white+grey zone and all the genes (Figure 3.5, circles) with 
which they physically interact (Figure 3.5, blue lines). Accordingly, the worm +1 
interactome (Figure 3.6) is composed of human orthologues of worm modifier screen 
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hits and their direct interactors. The gene networks were constructed and visualized 
using Cytoscape (Shannon, Markiel et al. 2003).  
 It is clear that the two +1 interactomes (Figure 3.5 & 3.6) are different in term 
of relative size; genes in worm +1 interactome have many more interactive genes as 
compared to GWAS +1 interactome. In fact, on average each human orthologue of 
worm screen hits have 53 interactors while genes in GWAS list have less than 14.  
Whether or not the human orthologues of worm screen hits were significantly 
more highly interconnected than one would expect by chance was determined by 
comparing the size of the observed +1 interactomes of these genes with the simulated 
+1 interactomes of a randomly generated list of genes.  
Our approach was to rank all the genes in BioGrid database according to their 
degree of node (number of interactors). We then assessed whether the human 
Figure 3.5 GWAS genes +1 interactome (Khabirova, Moloney et al. 2014)). The 
network contains the first-degree physical interactors (circles) of 52 GWAS genes 
with intermediate and high significance  (p<105).  There were in total 703 
interactions (blue lines) in the +1 interactome of 52 genes in the GWAS white+grey 
zones. Circle size and colour is proportional to the number of physical interactions 
associated with each gene product, where green colour represents fewer interactions 
whereas red colour indicates higher interconnectivity. 
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orthologues of worm screen hits tended to partition into the more highly 
interconnected bins.  However, the set of human orthologues of worm genes consisted 
of 7970 entries out of the 13928 genes in the BioGrid database at the time of the 
analysis. If we had simply clustered these 13928 genes into bins of equal size, then 
bias could be introduced if the human orthologues worm genes as a whole were more 
or less interconnected than the average human gene. We then clustered this ranked list 
of all human genes into 10 bins in such a way that each bin contains the same number 
of human orthologues of worm genes (specifically 797 genes in each bin). For 
instance, the most highly interconnected 952 human genes were assigned to the first 
bin, of these 797 were human orthologues of worm genes; in the same way the bin 
boundaries for the all the genes in BioGrid database were defined, resulting in bin 
boundaries as listed: 1-952, 953-2006, 2007-3175, 3176-4403, 4404-5735, 5736-
Figure 3.6 Worm genes +1 interactome (adapted from (Khabirova, Moloney et al. 
2014)). The +1 interaction network was constructed for the human orthologues of the 
60 worm RNAi screen hits (each circles represent a gene product). There were in total 
3191 interactions (blue lines) in the +1 interactome of the 60 worm-screen genes with 
human orthologues. Circle size and colour is proportional to the number of physical 
interactions associated with each gene product, where green color represents fewer 
interactions whereas red colour indicates higher interconnectivity. 
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7134, 7135-8624, 8625-10200, 10201-12104 and 12105-13928. As a control 
distribution, we generated 100 lists containing 60 randomly selected human 
orthologues of worm genes using Monte-Carlo approach (Metropolis and Ulam 
1949). 
The distribution of gene numbers per bin is shown on Figure 3.7. The y-axis 
represents the logarithmic change of number of genes that falls into each bin as a 
percentage and x-axis shows the bin boundaries of gene ranking in a log scale. As 
anticipated, genes from randomly generated lists fall into each bin with equal 
frequency (Figure 3.7, triangles). By contrast, the highly interacting property of genes 
in worm lists create a skewed linear distribution with more than 50% of genes falling 
into the first bin with the most highly interconnected genes (Figure 3.7, diamonds). 
 It is notable that the genes in worm list demonstrate the power law distribution 
(meaning that relative chance in one quantity results in a proportional relative change 
in other quantity) so that we can approximately fit a linear regression line (gradient -
1.1, R2 = 0.6) to a log-log plot of bin boundaries of gene ranks vs. frequency of 
observation. In order to establish if the distribution of worm genes interconnectivity is 
Figure 3.7 Distribution of rankings of worm genes (Khabirova, Moloney et al. 2014). 
The log of the gene ranking bin boundaries is presented in the x-axis in a decreasing 
order of gene-product connectedness from left to right. The y-axis represents the log 
of the fraction of genes that fall within each bin (where 100% is 60 genes). The 
dashed line represents the linear regression for the worm screen results. The results of 
the screens are shown as black diamonds and results of random simulations are shown 
as empty triangles 
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significantly different from the random distribution we performed two-tailed 
Student’s t-test (Rice 2006), comparing the gradient of the experimental regression 
line with the randomly generated data in the Monte Carlo simulations. The resulting 
p-value of 0.004 confirms that the genes in our worm screen list are indeed more 
highly interconnected as compared to a similar collection of random genes. 
 In order to check whether the bias towards the highly interacting genes is a 
common feature of worm RNAi screens, the equivalent analysis was repeated for 
three published worm RNAi screens of human neurodegenerative diseases (modelling 
polyglutamine aggregation (Nollen, Garcia et al. 2004), tau (Kraemer, Burgess et al. 
2006) and alpha-synuclein pathology (van Ham, Thijssen et al. 2008) as mentioned in 
1.1.2). The resulting distribution of gene interconnectivity in various worm screens is 
consistent with our results and characterized by the skew towards highly 
interconnected genes (Figure 3.8 A-C).  
Figure 3.8 Distribution of rankings of worm models of neurodegenerative diseases 
(Khabirova, Moloney et al. 2014). A) polyglutamine screen; B) α-synuclein screen; 
C) tau screen; D) GWAS candidate white+grey zone genes for AD. The log of the 
gene ranking bin boundaries is presented in the x-axis in a decreasing order of 
gene-product connectedness from left to right. The y-axis represents the log of the 
fraction of genes within each bin (where 100% is 135, 23, 22 & 52 genes for panels 
A, B, C & D respectively). The dashed line shows the linear regression for the 
worm screen results. The results of the screens are shown as black diamonds and 
results of random simulations are shown as empty triangles.  
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Using one-tailed Student’s t-test we found that the gradient of the fitted 
regression lines was significantly different from randomly generated data in all three 
worm screens, producing the p-value=0.0002 for polyQ screen (Figure 3.8, panel A), 
p-value=0.04 for alpha-synuclein screen (Figure 3.8, panel B) and p-value=0.04 for 
tau screen (Figure 3.8, panel C). By comparison, the gradient of the regression line 
fitted to the distribution of interconnectivity of genes in GWAS list was equal to zero, 
which is equivalent to the randomly generated population of genes (p-value=0.22, 
Figure 3.8, panel D).  
 As we have discovered, there exists the potential bias towards the highly 
interconnected genes in the results of all examined worm modifier screens, including 
our own. Under these circumstances, the straight forward analysis of the overlap 
between the worm screen and GWAS +1 interactomes is not possible due to the fact 
that some of the worm genes have many more interactors as compared to the genes in 
GWAS list and therefore they are likely to create the overlap simply by chance. For 
instance, a single gene in the list of human orthologues of worm screen hits, namely 
HSPA8, accounts for more than 30% of the overlap between worm and GWAS +1 
interactomes. Therefore, a different method was developed, as described below, to 
compare the overlap of worm and GWAS +1 interactome and determine if it is 
significant or not. 
 
3.3.4 COMPARING WORM AND GWAS INTERACTOMES 
In order to compare worm and GWAS interactomes and overcome the bias 
towards highly interacting genes in the worm list, we have developed the following 
Monte Carlo method: for each worm screen gene we have randomly generated +1 
interactome of the same size as the interactome of the gene being tested as described 
in 3.2.5. Briefly, the statistical significance (p-value) of the overlap between +1 
interactome of each worm screen modifier hit and GWAS +1 interactome was 
estimated by first generating 1000 random worm +1 interactomes of the same size as 
the experimental gene. The p-value for each gene in the list of worm screen hits was 
determined by counting the number of times the overlap between experimental +1 
interactome with GWAS +1 interactome was either greater or smaller that the overlap 
between a random +1 interactome with GWAS +1 interactome. Furthermore, to 
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evaluate the significance of these findings, the above-mentioned analysis was 
repeated 100 times for each of the worm gene, resulting in the generation of 100 
random lists of 60 worm genes. 
As a result, Monte Carlo simulations of 100 random lists of 60 worm genes 
have shown that on average 3.14 genes (confidence interval ±0.34) exhibit the +1 
interactome overlap with GWAS +1 interactome that is significantly different than 
expected by chance at the significance level p-value<0.05 (Appendix A.4). This result 
is consistent with the expected number of genes with non-random overlap with p-
value<0.05 occurred by chance when performing multiple comparisons (60 genes ∙  0.05 = 3 genes). 
 By contrast, the analysis of experimental worm screen list has demonstrated 
that 7 worm genes had a significantly non-random +1 interactome overlap with the 
GWAS network. Examining 100 runs of Monte Carlo simulations, we have 
discovered that only 5 simulations resulted in 7 or more genes having non-random +1 
interactome overlap, giving the p-value=0.05 for our experimental observation. 
  
3.3.5 GENES WITH SIGNIFICANT +1 INTERACTOME OVERLAPS 
Looking closely into the 7 experimental worm genes with non-random 
+1interactome overlap, we have noticed that 3 genes (NOP56, PSMA1 and RPL10L) 
had a lower +1 interactome overlap with GWAS network that one would expect by 
chance (Figure 3.9). In comparison, the remaining four genes had the +1 interactome 
overlap with GWAS +1 interactome that is significantly larger than expected by 
chance. 
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Figure 3.9 Venn diagram of the non-random overlap for genes from worm screen. Figure 3.9  i r  indicating the degree of the +1 interactome overlap for 
GWAS white+grey genes and each of the significant genes from the worm screen 
(Khabirova, Moloney et al. 2014). Seven genes from worm screen have been 
identified as having +1 interactome that overlap more or less than one would expect 
by chance with GWAS +1 interactome. Four of them (left panel) overlap more and 
three less (right panel) than expected. The area of the circle or overlap is 
proportional to the number of genes. The human orthologues of worm genes that 
interact directly with GWAS list are marked with asterisk. 
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Surprisingly, three of those genes (TCP1, CCT8 and MOB4) are constituents 
of the same chaperone complex TRiC/CCT and fourth gene actin (ACTB) is a major 
folding substrate of that particular chaperone complex (Goudreault, D'Ambrosio et al. 
2009, Cong, Baker et al. 2010). Moreover, all three genes that constitute the 
chaperone complex have a direct interaction with a single gene STK24 in GWAS grey 
zone gene list (Goudreault, D'Ambrosio et al. 2009) as shown on Figure 3.10. 
 
3.4 DISCUSSION 
 
Genome-wide association studies have provided some insight into the 
pathogenic pathways and genes involved in sporadic AD but the exact pathogenesis 
of this disease is still unknown. However, none of the genes implicated in familial AD 
are associated with the risk variants according to the number of GWAS in sporadic 
AD. These observations raise doubts about the involvement of Aβ toxicity, which 
clearly plays a role in the pathogenesis of familial AD, in a more complex case of 
sporadic AD. In order to further investigate this issue, we have used an invertebrate 
Figure 3.10 The interaction network of 4 significant worm genes (Khabirova, 
Moloney et al. 2014). Four human orthologues of worm screen hits (MOB4, TCP1, 
CCT8, ACTB) have +1 interactome that overlap more than expected with +1 
interactome of GWAS gene list. Two of those genes form the abundant cytoplasmic 
TRiC/CCT chaperone complex, third gene (MOB4) interact closely and fourth 
(ACTB), along with tubulin, is a major substrate of the same chaperone complex. 
TRiC/CCT interacts with STK24 and PP2a to form a complex that regulates the 
MAPK pathway.  This network of interactions may have a bearing on tau 
phosphorylation and neuronal regeneration. 
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model system reporting exclusivity on Aβ toxicity. This was done by implementing 
the genome-wide RNAi screen in C. elegans and finding the set of worm gene 
transcripts that modify the Aβ-induced paralysis phenotype. 
The goal of current analysis was to compare the results of worm modifier 
screen with GWAS finding in sporadic AD of borderline significance. The initial 
straightforward comparison has shown that none of the genes in GWAS white+grey 
zone is identical to the 61 human orthologues of worm modifier genes. The absence 
of genes associated with Aβ toxicity may suggest that, at least for predominantly 
Caucasian population, sporadic AD is governed by different pathogenic mechanism. 
Nevertheless, we have noticed that human orthologues of 6 worm screen hits 
presumably had direct interactions with genes in GWAS white+grey zone. So we 
decided to further investigate in this direction. 
The first noticeable property of the worm modifier genes was that they are 
more likely to have a human orthologue than expected by chance. This high level of 
conservation may implicate the involvement of core and essential genes in promoting 
the profound toxic effect of Aβ aggregates.   
Furthermore, examining closely the +1 interactome of worm screen hits 
reveals the highly interconnected nature of these genes. In particular, the distribution 
of interconnectivity according to the gene ranking has clearly shown the power law 
relationship as can be seen in Figure 3.7. For the worm screen hits, the gradient of 
regression line fitted to this distribution was significantly different from the gradient 
of random distribution, where the frequency of occurrence of a gene is independent of 
its interconnectivity.  
We have additionally examined the genes from other worm modifier screen of 
neurodegenerative diseases (polyQ, alpha-synuclein and tau) and have observed 
similar skewed distributions of interconnectivity. One potential explanation of the 
bias towards highly interacting properties of worm screen hits could be outlined as a 
“sociological bias” (Chen, Aronow et al. 2009). The main idea of this hypothesis is 
that the previous worm screens, which identified similar set of genes, have promoted 
further interest in those genes within the field and which has in turn lead to more 
interaction data being collected and deposited in BioGrid database. Indeed, we have 
found that worm screens for Aβ and polyQ have produced 27 common genes, with 20 
of them having highly interconnected properties (fall into first bin in plots on Figure 
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3.7 & 3.8). However, the presence of sociological bias does not discredit our 
subsequent results as we have carefully compensated for any differences in network 
connectivity. 
On the other hand, the alternative hypothesis could be that the genes reported 
by the worm screen do indeed have more highly interacting protein products as 
compared to a random set of human orthologues of worm genes (Goh, Cusick et al. 
2007). It is likely that these highly interconnected gene products, also known as 
protein hubs, have a higher chance to be involved in various biological pathways so 
that they are more likely to modify the disease-related phenotypes in our worm 
genome-wide RNAi screen. Interestingly, the genes in GWAS white+grey zone do 
not have the same highly interacting properties, with their distribution of 
interconnectivity is being similar to the one of random population of genes. However, 
taking into account that we have included the genes with borderline significance to 
GWAS significant findings, this could be explained be the presence of false-positives 
genes. 
In order to evaluate the statistical significance of the overlap between the 
worm and GWAS +1 interactomes we have developed the algorithm as described in 
Figure 3.3. In brief, for each gene in the worm screen hits list the significance is 
determined by observing to what extent the overlap of its +1 interactome with GWAS 
+1 interactome is greater or lesser than expected by chance. We have used Monte 
Carlo approach to generate 1000 random +1 interactomes of the same size as the 
experimental interactome and compute the distribution of overlap scores. As the 
result, 7 genes out of 60 experimental worm genes had the significantly different 
overlap from what one would expect by chance. 
  In particular, three of those genes have +1 interactome overlap with +1 
interactome of GWAS white+grey zone genes smaller than expected by chance, 
indicating that they could be the false positive modifiers of the worm phenotype and 
probably not involved in the human disorder. On the other hand, the remaining four 
genes have shown a greater than expected +1 interactome overlap with genes in 
GWAS white+grey zone. Moreover, two of those genes (TCP1 and CCT8) are both 
components of the same TRiC/CCT chaperone complex and third gene actin beta 
(ACTB) closely interact with it. It is noteworthy that two genes, namely TCP1 and 
ACTB, were identified as modifiers of polyQ toxicity in the RNAi worm screen 
(Nollen, Garcia et al. 2004) whereas CCT8 and MOB4 have not been observed in any 
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worm modifier screens modelling neurodegeneration. This might indicate that Aβ and 
polyQ share common pathological mechanisms, but might also mean that the 
modifiers of TCP1 and ACTB have non-specific effect in the worm model systems. It 
is also worth mentioning that TCP1 level are significantly reduced in foetal Down’s 
syndrome (Yoo, Fountoulakis et al. 2001). Besides, TCP1, CCT8 and MOB4 all 
interact directly with each other and additionally with the kinase STK24, one of the 
genes in GWAS grey zone, which has been associated with axonal regeneration in 
rats (Lorber, Howe et al. 2009). 
 The exact role of TRiC/CCT in the pathogenesis of sporadic AD is still 
unknown. Nevertheless, the fact that RNAi knockdown in the worm protects against 
Aβ-induced paralysis may indicate that this particular chaperone complex is somehow 
mediate Aβ toxicity. However, several studies have shown that the reduction of 
TRiC/CCT chaperone activity has a protective effect (Guisbert, Czyz et al. 2013) and 
speculated that the lower levels of misfolded proteins could activate, or maintain, the 
activity of regenerative pathways. 
 
3.5 CONCLUSION 
 
To summarize, the failure to find a direct overlap between genes implicated by 
GWAS in AD and worm modifier screen hits may suggest that Aβ toxicity cannot be 
considered equivalent to AD. However, implementing the +1 interactome network 
analysis has revealed 7 genes whose +1 interactomes overlap with the GWAS genes 
cannot be explained by chance. Four of these worm genes have exhibited a much 
bigger overlap with the GWAS network than expected by chance; three of these are 
part of cytoplasmic chaperone complex and the fourth is an important substrate of the 
same chaperone.  
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 CHAPTER 4: STUDY OF CIRCADIAN DISRUPTIONS 
IN ALZHEIMER’S DISEASE USING DROSOPHILA AS A 
MODEL ORGANISM 
 
It is widely known that Alzheimer’s disease (AD) is associated with memory 
problems, but the fact that AD is characterized by sleep disturbances as well is often 
omitted. Changes in sleep and behaviour patterns usually present themselves in the 
earliest clinical stages even before the memory problems start (Musiek 2015). 
Furthermore, several studies have suggested that circadian dysregulation may 
contribute to the pathogenesis of AD (Coogan, Schutova et al. 2013, Chen, Possidente 
et al. 2014). However, examining the reciprocal relationships between aging, 
neurodegeneration and circadian behaviour has proved to be a complicated problem 
due to the challenges of performing the experiment at different levels of biological 
system in a freely moving organism. In this chapter, I will describe novel 
collaborative method we have developed to capture molecular and behavioural 
circadian oscillations simultaneously for individual animals and analyse their 
relationships in terms of rhythm, period and amplitude stability. 
 
4.1 INTRODUCTION  
 
 As mentioned before in 1.4.2, patients with AD often have disorganized 
daytime activity patterns and fragmented sleep. Until quite recently, these sleep and 
circadian disruptions were considered to be a symptom of the disease, yet, 
increasingly, the evidence indicates that behavioural and circadian abnormalities 
precede other symptoms and most likely contribute to the pathogenesis of AD 
(Musiek, Xiong et al. 2015). 
 Generally, AD patients experience disturbances in timing and duration of the 
sleep cycle, mainly in terms of increased night time wakefulness and daytime 
sleepiness. Moreover, it has been shown that the duration of rapid eye movement 
(REM) stage of the sleep is significantly decreased in patients with AD as compared 
to the age-matched healthy people, resulting in the cumulative lack of REM sleep 
(Prinz, Peskind et al. 1982). In support of this observation, several studies in 
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transgenic mice have demonstrated that accumulation of Aβ peptides in the brain can 
induce the disruption of sleep patterns even before the characteristic emergence of 
amyloid plaques (Musiek, Xiong et al. 2015). In addition, a recent neuroimaging 
study supports the association between shorter sleep duration and increased Aβ 
depositions in 70 older adults (Spira, Gamaldo et al. 2013). 
 
4.1.1 CIRCADIAN RHYTHMS IN MAMMALIAN SYSTEMS 
Circadian rhythms are endogenous and entrained oscillations of any biological 
process with a period of around 24 hours. A wide range of biological processes and 
activities are controlled by circadian rhythms, including locomotor and feeding 
behaviour and sleep. The endogenous oscillations are driven by molecular and 
cellular circadian clocks, which in turn receive daily corrective signals from the 
environment. Such timekeeping mechanisms help maintain homeostasis and 
synchronize the behaviour with cycles of day and night; providing a competitive 
advantage to the organism by allowing it to predict changes in the physical and social 
environments. The sleep/wake cycle is an important example of a circadian rhythm in 
all mammals including humans. 
In mammals and other organisms circadian rhythms are manifest at the full 
range of biological levels starting with transcriptional and translational regulation of 
genes and proceeding through specific neuronal circuits that underpin the clock 
through to the highest levels of behavioural output. At the molecular level, circadian 
rhythms are governed by internal autonomous circadian oscillators that form negative 
and positive autoregulatory feedback loops. In mammals, the correct functioning of 
the oscillator is sustained by the so-called ‘master’, or central, clock, located in 
suprachiasmatic nucleus (SCN) of the hypothalamus. In addition, peripheral organs 
and tissues of the body also contain molecular clocks, which are controlled, by a 
greater or lesser extent, by the master clock (Mohawk, Green et al. 2012). The master 
clock receives light signals from the retina and synchronizes the peripheral clocks to 
the external subjective day. Even though molecular clocks located in the SCN and 
throughout peripheral tissues are thought to have essentially identical molecular 
architectures, they have a different degree of intercellular coupling. In particular, 
neurons in SCN have a higher degree of intercellular coupling and so form a neuronal 
network that is unaffected by the phase perturbations from internal cues, while 
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peripheral clocks are receptive to adjustments from the SCN clock. As a result of the 
tight coupling of neuronal network in the SCN, the master clock is able to faithfully 
maintain an intrinsic rhythm of about 24 hour (Partch, Green et al. 2014).  
 
4.1.2 CIRCADIAN RHYTHMS IN DROSOPHILA 
Recent studies have shown that circadian clocks are highly conserved 
throughout the animal kingdom, from flies to humans, and have allowed investigators 
to perform genomic analysis of circadian oscillations at the molecular level using 
animal model systems. In particular, much of the progress in this field has been driven 
by experimental work in Drosophila melanogaster (common fruit flies (Prussing, 
Voigt et al. 2013)). Moreover, the first clock gene, called the “Period” gene, was 
discovered in 1971 in a mutagenesis screen in Drosophila (Konopka and Benzer 
1971). This discovery has further on led to the finding of other genes involved in the 
circadian regulation. 
As a result, the basic molecular mechanisms of biological clocks have been 
studied comprehensively in Drosophila and there are many tools available to analyse 
their complex behaviour at the molecular and behavioural levels. Additionally, fruit 
flies have circadian patterns of locomotor behaviour that are easily measurable. For 
example, they have two peaks of locomotor activity (morning and evening) and it has 
been shown that these oscillations remain rhythmic even when external entraining 
cues are removed, such as in constant darkness (Peschel and Helfrich-Forster 2011).   
In Drosophila the central clock relies on the daily expression rhythms of the 
clock proteins period (PER) and timeless (TIM) as shown on Figure 4.1.  
Briefly, heterodimers of the transcription factors CLOCK and CYCLE 
(CLK/CYC) bind to the highly conserved Enhancer box (E-box), which acts as a 
promoter and drive the initial gene transcription of PER and TIM. As PER and TIM 
accumulate in the cytoplasm, they bind together and form dimers. The PER/TIM 
dimers translocate into the nucleus and bind to CLC/CYC and thus inhibiting further 
transcription of PER and TIM. This results in a decline of PER and TIM mRNA 
levels, until the inhibition is removed and cycle starts again. As such, the levels of 
TIM and PER are controlled by a delayed negative feedback, which means that the 
protein products of these genes in fact turn off production of more protein production 
and therefore generate an oscillation over time. 
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The oscillations of circadian rhythms can be visualized non-invasively in 
Drosophila by expression of a firefly luciferase reporter construct under the control of 
the promoter region of a clock protein, such as PER. A particularly effective reporter 
consists of the PER protein fused to luciferase, known as XLG-luc2 (Veleri, Brandes 
et al. 2003).  Feeding these flies with the luciferase substrate (luciferin) results in 
bioluminescence (light emission), with the intensity of emitted light reporting the 
level of the fusion protein (PER). This bioluminescence signal reports the cycling of 
the molecular clock in every cell where it is expressed (Brandes, Plautz et al. 1996).  
At the neuronal level, the central clock in Drosophila is positioned in the 
small ventral lateral neurons (LNvs) located in the lateral brain. Similar to the SCN, 
light signals transfers to LNvs from retinal photoreceptors in the compound eyes and, 
additionally, from extra-retinal photoreceptors within the brain. Interestingly, under 
constant dark condition, the central clock in the fly brain is able to maintain robust 
rhythms of gene expression and locomotor activity. Some studies have shown that 
circadian clocks in peripheral tissues in flies can also sustain robust rhythmicity for at 
least 7 days in cell culture, implying that fly peripheral clocks are not entirely 
dependent on the central clock found in the LNvs; in any case they are less closely 
coupled to the central clock as compared to mammalian systems. In particular, it 
appears that light can penetrate the fly cuticle in peripheral tissues and entrain 
peripheral clocks directly, therefore revoking the necessity of central clock to 
synchronize other oscillators (Glossop and Hardin 2002).  
Figure 4.1 Transcriptional-translational negative feedback loop of central clock 
regulation in Drosophila. Hererodimeric transcription factors CLC and CYC activate 
transcription of PER and TIM by binding to E-box. Stars represent sites of post-
transcriptional control. 
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4.1.3 PERIPHERAL AND CENTRAL CLOCK COMMUNICATION 
 Several lines of evidence have shown that in mammalian system circadian 
clocks comply with the “master-slave” theory, in which peripheral clocks are tightly 
coupled to the central clock and synchronized solely by it in a hierarchical order. 
According to this theory, the central clock in the SCN receives external entrainment 
cues, mainly light, and projects its rhythm onto cell-autonomous clocks in peripheral 
tissues. As a result, peripheral clocks are synchronized by the central clock with a 
constant phase delay. In mammals, the central clock in the SCN is able to entrain the 
peripheral oscillators with via the endocrine and autonomic nervous systems, both 
directly and indirectly. For example, it has been shown that in mice hormonal signals, 
modelled using glucocorticoid agonists that are normally sent by central clock, are 
capable of shifting the phase of peripheral oscillators (Balsalobre, Brown et al. 2000). 
A more indirect entrainment mechanism, for instance of the liver, is possible by the 
SCN controlling rest/activity cycle and consequently the feeding schedule. Therefore, 
it is possible to uncouple the peripheral clocks from SCN by artificially setting the 
timing of feeding (Reppert and Weaver 2002). Several studies have confirmed that 
temporal feeding restriction for several days can lead to the desynchronization of 
SCN and peripheral circadian oscillations, shifting the phase of clock gene expression 
in peripheral tissues but not in SCN (Stokkan, Yamazaki et al. 2001, Yoo, Yamazaki 
et al. 2004) 
Opposite to the mammalian system, it has been suggested that in simpler 
organisms, such as Drosophila, circadian rhythms can follow a so-called “orchestra” 
model, where the central clock is considered as a conductor and each of the peripheral 
clocks as an orchestra member. In this scenario, each peripheral clock can play its 
own “instrument”, or have its own rhythms, but nevertheless they are guided by the 
“conductor” to ensure the efficient and coordinated melody. Specifically, as 
mentioned before, most of the cell-autonomous clocks are light sensitive and can be 
individually entrained by the environment, meaning that the peripheral clocks can 
have their own rhythms according to the external or internal stimuli. Yet their 
oscillations maybe coordinated to varying degrees by the light-dark cues received by 
the central clock (Richards and Gumz 2012). One example of how a central clock 
may facilitate a functional, whole-organ rhythm has been illustrated by (Welsh, Yoo 
et al. 2004), where by using bioluminescence imaging of fibroblast cells they 
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observed that individual fibroblasts can maintain robust rhythms with undiminished 
amplitude but failed to synchronize to each other. Similar experiments, but in vivo, 
have shown that in SCN-lesioned hamsters the rhythmic oscillations were eliminated 
not only for circadian behaviour, but also for the expression of clock genes in 
peripheral tissues; this observation suggests that loss of rhythmicity for an organ may 
not be due to loss of the molecular rhythms within each cell but rather due to the loss 
of a conductor resulting in cell-cell desynchronisation. In the absence of a central 
clock the progressive desynchronisation within an organ is inevitable if coupling 
between cells is weak (Welsh, Yoo et al. 2004).  By comparison, the lesions of the 
SCN in mice did not destroy circadian oscillation in peripheral tissues, but rather 
caused the loss of phase coupling within different tissues of an animal and between 
animals (Yoo, Yamazaki et al. 2004). This indicates that coupling between cells 
within murine organs is stronger. 
With reference to AD pathogenesis, circadian rhythms in humans, for example 
sleep-wake cycle, hormone secretion and blood pressure, are directly controlled by 
central clock in SCN. The control centre in SCN sends the instructions via various 
mechanisms, in particular through autonomic nervous system and hormone release, to 
synchronize peripheral clocks in the body. For instance, the secretion of melatonin, 
also known as “the hormone of darkness”, regulates the sleep onset and several 
studies have reported that in mice the damage to SCN results in the disruption of 
circadian rhythms and consequently sleep-wake cycle (Musiek, Xiong et al. 2015). 
Postmortem studies of the brain of patients with AD imply that the loss of neuronal 
cells in SCN is linked to circadian abnormalities. However, it is still not clear at 
which stage of the signal transmission the damage occurs, in particular whether the 
damage is inflicted on the central clock itself or the communication pathway leading 
to the periphery. Interestingly, the recent study by (Chen, Possidente et al. 2014) has 
shown that despite maintaining an intact central clock, Aβ overexpression in 
transgenic Drosophila lead to age-related circadian behavioural disruption. Taking 
into account that circadian behaviour is driven by the central clock in SCN, this 
discovery might suggest that the damage caused by Aβ toxicity affect the 
communication pathways between different tissue clocks. 
This observations bring into question the mechanism of coupling between 
central and peripheral clock, and, consequently, behavioural rhythms. For example, it 
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is still unclear to what extent the peripheral clocks are being controlled by the central 
clock. Understanding the pathway by which the central and peripheral clocks 
communicate with each other and control behaviour can potentially shed the light on 
the role of circadian disruptions in the complex pathogenesis of Alzheimer’s disease. 
 
4.1.4 METHODS TO MEASURE CIRCADIAN CLOCKS AND BEHAVIOUR 
At the present, assessing the circadian biology in human subjects with AD is 
limited to largely non-invasive techniques, but several methods exist to do so in 
animal models of the disease, with Drosophila being arguably the most convenient. 
The first and most commonly used method to non-invasively measure the oscillations 
of molecular rhythms in vivo was developed by (Brandes, Plautz et al. 1996) with the 
use of bioluminescence, as mentioned in 4.1.2. In this method, the transgenic firefly 
luciferase gene was fused with the promoter region of one of the clock genes in 
Drosophila. When the organism is fed the luciferase substrate (luciferin), it emits 
light according to the rhythmic expression of luciferase and therefore, to the 
oscillations of clock gene expression. Such measurements are usually undertaken in 
constant darkness, practically this is because of the low intensity of the 
bioluminescence. Generally, two methods have been developed to automatically 
monitor the luciferase oscillations: using a luminometer or a charge-coupled device 
(CCD) camera.  
The first robust and frequently used method to observe the bioluminescence is 
based on using the Packard Topcount multiplate scintillation counter by Perkin Elmer, 
in this case functioning as a “luminometer”, in which the flies are placed in individual 
wells in a 96 well plate each of which is prefilled with fly food doped with luciferin. 
The light readout of each well containing a fly is then measured at the regular 
intervals by photomultiplier tube-based luminescence counter in which absorption of 
a photon results in the emission of many electrons. This method is an elegant 
approach for quantitatively monitoring the circadian rhythms but unfortunately is 
incapable of studying their circadian behaviour at the same time. This is due to the 
fact that flies are kept in circular domes and practically immobilized. 
Recent developments in imaging technology have opened up new avenues to 
analyse the circadian bioluminescence with the use of CCD cameras, allowing the 
highly sensitive imaging with low background noise. Capturing the images with CCD 
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cameras is based on the photoelectric effect, converting the photons that impact 
individual spots on a silicon chip into free electrons and channelling them in a 
controlled fashion to quantify the number of electrons at each picture elements 
(pixels). The sensitivity of the camera or proportion of incoming photons being 
detected is expressed as quantum efficiency and depends on wavelength of light, 
which is 560 nm for firefly luciferase. Occasionally, some of the free electrons are 
thermally generated in the absence of incoming photons and give rise to dark noise. 
The amount of dark noise is proportional to the exposure time, so that the long-
exposure images will contain more of the dark noise. Another technical issue of CCD 
cameras is the presence of readout noise due to the uncertainty during the process of 
quantifying the electronic signal. Recent improvements in CCD technology have led 
to the development of cameras suitable for low-light luminescence images with lower 
noise levels. One of the commonly used scientific camera is electron-multiplying 
CCD camera (EM-CCD), where the electrons are multiplied on-chip prior to readout 
event, so that the readout noise is negligible in comparison to pre-amplified low-light 
level signal. Overall, the equipment is comparatively expensive but a correctly chosen 
camera allows a highly sensitive and low-noise detection of dim signals. However, 
none of the existing CCD camera based methods reviewed to date have been able to 
monitor circadian clocks and circadian behaviour at the same time, at least in 
Drosophila. 
On the other hand, there are many techniques have been developed to track the 
fly movement in constant darkness. The easiest and traditionally used method was 
first introduced in 1971 in (Konopka and Benzer 1971) and called infrared beam split 
system. The automatic data collection monitors were later on developed by 
Trikinetics, USA and termed “Drosophila activity monitor” (DAM). This method 
analyses fly movement by quantifying the number of times each individual fly breaks 
an infrared beam located in the middle of the tube (Figure 4.2). According to this 
technique, each individual fly is placed in a long capillary tube that contains cotton 
plug on one end and food on the other end. Taking into account that fly circadian 
clock is not sensitive to infrared light, an infrared beam is shone from one side of the 
middle of the tube and detected by a sensor on the other side. When a fly crosses the 
beam, it disrupts the passage of the infrared light and generates a binary signal that is 
registered by a computer. The result is usually organized into half an hour bins, in 
which each bin represented by the number of times fly broke the infrared beam.  
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However, the main drawback of this technique when applied to locomotor 
activity and especially sleep analysis is the extremely low spatial resolution as the 
system only detects the movement when the fly crosses the midline of the tube. 
Moreover, it has been shown that the DAM system strongly overestimates sleep, 
particularly in case of single-beam system. Currently, there are a variety of methods 
used to register the locomotor activity of flies, most of which based on using the 
infrared camera and red LED illuminators (Donelson, Kim et al. 2012, Gilestro 2012, 
Oren, Tarrant et al. 2015). Despite the wide range of fly movement video tracking 
methods to date, none of them are capable of simultaneously monitoring the 
oscillation of circadian clocks.  
Therefore, the current experimental paradigm consists of measuring the 
oscillation of central/peripheral clocks for one subset of flies and locomotor behaviour 
for another subset of flies. As a result, assessing the relationship between different 
oscillations is only possible on the population scale and has large inter-individual 
variability. To overcome this technical issue, the new method of simultaneously 
measuring circadian clocks and locomotor behaviour, together with sleep structure, 
was developed to study the circadian disruptions in Drosophila model of AD. 
 
4.2 MATERIALS AND METHODS 
 
Recent advances in bioluminescence imaging has led to new techniques being 
developed to study how the central clock synchronizes oscillators in peripheral tissues 
Figure 4.2 The Drosophila activity monitor system. a) Infrared beam-split system. 
The activity of a single fly is estimated by counting number of times a fly breaks the 
beam of infrared light in the midline of the tube (red dashed line) by passing through 
it. b) Drosophila activity monitor by TriKinetics, USA. The activity monitors have 
the infrared emitters and receivers and are connected to the computer to record the 
data. 
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in mammalian systems (Saini, Liani et al. 2013), but no similar method has ever been 
developed for the Drosophila model. Therefore, the purpose of the project was to 
develop the system that will allow us to examine both the molecular clocks and the 
locomotor activity for the same individual organism, namely fruit flies.  
 
4.2.1 EXPERIMENTAL DESIGN 
The fruit flies for the first and second datasets were prepared by a postdoctoral 
fellow in Damian Crowther’s group (Department of Genetics, University of 
Cambridge), Kofan Chen, as part of a collaboration. With his training I subsequently 
prepared the flies and performed the third run of the experiment. The recording was 
undertaken using the EM-CCD camera incorporated within a Cairn Alligator system 
in Laboratory for Molecular Biology, together with the collaborator Dr John O’Neill. 
 
4.2.1.1 FLY STRAINS  
A model of the toxicity of the amyloid beta (Aβ) peptide in Alzheimer’s 
disease has been generated in Drosophila using the GAL4/UAS system (Figure 4.3) 
that allows overexpression of human transgenes in a specific tissue. This system has 
two parts: the GAL4 gene, encoding the yeast transcription activator protein Gal4, 
and the UAS (Upstream Activation Sequence), an enhancer to which GAL4 binds in 
order to activate gene transcription. As AD is a neurodegenerative disease that is 
thought to result from the overproduction and aggregation of the Aβ peptide; 
consequently the peptide, linked to a secretion signal peptide, was overexpressed 
using the pan-neural promoter elav (embryonic lethal, abnormal vision), so that the 
GAL4 expression is driven by the elav promoter and expressed specifically in the 
neurons of fly brain. The presence of GAL4 in those cells has little or no effect, since 
GAL4, being a yeast transcriptional activator, is inactive in insect cells in the absence 
of a cognate UAS region.  
In the reported line the Arctic variant of Aβ peptide 1-42 (Aβ42), as a model of 
amyloid toxicity, is placed downstream of a UAS activation domain that consists of 
GAL4-binding sites. This genetic construct is carried by every cell of the fly, but in 
the absence of GAL4 nothing happens, because the transgenic promoter is not 
activated. The transgenes are only activated by crossing flies from the elav-GAL4 
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driver line to flies with UAS-transgenes. Their offspring will express the human 
pathogenic transgene Aβ42 Arctic in all the neurons of the brain and so exhibit the 
symptoms of the disease (St Johnston 2002).  
Drosophila mutant strain w1118 was used as a background strain. This 
Drosophila mutant strain is characterized by the lack of eye pigment so that the flies 
have white-eye phenotype. The wild-type strain 51D without any insert was used as a 
control line. 
In order to monitor clock gene expression, the Period-luciferase fusion method 
was used as described above. Due to the low number of central clock neurons (150 in 
total), acquiring a bioluminescence signal using the available CCD camera proved 
impossible. As an alternative approach, both control and UAS-Aβ42 Arctic 
Drosophila strains were combined with flies carrying the period-luciferase transgene 
XLG-luc2, in which the expression of luciferase is driven by period promoter region 
in peripheral tissues. To ensure the correct genotype after crosses and prevent 
recombination between chromosomes, balancer chromosomes, that have different 
marker phenotypes, were used. For instance, we used flies with UAS-Aβ42 transgene 
expressed over the balancer CyO on the second chromosome, that produces curly 
wings in flies. Period-luciferase transgene XLG-luc2 was expressed over balancer 
TM6B in third chromosome, that produced a humeral (so called “hairy shoulder”) 
Figure 4.3 GAL4/UAS system. The GAL4 gene have been inserted at certain position 
in Drosophila genome so that GAL4 is expressed under the control of genetic 
enhancer.  The expression of human transgene can be activated by crossing the GAL4 
enhancer-trap line to flies with UAS-transgene. 
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phenotype (Figure 4.4).  
As shown in Figure 4.4, there are 4 possible phenotypic groups of offspring as 
a result of fly crosses, but only the one class (number 4, non-curly, non-humeral, 
Figure 4.4) was selected to ensure the presence of Aβ and period-luciferase 
expression according to the following criteria: normal wings shape (absence of CyO 
balancer, non-curly wings phenotype) and non-humeral  (absence of TM6B balancer, 
non-hairy shoulders phenotype). The same criteria were applied when generating the 
control flies that have an empty transgene receptor site on chromosome 2 rather than 
the Aβ transgene (strain 51D). 
 
4.2.1.2 FLY ARENA 
Individual flies were placed in capped glass tube of standard length (5mm x 65 
mm) so that they were able to walk horizontally up to 20 times of their body length 
(Figure 4.6, panel A). The tube was filled with fly food on one end and cotton wool 
on the other end. The food containing luciferin was prepared by mixing 5% sucrose 
Figure 4.4 Fly crosses. The flies with required genotype were generated by crossing 
virgin flies with GAL4 and XLG-luc2 expression in the peripheral tissues and male 
flies with UAS-Aβ42 expression. Out of 4 possible genotypes of the offspring, the 
flies with genotype number 4 were selected for the experiment. 
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with 1% agar and 15 mM (first run) or 50 mM (second and third run) of luciferin. The 
tubes containing flies were placed in a microscope slide storage tray and separated by 
the black card divider stripes. One tray could hold up to 48 tubes (Figure 4.5). 
 
4.2.1.3 BIOLUMINESCENCE RECORDING 
After flies hatched and collected, they were aged on standard cornmeal food 
until they reached the required age for the experiment. In order to synchronise the 
intrinsic circadian rhythms, flies were entrained to a 12:12 light-dark (LD) cycle for 3 
days. The tubes, each containing a single fly, were placed in the apparatus and kept in 
constant darkness in the incubator (Figure 4.5 A). The environment was also kept 
constant with regard to temperature and humidity over the course of the experiment to 
ensure that no environmental signals affect the circadian rhythms.  
 
The top of the incubator was equipped with cooled electron-multiplying 
charge-coupled device (EM-CCD) camera that summed the emitted bioluminescence 
over 5 min exposures (that integrates the photon counts) for a total of seven days 
(Figure 4.5). In order to compare the performance of the experiment with 
conventional methods of measurements, flies were additionally placed in 96-well 
Figure 4.5 Experimental setup. A) Incubator kept the constant temperature and 
humidity. The EM-CCD camera was incorporated in the top plate of the incubator B) 
Top view of the incubator. C) 48 cappilary tubes were placed in a storage tray. 
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plates and covered by pierced plastic domes to restrict their movement (Brandes, 
Plautz et al. 1996), as described in 4.1.4, and placed in the incubator, where the 
recording was done in parallel with tube-based setup. The circadian behaviour of 
comparable flies, contemporaneously housed in glass tubes with luciferin-free food, 
was also recorded using DAM infrared beam split system as described in 4.1.4. 
 
4.2.2 IMAGE ANALYSIS 
The images of the flies constrained within a glass capillary tube have been 
captured using EM CCD camera with 5 min exposure time so that each image is 
represents a 300 sec integration of photon counts. As a result, each image contains 
sufficient information to quantify the locomotor behaviour of the fly (with spatial 
resolution of the order of millimetres and temporal resolution of 300 sec), together 
with a simultaneous estimation of the level of peripheral clock gene expression (the 
total number of photons captured in the area of the tube). Taking into account that 
immobility is opposite to locomotor behaviour, it is possible to measure additionally 
the periods of inactivity and infer sleep-like events that satisfy standard criteria of 
sleep (Gilestro 2012). 
Analysis of the fly’s behaviour is one of the crucial parts and is based on the 
assumption that the images taken with EM-CCD camera translate into 300 seconds of 
fly movement. Given that each image is 300 seconds of photon integration and the 
flies emit light, we expect that if the fly were to spend the majority of time in one 
Figure 4.6 Examples of fly behaviour taken during the experiment. A) A single fly 
was placed in a capillary tube with the food on one end of the tube. B) Resting fly 
being stationary in one place will produce a bright spot. C) Moving fly will produce a 
smear of dots as it walks within the tube. 
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place it will produce bright localized spot in the image (Figure 4.6, panel B). By 
contrast, if the fly were to move continuously then it would produce a smear of dots in 
the image (Figure 4.6, panel C). 
In order to extract some meaningful features from the acquired images, the 
preprocessing stage is required. This involves several steps of image processing and 
analysis.  
 
4.2.2.1 NOISE REDUCTION AND IMAGE ROTATION 
As the EM-CCD camera is a very sensitive device and acquires images by 
summing the photon counts over 5 minutes; as such the images contain some level of 
read out noise.  In order to improve signal-to-noise ratio, the first step of noise 
reduction has been performed. It consists of estimating the background noise level by 
averaging the brightness of pixel intensities taken at the bottom left 64x64 square for 
each of the image (Figure 4.7). The average value of the background noise is then 
subtracted from every pixel of the image. 
Image rotation was performed so that all the tubes in the parallel rows are 
aligned with each other and tube centres can be easily identified. The required 
rotation angle was calculated based on the manual location of two marker points 
positioned at the top and bottom right hand side corners of the tray where fly tubes are 
placed (Figure 4.7) in the illuminated image, acquired at the end of the experiment. 
The angle is calculated based on the law of cosine and then rotation take place around 
the centre of the image using the rotation matrix. In the correctly rotated images the 
centres of fly tubes will be aligned above each other along the x-axis.  
The centre of the fly tubes can be found by summing up pixel intensities along 
y-axis (Figure 4.7). This summation is performed for 200 images to account for the 
intensity variability and random noise, such as cosmic rays. If the rotation step has 
been done correctly, the centres of the tubes will lie above each other and produce the 
peaks in intensity profile. In order to identify the top and bottom boundaries of the 
tubes similar process has been done, summing up the pixel intensities along x-axis 
(Figure 4.7). The rectangular boundaries of each tube were defined around the 
centres, assuming the tubes are 17 pixels wide and 185 pixels long.  
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4.2.2.2 IMAGE ENHANCEMENT 
The main core of the analysis is quantification of fly walking behaviour and 
periods of inactivity from the images, as will be described below. The quantification 
of images usually implies that the images have same level of background noise and 
overall background brightness. However, due to the luciferase decay, being reported 
in previous studies (Brandes, Plautz et al. 1996), the images at the end of 7-day 
experiment have considerably lower brightness as compared to the images at the 
beginning. Therefore, in order to reliable identify flies the contrast and brightness in 
the images were enhanced by using contrast-limited adaptive histogram equalization 
(Reza 2004). This algorithm increases the contrast between the darks and the lights. 
Figure 4.7 Rotating images and finding the boundaries of the tubes. Three circles 
(grey circles) were attached at the corners of the tray as landmark for image rotation. 
The boundaries of the tubes within the image were identified by summing up the pixel 
intensities along x-axis (right plot) and y-axis (top plot). 
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Contrast enhancement was limited inversely according to the number of images (as 
images were numbered every 5 minutes) meaning that the contrast for initial images 
was enhanced to a lesser extent than for images at the end. As a result, using this 
algorithm will transform all of the images so that all of them will have uniform 
contrast histograms. These enhanced images were only used to allow sensitive feature 
detection, principally spot detection, but quantitative measurements were based on the 
raw images, processed only to remove background noise. 
Another technical issue is that the limitations of the lens optical system of 
EM-CCD camera cause the vignetting effect in the images, which means that there is 
a small systematic variation in pixel brightness between different regions of the 
image. In order to account for this effect, second step of background subtractions has 
been performed. In this case background noise level was evaluated on tube-by-tube 
basis to get the best possible estimate of background pixel brightness in the region 
next to the tube of interest. The boundaries of the appropriate background rectangle 
(Figure 4.7, red rectangle) were set as the top and bottom boundaries of the tubes on 
y-axis and on x-axis it was taken as a 5 pixels wide region in between the pair of 
tubes (Figure 4.7, tube rectangles shown as blue rectangles). 
 
4.2.3 BIOLUMINESCENCE AND LOCOMOTION ESTIMATION 
 
 Based on the images taken with the EM CCD camera, we were able to 
calculate different parameters characterising fly circadian clock oscillations and 
circadian behaviour, including sleep.  
 
4.2.3.1 MEASURING MOLECULAR CLOCK OSCILLATIONS 
 The level of the circadian reporter construct was defined as the sum of noise-
corrected signal intensity within each tube rectangle. The oscillation of circadian 
clocks was estimated by plotting the summed intensity over time. This parameter 
reflects the cellular circadian rhythms of clock gene expression in peripheral tissues 
of the fly. 
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4.2.3.2 ANALYSIS OF ACTIVITY AND SLEEP 
In order to convert the array of dots in the image into the timeline of fly 
movement, we first needed to find the regions where fly was stationary (resting 
periods).  As each tube containing the fly is identified as 185 pixels long and 17 pixels 
wide, each tube was divided into 4 pixels high bins along long axis (y-axis) to reduce 
the effect of minor observation errors, resulting in 46 bins of 4 pixels long and 17 
pixels wide. If we sum the intensity of light in each bin and plot the profile, we can 
identify those resting periods (Fig. 4.8). Bins containing a stationary fly are identified 
as peaks in the intensity profile along the tube; we call them resting peaks. On the 
contrary, we expect that and actively moving fly will produce smear of dots (Figure 
4.6, panel C) and we approximate this profile to a horizontal line across the bins at a 
particular level above background (Fig. 4.8); we call this the activity level.  
Assuming that the shape of the resting peaks follows a normal distribution, the 
dominant peaks can be identified if the value of the intensity in particular bin is above 
the mean value plus a standard deviation of the light intensity among all the bins in 
the enhanced images (Figure 4.8, “Mean+SD” values). The boundaries of resting 
peaks were assigned to the adjacent non-peak bins or to the value of activity level 
(“Mean-peak”) in case when the value of adjacent bin was below “Mean-peak” value 
(Figure 4.8, blue shade). Once the enhanced data was used in this way to identify bins 
containing data from a resting flies thereafter only raw data was used.  Specifically, 
the mean level of bin intensity was calculated (using the raw data), but only 
considering bins that do not contain a resting fly (“mean-peak”, right hand panels in 
Figure 4.8).  
Assuming that there are only two distinct kinds of fly locomotor behaviour, 
namely resting and walking, it follows that the 300 sec of exposure time must be 
partitioned between these two states for each camera image. Using the raw image 
data, the contribution of each parameter was estimated as an area under the 
corresponding curve. Total area is defined as: 𝑇𝑜𝑡𝑎𝑙  𝑎𝑟𝑒𝑎  (300 𝑠𝑒𝑐) =    𝑟𝑒𝑠𝑡𝑖𝑛𝑔  𝑝𝑒𝑎𝑘𝑠!  !"#$% + 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦  𝑙𝑒𝑣𝑒𝑙 (4.1)  
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Under this notation, the contribution of activity to the intensity profile was 
estimated as an area between the activity level (“Mean-peak”) and the background. 
Likewise, the proportion of resting episodes was evaluated as the sum of areas under 
each resting peaks. 
Figure 4.8 Frame-by-frame identification of behavioural status. The intensity pixel 
profile was binned into 46 segments along the length of the tube for each timeframe. 
The enhanced images were used to detect the bins containing the peaks of intensity 
(resting peaks, blue area under the peaks): if intensity value of the bin was above 
mean and standard deviation of the pixel intensities (Mean+SD) for the tube. Using 
the raw images, the activity level was estimated (yellow shade). The total of the areas 
under resting peaks (blue shade) and activity level (yellow shade) is equal to 300 sec. 
Representative data is shown for (A) an active fly, (B) an active fly with periods of 
rest and (C) a sleeping fly. 
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𝑇𝑖𝑚𝑒!"#$%& = 300  𝑠𝑒𝑐 ∙ !"#$%$#&  !"#"!!"#$%  !"#!  (4.2) 𝑇𝑖𝑚𝑒!"#$%&' = 300  𝑠𝑒𝑐 ∙    !"#$%&'  !"#$%!  !"#$%!"#$%  !"#!  (4.3) 
Several studies have demonstrated that in Drosophila, sleep-like behaviour is 
characterized by increased arousal threshold and homeostatically regulated rebound 
following sleep deprivation. In these studies sleep is defined as a period of immobility 
for at least 5 consecutive minutes (Gilestro 2012). Therefore, with reference to such 
sleep-like states, the presence of a sleep episode is defined by three criteria: 1) an 
image frame may be part of a sleep episode only if it contains a single resting peak, 
meaning that the fly was resting in one position; 2) for subsequent images of the same 
tube there must be a resting peak at the same position, indicating that the fly did not 
move between frames; if there are no resting peaks, in a subsequent images of the 
tube then the sleep episode is assumed to be over; 3) the rest times summed across 
two consecutive frames must exceed 300 sec. Even though this definition of sleep in 
Drosophila is conservative, it does not overestimate the short rest episodes as sleep 
episodes. Using this approach, each fly within each image frame was assigned either 1 
or 0 in the binary sleep array (1=asleep and 0=awake).  
Under these circumstances, each fly in each image frame was designated with 
one of two possible behavioural states: active (that allows for resting periods <300 
sec) or sleeping (Figure 4.8).  However, the binary representation of the sleep data 
provides an insight into the total amount of sleep but not the “quality” or length of 
sleep episodes.  Because sleep fragmentation is a feature of AD and other disorders 
the data was analysed further and a novel sleep consolidation index was calculated, 
that measured the length of each sleep episode block (Figure 4.14). For a particular 
fly, this index was calculated by examining the binary sleep array and estimating the 
duration of each sleep block. The sleep consolidation array consisted of a value for 
each frame representing the total duration of the sleep episode of which it was a part.  
Two examples of the sleep consolidation array could be: 1) an active frame that has a 
value of zero and 2) each component frame of a five frame sleep event containing the 
value of five. 
As a result, five different parameters were calculated and presented as a time 
series for each fly: 1) intensity of emitted light (the molecular clock signal), 2) time 
spent active (locomotor activity), 3) time spent resting (reciprocal to time spent 
active), 4) sleep binary array (presence of sleep-like episodes), 5) sleep consolidation 
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array (duration of any sleep episode that the frame is a part of). 
 
4.2.3.3 BINNING OF FINAL TIME SERIES 
 As mentioned in 4.1.4, the sampling interval of the circadian activity data 
collected by DAM system is conventionally set to be 30 minutes. Therefore, in order 
to assess the performance of the newly established method with performance of the 
widely used DAM system, the temporal resolution of the computed time series of 
circadian oscillation was reduced from 5 minutes to 30 minutes by binning the 
consecutive time points. Binned values of sleep binary and time spent active or 
resting were represented by the sum of constituent timepoints, while for sleep 
consolidation the bin was assigned with the average consolidation of non-zero entries 
in the constituent timepoints; for bioluminescence, average light intensity value of the 
constituent timepoints was set as a binned value. 
 
4.2.4 TIME SERIES ANALYSIS 
 Within our experimental data, we are mainly interested in robustness of the 
rhythmicity exhibited by the oscillations of molecular clock and circadian behaviour 
of the flies in free run (constant darkness, no external cues). Most of the circadian 
rhythms have a repeating pattern of around 24 hours, so that the analysis of circadian 
oscillation requires the analysis of time series data. However, it has been previously 
shown that other than 24 hours periodicities are also present in the circadian rhythms 
of Drosophila. For example, periodicities in the range of 5 to 18 hours, called 
ultradian rhythms, have been found in the Drosophila circadian clock mutants and can 
occur in either the presence or absence of normal circadian rhythms (Dowse and 
Ringo 1992). Likewise, long-range periodicities can also arise as a result of 
behavioural or enzymatic activity that are independent of circadian rhythms. Both of 
these additional short- or long-range rhythms can interfere with the analysis of 24-
hour periodicities and therefore experimental data required a pre-filtering stage. 
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4.2.4.1 SIGNAL FILTERING 
 Several studies have previously reported that luciferase decays over time, so 
that the absolute amplitude of bioluminescence decreases exponentially over the 
course of experiment (Brandes, Plautz et al. 1996). This type of decreasing trend can 
interfere with the extraction of periodicity in the circadian range and therefore need to 
be taken into account before performing the time series analysis. Indeed, the visual 
inspection of the bioluminescence time series reveals the exponential decay (Figure 
4.9, top).  
 The trend curve was identified by using low-pass filter that only passes the 
signal with a frequency lower that 1/72, or with periodicity longer than 72 hours, and 
attenuates signals with higher frequencies (Figure 4.9, dashed line). The 
bioluminescence signal was then detrended by dividing each data point by the 
corresponding data point on the trend curve, resulting in a detrended signal with a 
mean value of 1 and preserving the amplitude of the variation around the trend curve 
Figure 4.9 Detrending time series data. Trend curve for the bioluminescence decay is 
indicated as a dashed line and superimposed on the data (top plot). Detrending of the 
original data was achieved by dividing each point in the time series by the 
corresponding point on the trend curve 
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(Levine, Funes et al. 2002). As a consequence of such filtering, the signal appears to 
be more robust than in the raw data and the units of measurement are eliminated so 
that the temporal features can be compared with other signals such as behavioural 
rhythms. 
 
4.2.4.2 ESTIMATION OF RHYTHMICITY 
 The robustness of the circadian oscillations can be assessed quantitatively by 
the well-established autocorrelation method (Levine, Funes et al. 2002), that measures 
the degree of periodicity of the time series. This method is based on the cross-
correlation of the signal with itself at different time delays so that when the lag 
between two series is equal to 0, the signals are perfectly aligned and the correlation 
coefficient is 1; however, when the two signals are slipped out of register with one 
another, the correlation coefficient decreases. For example, the correlation of random 
signal will rapidly decrease close to zero and remain there. On the other hand, if there 
is repeated pattern within the signal then peaks and troughs will slip back into register 
at the lag time close to the pattern period and the correlation coefficient will increase 
again (Hansen 1995). The autocorrelation coefficient ρ for the observed values x1,…, 
xN and lag h is given by: 
         𝜌! =    (!!!!)(!!!!!!)!!!!!! (!!!!)!!!!!  (4.4) 
Conventionally, the strength of the rhythmicity as a function of regularity of 
the underlying process can be measured numerically in terms of the rhythmicity index 
(RI) value as described in (Levine, Funes et al. 2002). This index is assessed as the 
height of the third peak (equivalent to a lag time of two periods) in the autocorrelation 
function. When multiple experiments are performed an estimate of the statistical 
significance of the periodicity, called rhythmicity statistic (RS) value, may be 
evaluated as a ratio of the RI value to the absolute value of 95% confidence interval at 
each timepoint. In practice, based on 30 minutes sampling intervals, it is widely 
accepted that statistical significance is achieved if the RS value is above 1.5. 
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4.2.4.3 ESTIMATION OF PERIOD 
 There are many different methods for period estimation, most of which is 
based on Fourier analysis, also known as spectral analysis. First applied to the 
analysis of circadian rhythms in early 1950s, Fourier analysis is based on the 
assumption that any function, regardless of its shape of regularity, can be decomposed 
into a series of cosine and sine waves of different frequencies as determined by the 
goodness-of-fit to the data. In Fourier analysis, at a given frequencies 1/N, 2/N…(N-
1)/2N, the sum of cosine and sine waves represents the spectral energy of the signal at 
that frequency. Although Fourier analysis has proven to be efficient method of period 
estimation, it has some disadvantages when applied in chronobiology. For example, 
Fourier analysis is only able to estimate what frequencies are present but not how the 
period of oscillations is changing over time. Shortcomings of the approach include 
poor frequency resolution, unless the number of cycles is large, and artefactual 
boosting of long-period signal in noisy time series with uneven sampling. One 
particular variation of Fourier analysis, namely the Lomb-Scargle (LS) method, can 
address this issue quite successfully. In addition, this method allows the analysis of 
non-evenly spaced data (as a result of equipment failure or other problems).  
 Lomb Scargle method is a variation of Discrete Fourier transform and 
estimates the frequency spectrum based on the least squares fit of sine and cosine 
waves to the data. Given N observations and xi values obtained at times ti = 1…N, 
first the mean 𝑥  and variance 𝜎! of the signal is calculated as follow: 
  𝑥 = !! ∙ 𝑥!!!!!  ; (4.5) 
 𝜎! =    !!!! ∙ (𝑥! − 𝑥)!!!!!  (4.6) 
For a given frequency component f, the time offset 𝜏  of the angular frequency 𝜔 = 2𝜋𝑓 is calculated as: 
 tan 2𝜔𝜏 = !"#  (!!!!)!!!!!"#  (!!!!)!!!!    (4.7) 
The Lomb Scargle periodogram estimates the spectral power of the given frequency 
in the signal as a function of 𝜔 and is defined by: 
 𝑃!" 𝜔 = !!!! ∙ (!!!!)∙!"#  !(!!!!)!!!! !!"#!!(!!!!)!!!! + (!!!!)∙!"#  !(!!!!)!!!! !!"#!!(!!!!)!!!!  (4.8) 
The periodogram is normalized by the variance of the data to ensure that the power 𝑃!" 𝜔  is uniformly distributed and provides the probability  𝑝 that the power 𝑃!" at a 
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given frequency 𝜔 is real: 
 𝑝 𝑃!" 𝜔 = 1− (1− 𝑒!!"#  (!!"))! (4.9) 
A review of circadian period estimation methods by Zielinski and colleagues 
(such as Enright periodogram, Lomb-Scargle periodogram, Fast Fourier Transform 
Non-Linear Least Squares, mFourfit, Maximum Entropy Spectral Analysis (MESA) 
and Spectrum Resampling) has shown that MESA was able to more precisely identify 
the underlying rhythms as compared to the other methods, however the amount of 
noise in the artificial data was not comparable with our experimental data (Zielinski, 
Moore et al. 2014). Another recent review compared the performance of the 
commonly used method for the analysis of circadian rhythms, including Discrete 
Fourier transform, Autocorrelation and Enright periodogram, but did not consider 
MESA or Lomb Scargle periodogram (Mourao, Satin et al. 2014).  
Therefore, I undertook a comparison of the four conventionally-used methods 
(Lomb Scargle periodogram, MESA, Autocorrelation and Enright periodogram) using 
synthetic signal data contain circadian oscillation with an appropriate level of noise, 
comparable to our experimental data. The principles of MESA, Autocorrelation and 
the Enright periodogram are described in (Mourao, Satin et al. 2014) 
First, the synthetic signal was generated, consisting of sine waves and added 
noise. Synthetic signal with one period as a function of time 𝑡 was generated as 
follows: 
 𝑦 𝑡 =   𝐴𝑠𝑖𝑛(!!! ∙ 𝑡 + 𝜙), (4.10) 
where A – amplitude, 𝑇 – period and 𝜙 – phase. 
In addition, synthetic signal with 2 periods 𝑇! and 𝑇! (fast and slow), as an example of 
ultradian rhythms, was generated according to the following expression: 
 𝑦 𝑡 =   𝐴!𝑠𝑖𝑛(!!!! ∙ 𝑡 + 𝜙!) +  𝐴!𝑠𝑖𝑛(!!!! ∙ 𝑡 + 𝜙!)   (4.11) 
The noise was introduced to the synthetic time series to represent experimentally 
observed errors during the measurements. As a result, the synthetic signal with 
Gaussian distributed random noise can be generated as: 
 𝑌 𝑡 =   𝑦 𝑡 + 𝜀 ∙ 𝑁(0,1),  (4.12) 
where  𝜀 represents the strength of the noise and 𝑁  (0,1) is Gaussian distributed error 
with mean 0 and standard deviation 1. For example, Figure 4.10, panel A shows the 
sine wave component of the synthetic signal in blue and 20% noise component in red; 
the resulting synthetic signal is presented in Figure 4.10, panel B. 
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 As it can be seen from Figure 4.10, only Lomb Scargle and Enright 
periodograms identified the correct period of 24 hour in the synthetic signal with 20% 
added noise, while MESA and autocorrelation methods underestimated the period 
value. 
The relative difference (RD), or accuracy of the estimation of a simulated 
period, for each method was calculated as follows: 
 𝑅𝐷 = !!!!!!! , (4.13) 
A B 
C D 
E F 
Figure 4.10 Comparison of period estimation methods. A) Synthetic signal was 
generated as a sine wave with 24 hour period (blue traces) and 20% of the random 
noise was added (grey traces). The period (value after *peak) of resulting synthetic 
signal (B) was estimated using 4 different methods (C-F)  
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where 𝑃!  - period identified by a particular method, 𝑃! - real period used to generate 
the data. 
Using the synthetic data with different amount of added noise, the accuracy of 
each method was evaluated as shown in Figure 4.11; panel A shows the value of RD 
according to the percentage of added noise and panel B shows the mean value of RD 
for different methods. As it can be seen, each method estimated the period of 
synthetic data with high accuracy (<4% error in period estimation), whereas Lomb 
Scargle and Enright methods produced the best estimates of the period of interest. 
 As mentioned before, circadian rhythms in Drosophila can have multiple 
periodicities. To evaluate the accuracy of multiple period estimation of different 
considered methods, synthetic data with two periods was generated with different 
amount of noise. For example, Figure 4.12 panel A illustrates the 12- and 24-hour 
period components (red and blue traces accordingly) and 180% of added noise; the 
A 
B 
Figure 4.11 Period estimation errors for different methods. A) Period of oscillations in 
synthetic data with 5 different amounts of added noise was estimated by 4 methods. 
The values of relative distance (RD), or accuracy of the period estimation, were 
calculated and plotted on y-axis for each method. B) The bar chart shows the mean 
RD value of estimating the period in synthetic data with 5 amounts of added noise for 
each method. 
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resulting synthetic signal is shown in panel B. 
 As it can be seen, only Lomb Scargle has identified both periods correctly, 
while MESA found only one period and considerably underestimated 24-hour 
component. Autocorrelation method similarly identified only one period, whereas 
although Enright periodogram recognize two periods, the 12-hour component was 
A B 
C D 
E F 
Figure 4.12 Comparison of period estimation methods for oscillations with multiple 
periods. A) Synthetic signal was generated as combination of a sine wave with 24 
hour period (blue traces) and with 12 hour period (red traces) and 20% of the random 
noise was added (grey traces). The period (value after *peak) of resulting synthetic 
signal (B) was estimated using 4 different methods (C-F)  
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misidentified as having a 36 hour period. 
 The accuracy of the period estimation for synthetic data with two components 
have (Figure 4.13) demonstrated the supremacy of Lomb Scargle periodogram, 
especially in the presence of high noise level. 
 Therefore, the Lomb Scargle periodogram was chosen as the main method to 
evaluate the periodicity of circadian oscillations. In order to investigate how the 
rhythmicity of data changes over the course of the experiment, the Lomb Scargle 
method was implemented based on a series of overlapping windows of analysis, in 
which the rhythm variability in periods was detected using 3 days worth of data and 
12 hours offset (first window contained the first 72 hours (day 1-3) of experimental 
data, second window: 12-84 hours (day 1.5-3.5) and so on). 
Figure 4.13 Period estimation errors for synthetic signal with two waveforms. Two 
periods of oscillations in synthetic data with 5 different amounts of added noise were 
estimated by 4 methods. The values of relative distance (RD), or accuracy of the 
periods estimation, were calculated and plotted on y-axis for each method (top plot). 
The bar chart shows the mean RD value of estimating the periods in synthetic data 
with 5 amounts of added noise for each method (bottom plot). 
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4.3 RESULTS  
 
This project was initiated to test whether it was possible to record concurrent 
circadian molecular rhythms and behavioural characteristics for the same individual 
fly. For this purpose, the experimental strain of period-luciferase transgenic flies was 
crossed with mutant strain of Aβ42 expressing flies so that their offspring will have 
the overexpression of Aβ42 peptide in the brain and produce bioluminescence 
according to the period gene expression in peripheral tissues (Figure 4.4). Collected 
flies from the offspring were monitored using sensitive EM CCD camera with five 
minutes exposure time so that, when flies are constrained within horizontally 
positioned capillary tubes, they demonstrate the one-dimensional locomotor 
behaviour (Figure 4.6). The images were preprocessed to remove the background 
noise and neutralize the vignetting effect and saved as raw images; additionally, raw 
images were further enhanced using contrast-limited adaptive histogram equalization 
(saved as enhanced images). 
 
4.3.1 ANALYSIS OF PARAMETERS 
Each image frame consisted of 300 seconds of photon integration that can be 
directly translated into the timeline of fly behaviour (spatial distribution of photons 
within the tube) and be used to measure the oscillations of clock gene expression 
(sum of pixel intensity within the tube, Figure 4.6). The spatial distribution of photons 
for each fly was presented in forms of two intensity profiles: active fly appeared as a 
smear of dots and the duration of the movement in each image frame was estimated as 
rectangle area in the intensity profile (Figure 4.8, yellow shade); in comparison, a 
resting fly generated a bright, localized dot and produced resting peaks along the 
intensity profile (Figure 4.8, blue shade). Using the enhanced images, the resting 
peaks and activity level were identified. Based on the intensity profile in the raw 
images, the area under resting peaks (Figure 4.8, blue shade) was quantified in terms 
of time a particular fly spent stationary and the area under the activity level (Figure 
4.8, yellow shade) was used to evaluate the time a particular fly spent moving; the 
sum of the areas under those curves was assumed to be equal to 300 seconds for each 
fly in each image frame. Moreover, given the sufficient sampling frequency, the 
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sleep-like episodes were inferred according to the standard criteria (Gilestro 2012). 
Overall, four different parameters were estimated for every fly at each time frame: 1) 
the intensity of bioluminescence, 2) the duration of activity & rest, 3) the presence of 
sleep-like episodes and 4) the sleep consolidation index. The time series of calculated 
parameters were binned into 30 min bins to compare the performance of this novel 
technique with the performance of other conventional assays. 
Due to the luciferase decay, the bioluminescence raw data was detrended in 
such a way that the signal have the same mean and amplitude the over the course of 
the experiment using the method described in 4.2.4.1. The example of the time series 
for a particular fly from the control strain is presented in Figure 4.14 A, where 
molecular clock represents the oscillations of the peripheral circadian clocks and 
locomotor activity is plotted as an average percentage of time the particular fly spent 
moving around with 100% being 300 seconds. The conventional sleep binary array 
depicted the presence of sleep episode but do not provide any information about the 
sleep structure and episode duration. Moreover, most Drosophila sleep studies report 
the total amount of sleep or average length of sleep episodes with the data collected 
usually for less than three days, which make the analysis of circadian fluctuations 
unfeasible. In my study I further analysed the sleep data by creating the sleep 
consolidation array as described in 4.2.3.2, in doing so I revealed the circadian 
oscillations of sleep episode length (Figure 4.14, C). Clearly visible is the transition of 
sleep from a consolidated state, with long sleep episodes, during the subjective night 
(black blocks along the x axis) to the short naps in the daytime.  
The close examination of the sleep consolidation plot (Figure 4.14C) showed 
that the longest and most consolidated sleep episode usually occurred during first 6 
hours in the subjective night, whereas shorter discrete episodes of 40-50 minutes long 
are presented later in the night. Remarkably, I observed sleep episodes of over 3 hours 
that usually occur in the early part of the night, being observed in at least one night in 
52% of control flies. The observed sleep architecture is consistent with the previously 
reported circadian sleep patterns in Drosophila (Gilestro 2012) and resembles the 
structure of human sleep, when a greater amount of deep sleep occurs particularly in 
the early night while the proportion of rapid eye movement (REM) sleep increases 
towards the morning (Wulff, Gatti et al. 2010). 
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Figure 4.14 Example of calculated parameters for a particular fly. A) The oscillation 
of the molecular clock is reported by the bioluminesence intensity of a single fly 
during the 7 days of the experiment in contant dakrness. The percentage of time a 
particular fly spent active (Locomotor activity) was estimated and the sleep status 
(Sleep binary) was assigned to each time frame. B) The presence of sleep-like episode 
(Sleep binary array) was estimated based on three criterias described in 4.2.3.2. Each 
sleep frame in sleep consolidation array contained the total length of the 
encompassing sleep episode. C) The structure of the sleep consolidation exhibited 
circadian oscillations. X-axis in A) and C) represent the circadian time in hours with 
indicated subjective day (grey) and subjective night (black). The recording started at 
subjective dusk, when circadian time=12 hr. 
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4.3.2 COMPARISON OF THE FLYGLOW PERFORMANCE WITH EXISTING 
METHODS 
 To evaluate the performance of the developed system, named FLYGLOW, 
circadian behavioural and molecular oscillations were recorded for 23 day old control 
period-luciferase transgenic flies, and flies co-expressing both luciferase and Aβ42, for 
seven days in constant darkness and temperature. Previously, it was demonstrated that 
the Aβ42 flies of similar age show progressive behavioural arrhythmia, despite their 
central molecular clock remaining rhythmic (Chen, Possidente et al. 2014). 
Additionally, the locomotor behaviour of flies with the same genotype was 
recorded using the conventional infrared beam split system (DAM). Visually, the 
average locomotor rhythm profile of control flies measured by FLYGLOW appear 
more rhythmic as compared to the one detected by DAM (Figure 4.15). As expected 
(Chen, Possidente et al. 2014), Aβ42-expressing flies exhibit considerably weaker 
rhythmicity as compared to the control group, however the locomotor traces identified 
by DAM appeared substantially arrhythmic whereas spatial resolution of FLYGLOW 
allowed the detection of the retained oscillations.  
The robustness of the fly’s behavioural rhythmicity was quantified using the 
autocorrelation rhythmicity index (RS value, (Levine, Funes et al. 2002)), where the 
oscillations are considered as rhythmic if RS>1.5. Provided the same temporal 
sampling resolution (30 minutes binning), it was observed that RS values of Aβ42-
expressing flies detected by both FLYGLOW and DAM are significantly lower as 
compared to control group (Figure 4.15 B). Comparison of the distribution of RS 
values for the population of flies recorded by FLYGLOW and DAM revealed an 
essentially identical pattern (χ2 test, p<0.05), yet FLYGLOW identified more highly 
rhythmic flies (green bars on the right, Figure 4.15 C), demonstrating higher 
sensitivity of detecting rhythm variation. 
Furthermore, in order to test the possibility that the freedom of movement seen 
in FLYGLOW could add a systematic artefact we sought to compare the molecular 
clock signal with the well established luminometer method (described in 4.1.4, 
Brandes, Plautz et al. 1996) where the flies are restrained under a small plastic dome.  
A possible source of artefact could be the lower abundance of luciferin substrate in 
the tubes as compared to domes may result in a false variation in bioluminescence.  
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Figure 4.15 Comparison of FLYGLOW with conventional methods. A) The mean 
locomotor activity for control and Aβ42-expressing flies was estimated using DAM 
(y-axis represents the percentage of beam breaks per 30 mins) and FLYGLOW. X-
axis represents circadian time in hours with subjective day (grey bars) and night 
(black). B) The robustness of locomotor rhythmicity was quantified by calculating 
RS values. Rhythms were significantly stronger in control flies as compared to 
Aβ42-expressing flies (determined by 2-way ANOVA test). RS values identified by 
FLYGLOW were not different from that of DAM (2-way ANOVA). C) Frequency 
distribution of RS values from FLYGLOW is similar to those from DAM. D) 
Comparing the mean bioluminescence from FLYGLOW and flies observed in 
domed well plate indicate that molecular clock signals are equivalent (right). No 
significant difference was found between RS values of molecular clock oscillations 
between FLYGLOW (blue) and classical approach (red). 
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After accounting for the luciferase decay, it was observed that both FLYGLOW and 
the current gold standard housing designs generated essentially identical molecular 
clock oscillations with similar distribution of RS values (Figure 4.15D). In summary, 
the above-mentioned comparison indicates that the novel FLYGLOW system is 
capable of detecting locomotor and molecular oscillations simultaneously with better 
sensitivity and resolution than existing methods. 
 
4.3.3 SIMULTANEOUS COMPARISON OF CIRCADIAN PARAMETERS 
 The following analysis considers three time series datasets from control flies 
expressing only the luciferase reporter construct and also those flies expressing the 
Aβ42 peptide. The dataset are: 1) oscillations of the peripheral molecular clock as 
reported by the intensity of emitted light, 2) locomotor activity as a percentage of time 
spent moving and 3) sleep consolidation. For convenience, these parameters are 
presented as mean traces for a population of flies (Figure 4.16).  
As it can be seen in Figure 4.16 A, the detrended time series of molecular 
clock for control flies from three experiment runs (total number of flies in control 
group N=60) are characterized by the high amplitude of oscillations that peak in the 
early part of subjective night (black bars along x axis) and robust circadian 
oscillations with gradual dampening over the course of 7-day experiment (Veleri, 
Brandes et al. 2003). Similarly, Aβ42-expressing flies (three experiment runs, total 
number of flies N=45) exhibited the rhythmic oscillations of peripheral molecular 
clocks, however the deterioration started from day 4 onwards.  
The locomotor activity of control flies, as estimated by percentage of time fly 
spent in activity, showed highly circadian rhythms with two distinguishable peaks of 
activity; the first usually occurred just before the subjective dusk, when flies spent up 
to 50% of time moving, and second just before dawn with approximately 40% of time 
spent on movement (Figure 4.16 A). In contrast, Aβ42-expressing flies exhibit low-
amplitude and less rhythmic oscillations of locomotor activity that can be described as 
a state of continuous restlessness during the subjective day and night. 
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Figure 4.16 Comparing the rhythmicity of control and Aβ42-expressing flies.                 
A) Population mean of bioluminescence (Molecular clock), percentage of time spent 
active (Activity) and length of each sleep episodes (Sleep consolidation) were plotted 
for control and Aβ42-expressing flies. Insert demonstrated that daytime sleep episodes 
were longer in Aβ42-expressing flies (red) as compared to controls (black). B) All 3 
rhythms are significantly less robust in Aβ42-expressing flies (red dots) as compared to 
controls (black dots), determined by RS values. The same letter alphabet is indicated for 
the group with no difference in the RS values (one-way ANOVA). C) The distribution 
of relative partitioning of time between sleep, activity and rest showed no difference for 
Aβ42-expressing flies (red) and controls (black). D) Panels I and II: Aβ42-expressing 
flies exhibited weak behavioural rhythms (activity in red and sleep consolidation in 
blue) 
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As can be expected, the oscillations of sleep consolidation are in anti-phase 
with oscillations of locomotor activity, where often the longest sleep episodes occur 
when locomotor activity is at its lowest (Figure 4.16 A). Specifically, in the early part 
of the subjective night, when control flies spend less than 5% of their time moving, 
the duration of an average sleep episode in flies is surprisingly high, exceeding 2 
hours of undisrupted sleep. This structure of sleep consolidation superficially 
resembles the inverted human hypnogram (graph representing sleep stages as a 
function of time), where the deep sleep stage, as analogues to the longest sleep 
episode in flies, is usually appear earlier in the night. During the morning time of the 
subjective day, the flies normally take short naps, not longer than 30 minutes, and 
start to demonstrate significant locomotor activity (20-30% of time spent moving). 
Peak locomotor activity was observed in the late afternoon coincide with the shortest 
sleep episodes. Remarkably, the inset in the in Figure 4.16A, that represent duration 
of daytime sleep episodes, suggests that Aβ42-expressing flies (red), similarly to 
patients with AD, have longer sleep episodes in the subjective day as compared to the 
control group of flies (black). 
The visual interpretation of circadian oscillation assessed at the population 
level (Figure 4.16 A) has been validated quantitatively by calculating rhythmicity 
statistic (RS) value for each individual fly. According to the RS values (Figure 4.16 
B) Aβ42-expressing flies (red dots) are characterized by the significantly reduced 
robustness of all three rhythms as compared to control group of flies (black dots). 
Moreover, significantly higher proportion of flies in the control group exhibit 
rhythmic oscillations (85% for molecular clock, 71% for locomotor activity and sleep 
consolidation) in comparison with Aβ42-expressing (66% for molecular clock, 42% 
for locomotor activity and 42% sleep consolidation). Importantly, the average 
proportions of sleep (sum of rests longer than 5 minutes), activity and rest (sum of 
rests shorter than 5 minutes) was the same for both control and Aβ42-expressing flies 
(Figure 4.16 C). Notwithstanding this, Aβ42-expressing flies on average had 
significantly longer sleep episodes during the daytime. This observation indicates that 
the differences in sleep are attributed to its temporal organization rather than total 
amount of sleep. 
The simultaneous recording of different circadian oscillation gives an 
opportunity to investigate the relationships between the individual rhythms using 
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single-fly data (Figure 4.16 D). For example, a large proportion of Aβ42-expressing 
flies exhibits arrhythmic behaviour but have rhythmic oscillations of molecular clock 
(panel I and II). Moreover, some of the individual Aβ42-expressing flies had disrupted 
rhythmicity of all three parameters (panel III), whereas the majority of the flies in 
control group retain the rhythmic oscillations of all three parameters throughout the 
course of the 7-day experiment (panel IV). In general, these observations might 
suggest that Aβ expression in the nervous system in the Drosophila can potentially 
results in the progressive deterioration of behavioural and molecular rhythms, but 
these oscillations decay independently of each other. 
 
4.3.4 SPECTRAL ANALYSIS OF PERIODICITY OF THE OSCILLATIONS 
 In order to examine more closely the period stability and estimate if the 
circadian oscillations undergo the period doubling bifurcation, spectral analysis was 
employed. Conventional methods of spectral analysis, such as MESA and FFT-based 
periodograms, normally estimate the multiple components of the period for the whole 
time series and report the result in terms of global periodicities detected over the 
course of experiment. Therefore, to investigate how the circadian oscillations 
progressively deteriorate over the course of the experiment, which applies especially 
to the rhythms exhibited by Aβ42-expressing flies, Lomb Scargle periodogram was 
implemented based on a sliding window principle, as mentioned in 4.2.4.3. The 
application of this approach to the time series of sleep consolidation (Figure 4.17 A), 
revealed the most significant differences in period during the course of the 
experiment. This spectral analysis reveals that control fly retained stable periods of 
around 24 hours for sleep consolidation (Figure 4.17 B, left) throughout the 7 days of 
the experiment. In contrast, sleep consolidation in Aβ42-expressing fly is 
characterized by the progressive period deviation from 24 hours (Figure 4.17B, right). 
At a population level, the average spectral power of the sleep rhythms (black traces in 
Figure 4.17 C, left) demonstrates that control flies exhibit strong 24-hour period of 
oscillations, which is consistent among the flies in control group (pink shade in Figure 
4.17 C, left). In Aβ42-expressing flies, spectral power for 24-hour component is less 
pronounced and has higher variability between within the population of flies (Figure 
4.17 C, right), indicating that Aβ42-expressing flies have difficulties in maintaining a 
regular sleep homeostasis in constant darkness.  
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4.3.5 COORDINATION BETWEEN MOLECULAR CLOCKS AND CIRCADIAN 
BEHAVIOURS  
 An additional benefit of recording multiple circadian rhythms simultaneously 
with FLYGLOW is that subtle correlations between signals can be detected.  Of 
particular interest are correlations in rhythm robustness between two signals 
suggesting they may be coupled.  Moreover, correlations between the free-running 
periods of rhythms may indicate that there are underlying mechanistic similarities 
even if the rhythms are not directly coupled. Moreover, simultaneous measurement of 
multiple circadian rhythms for the same individual fly provide opportunities to 
Figure 4.17 Spectral analysis of sleep consolidation time series. A) Sleep 
consolidation for representative single control or Aβ42-expressing fly was plotted as a 
function of time. B) The spectral analysis of sleep time series using the sliding 
window approach showed the stable period of oscillations for control fly but in Aβ42-
expressing fly period progressively deviates from 24 hour component. C) Average 
spectral profile of control fly (black line) demonstrated the presence of strong 24 hour 
component with additional ~12 hour component in the sleep time series. Aβ42-
expressing flies are characterized by the higher variability within the population of 
flies (pink shade). 
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perform paired statistical tests, which has not been possible previously because 
different rhythms were observed in different groups of flies using different 
experimental equipment. With regards to the robustness of rhythm, the general 
assumption is that if RS values of two rhythms of interest are correlated, then they 
might be coupled together. For instance, if one rhythm is coupled to another then if 
one of the rhythms is robust, then it is expected that the other will also be robust, and 
vice-versa. Moreover, if a master rhythm drives a slave then it is impossible that the 
slave can be rhythmic if the master is arrhythmic. 
Implementing a three-way analysis of RS correlations for individual rhythmic 
flies in control group have indicated that there is no coupling between molecular 
clock and either of the behavioural rhythms (black dots in Figure 4.18 A, panel I and 
II) as no significant correlation was found using Pearson correlation coefficient. 
However, significant correlation was found for RS values for locomotor behaviour 
and sleep consolidation (panel III).  Taking into account that sleep consolidation is 
not the simple reciprocal of activity (but rather represents the length of each sleep 
episode) and so this is not a trivial correlation, it might suggest that both locomotor 
activity and sleep rhythms are coordinated by the same central clock mechanism, but 
supposedly through different output pathways. Likewise, there were no robustness 
correlations observed between behavioural rhythms and peripheral clock oscillation in 
rhythmic Aβ42-expressing flies (red dots in Figure 4.18 A, panel I and II). 
Furthermore, there the correlation between sleep and locomotor activity rhythms seen 
in control flies (red dots in Figure 4.18 A, panel III) was not present in Aβ42 flies. 
This dissimilarity might indicate that neuronal coordination is compromised in Aβ42-
expressing flies and consistent with significantly reduced robustness of behavioural 
rhythms even in rhythmic Aβ42-expressing flies as compared to controls (lower RS 
values in Figure 4.18 A). 
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Figure 4.18 Investigating the RS values and periods correlations. A) Paired RS 
values for various rhythms were plotted for each fly in control (black) or Aβ42-
expressing population of flies (red). B) Paired periods for various rhythms were 
plotted for each fly. C) The correspondent pairwise rhythm comparisons were 
plotted. X-axis represents the circadian time in hours. D) The phase difference 
between rhythms across the time course was calculated using the sliding window 
approach and plotted for each fly (the phase differences were plotted between the 
oscillation of molecular clock (intensity) and locomotor behaviour (activity) in 
panel I, between  molecular clock and sleep consolidation in panel II and 
locomotor activity and sleep consolidation in panel III. 
A 
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A similar systematic three-way analysis of rhythm periods in individual 
control flies have demonstrated the correlation between peripheral molecular clock 
and both of the behavioural rhythms, even though their RS values are not correlated 
and the actual periods of the rhythms are different (Figure 4.18 B, panel I and II). 
These observations indicate that period co-variation is significant for molecular clock 
vs. locomotor activity and for molecular clock vs. sleep consolidation.  The 
implications are that these pairs of rhythms share common underpinning mechanisms 
because, taking into account slight variation between individuals, control elements 
that change period of one rhythms also tend to modify the period of the correlated 
rhythms. Interestingly, there we could not detect period correlations for sleep 
consolidation and locomotor activity (panel III).  While the underpinning molecular 
mechanisms are likely to be identical, as deduced from the two period correlations 
described above, the implication is that sleep rhythms are modified by additional 
environmental factors that are highly variable between flies, such as the need for 
homeostatic regulation of total sleep in an environment that may disturb sleep (Wu, 
Koh et al. 2008, Kunst, Hughes et al. 2014). Similarly to the control flies, the periods 
of the sleep and activity rhythms do not show any correlation for Aβ42-expressing 
flies. Furthermore, the periods of peripheral clocks did not correlate with either of 
sleep or activity rhythms (red dots in Figure 4.18 B), indicating that the accumulation 
of Aβ in the brain damages the connections between the molecular clock and 
behavioural oscillations even in flies with rhythmic oscillations of molecular clock.  
Notably, comparison of the periods of each rhythms using the paired t-test 
have demonstrated that the periods of sleep and activity oscillations (23.7 and 23.6 
hours respectively) are in fact significantly longer than the period of peripheral 
molecular rhythms (~23 hours) in control population of flies (Figure 4.18 B), 
suggesting the involvement of non-circadian mechanism in the daily behavioural 
oscillations. The shorter period of the molecular clock can be visualized by its 
progressive desynchronisation with respect to the behavioural readouts.  Indeed, in 
Figure 4.18C there are 8 peaks of the molecular clock signal for only 7 peaks of the 
behavioural rhythms).  
In order to explore this difference in period in more detail, the phase of the 
peaks in both behavioural rhythms and molecular oscillations for each individual fly 
were compared with each for 3 day windows across the recording time. As can be 
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seen in Figure 4.18 D, for control flies there was a progressive change in the phase 
difference between behavioural and molecular oscillations over the course of the 
experiment (black symbols, decreasing trend between activity and molecular rhythms 
in Figure 4.18 D-I and increasing differences between molecular and sleep rhythms in 
Figure 4.18 D-II), while for control flies the phase difference between the two 
behavioural rhythms exhibited a stable ~6 hours phase delay (black symbols, Figure 
4.18 D-III). 
On the other hand, no significant phase difference was detected between either 
of the activity or sleep oscillations and molecular rhythms (red dots, Figure 4.18 D) 
for Aβ42-expressing flies, probably because of the compromised rhythmicity of the 
oscillations (Figure 4.18 C, red). Visually quantifying the difference in peaks numbers 
between averaged behavioural and molecular rhythms is more challenging for what 
seems like chaotic waveforms. In particular, sleep oscillations of Aβ42-expressing 
flies are characterized by the emergence of the shorter wave components (~12 hours) 
towards the end of the experiment (Figure 4.18 C, panel II), suggesting the disruption 
of sleep structure and sleep fragmentation. 
 Overall, systematic correlation analysis has implied that behavioural rhythms 
and peripheral molecular clock oscillate in the constant darkness with different 
periods for control flies. However, neuronal damage caused by Aβ expression in fly 
brain likely lead to the independently compromised rhythmicity of behavioural and 
molecular oscillations and result in period instability and chaotic phase relationships 
between rhythms. 
 
4.4 DISCUSSION  
 
 Recent studies have shown that circadian rhythms, in addition to their role in 
the regulation of a variety of biological processes in living organism, also either 
associated or constitute risk factors for human disease. Several lines of evidence 
suggest that environmental disruption of circadian rhythms increases the risk of the 
diseases, while in contrast some studies have demonstrated that some diseases are 
accompanied by the circadian deficits from the early stage (Reddy and O'Neill 2010, 
Rakshit, Thomas et al. 2014). Moreover, circadian abnormalities, such as disrupted 
daily rhythms of sleep and activity, have been observed as one of the symptoms of 
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several neurodegenerative disorders, including Alzheimer’s disease. Generally, until 
recently the circadian deficits have been conventionally viewed as a consequence of 
the neurodegeneration. However, emerging literature indicate that disruptions of 
circadian rhythms may contribute to the neurodegeneration process and influence 
disease pathology (Musiek 2015). Recent finding that use of sleeping tables (in 
particular, benzodiazepine) is associated with 50% increase in risk of AD show the 
involvement of circadian deficits at the early stage of the disease, as a part of 
dementia prodrome (Steurer 2014). As the disease progresses, patients with AD 
experience poor quality sleep fragmentation and disruption of normal day/night 
pattern.  
Since circadian clocks are highly conserved, it is a common practice to use 
animal models to study disease pathogenesis. The circadian mechanisms of one of 
such model organism, namely Drosophila melanogaster, have been comprehensively 
studied and, when used as model of AD, it successfully mimics key phenotypical 
aspects of disruption of circadian/sleep regulation associated with human aging and 
neurodegeneration (Tomioka, Uryu et al. 2012, Chen, Possidente et al. 2014, Rakshit, 
Thomas et al. 2014). Understanding the mechanisms by which the molecular clock 
controls behaviour may provide a valuable insight into the disease pathogenesis but to 
date no appropriate methods have been available, at least for Drosophila, to 
longitudinally monitor multiple behavioural and molecular oscillations in individual 
animal. 
In order to investigate the causal relationship between multiple circadian 
rhythms, a novel recording system, FLYGLOW, has been developed to 
simultaneously record peripheral molecular oscillations, sleep and activity rhythms in 
the same fly. To recognize the oscillations of the molecular clock, a fly strain which 
expresses period-luciferase transgene XLG-luc2, was studied, with and without 
crossing in a transgene for Aβ-expression. Using a sensitive EM-CCD camera 
mounted in the environmentally controlled incubator, images were recorded with the 
temporal resolution that is compatible with the current working definition of fly sleep 
(300 sec of immobility) in such a way that the spatial distribution of light signal in a 
particular tube can be translated into the duration of fly movement or inactivity. This 
conversion was performed using image analysis techniques (described in 4.2 
Materials and Methods), allowing the quantification of multiple circadian parameters, 
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such as molecular, locomotor and sleep oscillations for the individual organism kept 
in constant darkness for 7 days. Even though FLYGLOW is not designed to run the 
experiment in light-dark cycles, it can be used a powerful tool to study non-photo 
entrainment, using cues such as temperature. FLYGLOW system is an improvement 
over current alternative methods in Drosophila, which can measure only one of the 
circadian parameters in any given experiment (either circadian behaviour or 
bioluminescence). Because of the experimental limitations of the current paradigm, 
comparative rhythm analysis is only possible on a population level, rather than for 
individual flies, and is unable to assess intra-individual correlations. 
Careful examination of the results has shown that, as a population, control 
flies exhibit complex oscillations of sleep and locomotor behaviour, that remain 
robust for the duration of the experiment in constant darkness (Figure 4.16). Notably, 
in the early night the typical duration of sleep episode reaches up to 3 hours of 
undisrupted sleep. However, in Aβ42-expressing flies this long, consolidated sleep 
was lost early and replaced by fragmented sleep distributed uniformly across the day, 
with longer daytime naps, as have been confirmed in a recent study (Tabuchi, Lone et 
al. 2015). Similar disruptions of normal sleep structure and destabilization of sleep 
mechanism have been observed in patients with AD (Wulff, Gatti et al. 2010, Coogan, 
Schutova et al. 2013). Remarkably the total amounts of rest, sleep and activity in 
Aβ42-expressing flies are essentially identical to control flies, indicating that the 
disruption is of sleep architecture rather than the total amount of sleep. In particular, 
spectral analysis of sleep consolidation time series provided evidence of the 
progressive period destabilization in Aβ42-expressing flies, suggesting the disruption 
of the control mechanism of a regular sleep homeostasis. 
Simultaneously measuring the circadian oscillations using FLYGLOW have 
revealed that molecular clock in peripheral tissues was more robust than behavioural 
rhythms in Aβ42-expressing flies. Consistent with previous observations that central 
molecular clock becoming progressively desynchronized from behaviour in Aβ42-
expressing flies (Chen, Possidente et al. 2014, Long, Blake et al. 2014), the 
comparisons of rhythm quality for individual Aβ42-expressing flies have demonstrated 
many examples of flies with robust molecular rhythms but arrhythmic behaviour. 
These recurring findings of the molecular-behavioural asynchrony may imply that 
behavioural deficits during Aβ related neurodegeneration may be due to the 
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disruption in outputs of the clocks rather than damage to the peripheral or central 
clocks themselves (Luo, Chen et al. 2012, Chen, Possidente et al. 2014, Rakshit, 
Thomas et al. 2014). 
The advantage of simultaneous single-fly observations of multiple circadian 
rhythms using FLYGLOW is the opportunities provided to dissect the causal 
relationships between circadian oscillations by performing paired correlation analyses 
of rhythm robustness and period length, which have not been possible before at a 
population level analysis. As a result of my study, no correlation was found between 
RS values of the peripheral molecular clock and either sleep or locomotor behavioural 
rhythms in mid-aged control and Aβ42-expressing flies. These observations indicate 
an absence of inter-coupling between peripheral molecular clock and behavioural 
rhythms, as have been previously suggested by several studies (Hege, Stanewsky et 
al. 1997, Giebultowicz, Stanewsky et al. 2000). Performing similar correlation 
analysis of periodicities of the circadian oscillation has revealed the interdependence 
of peripheral molecular clock and locomotor behavioural rhythms despite non-
correlated RS values, confirming the common belief that the pace of the central 
molecular clock determines the pace of circadian behaviour. Notably, such correlation 
was not recognized for Aβ42-expressing flies, providing the evidence that 
Aβ−mediated toxicity damages the connection between molecular clock and circadian 
behaviours. Under these circumstances, the developed method may be of particular 
interest to investigate the role of peripheral clock in the age-related behavioural 
arrhythmia (Luo, Chen et al. 2012, Rakshit, Thomas et al. 2014), which characterized 
by the higher degree of inter-individual variation in the progressive circadian 
behavioural disruptions (Koudounas, Green et al. 2012). 
On the other hand, the observed correlation between robustness of sleep 
consolidation, which characterises the daily fluctuations of sleep duration rather than 
being a simple reciprocal of locomotor activity, and locomotor behaviour indicate a 
degree of coupling between their rhythms. However, the absence of correlation 
between the periods of sleep and activity oscillations suggests more complex 
mechanism of sleep/wake regulation that may respond to other homeostatic and 
regulatory cues (Bushey, Tononi et al. 2011). In particular, in humans forced 
desynchrony of 14:14 light:dark cycle lead to the similar dissociation, when circadian 
rhythms become progressively decoupled from sleep-wake cycle. 
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Interestingly, it was observed that peripheral and behavioural rhythms free run 
in the constant darkness with slightly different endogenous periods. The shorter 
period (22.6 hour) of luciferase oscillations of the XLG-luc2 transgenic flies has been 
reported in previous studies, but the period of circadian behaviours has not previously 
been documented (Veleri, Brandes et al. 2003).  The difference in periodicity between 
behavioural and molecular rhythms is visualized graphically by plotting the phase 
relationships between two oscillations throughout the course of the experiment. My 
observation confirms an earlier study showing that when the peripheral clock in 
transplanted Malpighian tubules is out of phase it continues to free run independently 
of the circadian clock of the host fly (Hege, Stanewsky et al. 1997). Even though 
FLYGLOW recorded the bioluminescence emitted from the whole adult fly and 
unlikely obtained signal from this specific excretory organ, it nevertheless agree with 
the hypothesis that the majority of peripheral clocks in Drosophila are autonomously 
entrained by environmental light cues and are independent of central clock (Plautz, 
Kaneko et al. 1997). 
 
4.5 CONCLUSION 
 
 In this chapter, a novel recording system FLYGLOW was developed to 
simultaneously monitor circadian behaviours and peripheral molecular clocks, which 
gives an opportunity to study the causal relationships between multiple circadian 
rhythms in the freely moving flies. The results of the experiment have demonstrated 
that the peripheral clock is not directly coupled to circadian behaviour in mid aged 
flies. The advantage of the simultaneous measurements of circadian rhythms 
permitted paired statistical comparisons that boost the statistical power of my insights 
into the aetiology of complex age-related neurodegenerative diseases, such as 
Alzheimer’s disease. Moreover, FLYGLOW can be readily applicable to more 
broadly based behavioural, genetic and drug-based screens. 
 
CHAPTER 5: STUDY OF POSITIONAL PREFERENCE IN DROSOPHILA AND HOW THIS IS DEGRADED IN A MODEL OF 
ALZHEIMER’S DISEASE 
 91 
CHAPTER 5: STUDY OF POSITIONAL PREFERENCE 
IN DROSOPHILA AND HOW THIS IS DEGRADED IN A 
MODEL OF ALZHEIMER’S DISEASE 
 
It is commonly observed that patients with Alzheimer’s disease, in addition to 
the progressive memory loss, experience spatial and temporal disorientation as one of 
the main symptom of neurodegeneration. Spatial orientation is complex cognitive task 
that relies on the topographic learning and perception of the surrounding and may be 
impaired in AD, leading to the severe difficulties to navigate in a familiar 
environment (Giannakopoulos, Gold et al. 2000). This chapter will focus on 
understanding the spatial orientation in Drosophila and how this may be disturbed in 
a model of AD. 
 
5.1 INTRODUCTION 
  
 In most cases of AD the hippocampus, which is responsible for memory 
formation, is one of the first regions of the brain to be damaged. As the disease 
progresses, the neurodegeneration spreads to the cortical regions, resulting in a wide 
range of cognitive dysfunction, one of which is spatial disorientation. Recent 
discovery of the positioning system within the brain have demonstrated the 
involvement of hippocampus in the spatial memory, where the “place cells” formed a 
map within the brain alongside the “grid cells’ in the entorhinal cortex, which are 
responsible for navigation and positioning (O'Keefe and Dostrovsky 1971, Fyhn, 
Molden et al. 2004).  
Moreover, the ability to navigate and orient themselves is an important 
survival skill for the any motile organisms, from bacteria to flies and vertebrates. In 
order to succeed, living organisms have to extract relevant cues from the 
environment, process them and incorporate into internal representation to determine 
the adequate respond to any situation. For example, simple organisms, such as 
bacteria E.coli, direct their movement according to the chemical stimuli, a process 
known as chemotaxis. These œbacteria use locomotor organelles called flagella to 
propel themselves at speeds of 10-20 body lengths per second. In uniform chemical 
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environment, E.coli swims in random walk pattern as a result of episodes of straight 
runs lasting for about a second and episodes of random flagella rotation. In an 
attractant or repellent environment, the cell assesses chemical concentration and 
modulates the probability of tumbling frequency. It is important to note that during a 
tumbling event E.coli is unable to choose the subsequent direction of movement but 
simply resets its orientation randomly. Thus bacteria have a “run-and-tumble” method 
of locomotion consisting of two modes; the first is the “run” where the microbe 
moves in a straight line and the second is the random tumble. As a result, bacteria 
direct their movement towards the favourable location, up the gradient of a 
chemoattractant, by controlling the probability of transition between these two modes 
of motion in a stimulus dependent manner (Berg and Purcell 1977).  
It has been found that other living organisms use similar chemotactic strategy 
to some extent. Several lines of evidence shown that insects may use stereo 
chemosensation, a mechanism of locating odour sources by comparing the inputs 
transmitted by each antenna. For example, adult flies demonstrate a wide range of 
odour driven behaviours. Odour cues regulate not only identification of food sources 
and social communication between individual flies, but also walking and flight 
behaviour (Gomez-Marin, Duistermars et al. 2010). In general, the information 
obtained from the olfactory system is integrated with input from other modalities, 
such as visual system, and translated into the set of motor commands that direct the 
fly towards its target. Interestingly, it has been demonstrated that motor response to 
the visual and olfactory cues presented simultaneously are identical to the linear 
superposition of stimuli presented in isolation, suggesting that they are governed by 
separate but parallel sensorimotor pathways (Frye and Dickinson 2004). However, in 
absence of both visual and olfactory stimuli, such as for example in case of confined 
space and complete darkness, Drosophila can estimate its position relative to the 
reference point by continuously monitoring its movement and therefore relying on 
self-motion cues. Moreover, in the absence of both visual and self-motion cues, the 
representation of the fly position is sustained through persistent activity, a potential 
equivalent to the short-term memory (Seelig and Jayaraman 2015). 
In addition, several reports about fly behaviour have found that Drosophila 
have periodic preference patterns for their position within a tube, specifically that 
prior to rest, the flies positioned themselves relative to their food (Hendricks, Finn et 
al. 2000, Donelson, Kim et al. 2012). However, little is known about the rationale 
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behind the positional preferences, indeed the current literature indicates that flies use 
presumed odour gradients to position themselves in a tube in the absence of other 
stimuli.  Furthermore it is unknown to what extend the neurodegeneration associated 
with AD affects spatial orientation in the flies. Therefore, in order to investigate the 
control function underpinning diurnal orientation of the flies, the previously 
developed FLYGLOW system was used to observe flies behaviour as described in 
chapter 4. The flies were confined in what is essentially a one-dimensional space, 
provided by the capped capillary tubes, and polarized by food at one end and air at the 
other end of the tube. The experimental design ensured that the flies were maintained 
in constant darkness, ensuring that no visual cues were present and we reasoned 
therefore that the fly can estimate its position along the tubes based only on olfactory 
and self-motion cues. However, the exact mechanism of how fly integrate the 
feedback from these cues is still unclear. For this reason, two models of fly behaviour 
in response to the olfactory cue (food smell) in constant darkness were developed. In 
model 1 it is assumed that flies use olfactory cues (food odour stimuli) to orient 
themselves in the tubes and therefore their location preference relies on judgment of 
the relative distance along the tube, namely the percentage of the tube length away 
from the food. In comparison, model 2 is based on the assumption that flies use self-
motion cues to estimate their position and, as a result, the positional preferences are 
based on the absolute distance from the attractant source, meaning that flies can 
effectively count their steps away from the food. For example, Donelson and 
colleagues (Donelson, Kim et al. 2012) suggested that flies have a positional 
preference to sleep a quarter of the way along the tube close to the food. This 
observation does not distinguish however between model 1, where the flies estimate 
their position based on the olfactory gradient of food, or model 2, where spatial 
awareness is based on the absolute distance away from the food end of the tube. It 
was only possible to determine which model best accounts for the position 
preferences by housing the flies in capillary tubes of different lengths and using 
FLYGLOW to observe their movements.  
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5.2 MATERIALS AND METHODS 
 
To study the positional preferences in Drosophila, the FLYGLOW system (as 
described in chapter 4) was used to monitor the locomotor activity and determine the 
presence of sleep-like state of control and Aβ42-expressing flies constrained in tubes 
of different length. 
 
5.2.1 EXPERIMENTAL DESIGN 
 For this project, the experiment was set up in a same way as FLYGLOW 
system described in chapter 4. Control and Aβ42-expressing strains of flies were 
generated with the same genotype as described in 4.2.1.1. In brief, to monitor fly 
movement in constant darkness, period-luciferase transgenic fly strain XLG-luc2 was 
crossed to the UAS-Aβ42 or a background control strain. The resulting Aβ42-
expressing fly strain, elav-gal4;UAS-Aβ42/+;XLG-luc2/+, and control strain, elav-
gal4; +/+;XLG-luc2/+, were used in the experiment.  
 In order to examine the fly spatial navigation and positional preference in 
either sleep or wake state, custom made glass tubes of different length were used.  
Control and Aβ42-expressing flies were placed in capped glass tubes with 5 mm in 
diameter and 4 different lengths: 1) 3.5 cm, 2) 7 cm (standard length, conventionally 
used), 3) 10.5 cm and 4) 14 cm. Due to the limited capacity of the incubator, 8 flies of 
each of the required genotypes were loaded into tubes of each of the four different 
lengths. 
 The bioluminescence images of control and Aβ42-expressing flies, taken with 
EM CCD camera, were analysed and five different parameters were calculated for 
each fly as described in 4.2.3. The original 5 minutes temporal resolution of time 
series was used for the analysis of fly positional preference (1961 time points taken 
every 5 minutes = 6.8 days of experiment). 
 
5.2.2 FLY POSITION IN A TUBE 
 In order to establish the position of a particular fly in a tube, two time series of 
the circadian parameters, measured with the FLYGLOW system, were used: 
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bioluminescence data in terms of intensity of emitted light and the sleep binary array, 
that codes for the presence of a sleep-like state.  
As several studies have shown, most animals exhibit environmental 
preferences for sleeping (Campbell and Tobler 1984), accordingly fly positional 
preferences were assessed when the fly was in each of two behavioural states: when 
awake and when asleep. The data can be acquired from the series of captured images, 
as a time series of bioluminescence distributions of a particular fly along a tube over a 
300 sec exposure. A sleep or wake state that was inferred is held in the sleep binary 
array, calculated as described in chapter 4. The length of tubes was represented as the 
number of pixels the tube occupies in an image. Knowing the absolute length of 
tubes, it was estimated that 1 mm corresponds to 3 pixels. As stated in 4.2.3.2, the 
tube length represented by the image was divided into 4 pixel high bins along long 
axis to reduce the effect of minor errors, resulting in 27 bins for 3.5 cm long tube, 48 
bins for 7 cm tube, 76 bins for 10.5 cm tube and 101 bins for 14 cm tube. The slight 
variation of the tube lengths was due to the fact that effective length of the tube, 
proportional to the tube length available to the fly for movement, was limited by the 
cotton wool on one end and fly food loaded in the tube on the other end.  
Considering the data for either wake or sleeping flies separately, the fly 
position in a tube was visualized using the heat map approach, where individual 
values of intensity of light are represented as colours. In order to standardize the 
fluctuation of the intensity across the time points, the intensity values 𝑋!  for an 
individual fly for a given image frame 𝑖 were normalized as follows: 𝑋!" = !!!!!"#!!"#  !!!"#  (5.1) 
where 𝑋!" - normalized intensity of emitted light in the range [0,1], 𝑋! – original 
intensity value, 𝑋!"#/𝑋!"#   – minimum and maximum values of the intensity at a 
given image frame. The x-axis in the heat map represents the elapsed time, while the 
y-axis corresponds to the spatial bin location. The colours in the heat map indicate the 
probability of the fly being at a given location in terms of spatial distribution of the 
bioluminescence across the tube, where lighter colour represent the highest 
probability and black indicate the absence of the fly presence at a given position. The 
heat map plots consisted of the mean residency probability for the 8 flies of each 
genotype for each position within each tube and at each time point. 
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Furthermore, the average residency of every fly along the tube was 
established. First, a mean values of the intensity profile were extracted for day 1 to 
day 3 (in accordance with multiple experimental procedures, for example, by 
(Donelson, Kim et al. 2012, Faville, Kottler et al. 2015), averaging the data across the 
time points. To get the average positional preference, these values for day 1-3 were 
summed and normalized as described above, so that values are in a range [0, 1]. 
 
5.2.3 MODELLING FLY MOVEMENT 
 In order to determine the underlying mechanism behind the food attraction and 
positional preferences, specifically during the awake periods when the fly is mobile, 
two models of fly location preferences were developed.  
 
5.2.3.1 MODEL 1: OLFACTORY CUES 
It is assumed that the odour gradient in a confined space is distributed linearly 
as a result of gaseous diffusion, with the highest concentration near the food source 
and lowest near the air end of the tube.  
Assuming that the particles diffuse at a constant rate in an approximately one 
dimensional space with the open end, the equation of the volumetric concentration of 
particles is given by: 
 −𝐷 ∙ !"!" = 𝐴 (5.2) 
where 𝜕𝑐 𝜕𝑥  – change of the particle concentration 𝑐  along the position 𝑥 ,   𝐷  - 
diffusion coefficient, 𝐴 – constant. 
Solving the equation for 𝜕𝑥 gives the linear equation of the concentration gradient: 
 𝐶 𝑥 = −𝐴𝑥 𝐷 + 𝐵 (5.3) 
Assuming that the concentration of the particles at position 𝑥  = 0 (food end): 𝐶(0) = 𝐶! and at position 𝑥 = L (air end): 𝐶(𝐿) = 𝐶!: 
            𝐶! = −𝐴 𝐷 ∙ 0+ 𝐵, ⇒   𝐵 = 𝐶! (5.4) 
 𝐶! = −𝐴 𝐷 ∙ 𝐿 + 𝐶!, ⇒ −   !! = !!!!!!  (5.5) 
 𝐶 = !!!!!! ∙ 𝑥 + 𝐶! (5.6) 
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Approximating the boundary conditions so that the particle concentration at the food 
end will be equal to 100% (𝐶! = 100 %) and at the air end concentration decreases 
down to the unknown value y near zero (𝐶!  = y %), the equation of particle 
concentration will be as follows: 
 𝐶(𝑥) = (!!!"")! ∙ 𝑥 + 𝑦 (5.7) 
 According to this simplified equation of particle diffusion with the assumption 
of steady state environment and the constant rate of the concentration flux, 
concentration of the food smell in the capped capillary tube with open end on one side 
is a linear function of position, 𝑥.  
  The concentration gradient of the food smell along the tubes of different 
length decreases linearly from 100% near the food end to some constant values y% 
near the air end and can be plotted as shown in Figure 5.1. 
 With reference to the finding from (Donelson, Kim et al. 2012) that flies 
prefer to stay quarter of the tube length away from the food, if the fly behaviour 
follows model 1, meaning that the fly choose preferred position based on the olfactory 
cues, then we can expect that flies will stay at the location with 75% of the 
concentration gradient and in tubes of different length this will result in the 25% of 
the tube length away from the food (1.1, 2.2, 3.3 and 4.4 cm away from food end for 
3.5, 7, 10.5 and 14 cm long tubes respectively, dotted line in Figure 5.1). 
Figure 5.1 Concentration gradient in different lengths tubes. It was assumed that in a 
capillary tube of length L the concentration of the food smell will diffuse linearly 
from 100% near the odor source to a relatively small value y% near the air end of the 
tube (left). The plot on the right showed the distribution of the concentration gradient 
(y-axis) within the tube of different length (represented in x-axis). 
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5.2.3.2 MODEL 2: SELF-MOTION CUES 
 According to model 2, it is assumed that the flies have absolute spatial 
awareness and use self-motion cues instead of olfactory stimuli. Generally, this means 
that irrespective of tube length, flies will always prefer to stay at certain position away 
from the food (example is shown in Figure 5.2).  
 Considering the above-mentioned observation made by (Donelson, Kim et al. 
2012), the fly preferred position according to model 2 will be quarter of the tube 
length away from the food, which is 1.75 cm for the standard 7 cm long tube used in 
the experiment. 
 
5.2.4 SIMULATING FLY MOVEMENT USING RANDOM WALKS 
Fruit fly has an ability to navigate in the environment to search for food, mate 
or shelter which is mainly achieved during walking. As it has been previously 
observed that without visual and self-motion cues fly walks persistently towards the 
target, careful analysis of the fly positional behaviour in the tube may be used to infer 
some attributes of complex locomotor behaviour. As a consequence, understanding 
the rules underlying fly locomotion and positional preferences is complicated process. 
Therefore, in this project we propose to develop a stochastic model of fly locomotion, 
akin to the run-and-tumble model for E. coli, and use the experimental data to test it. 
Figure 5.2 Model 2: self-motion cues. Fly stays a certain distance away from the food 
(for example, 1.75 cm) 
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The model of fly movement was based on the assumption that in one-dimensional 
space the flies move in random walk manner and the persistence of the activity was 
simulated as a probability of changing direction (where the directional persistence 
probability, DPP=1 the fly will always walk in one direction and where DPP=0 the fly 
will change direction with every step). As we observed from the experimental data, 
the positional preference appears as a skewed normal distribution, specifically the 
DPP was modelled as a log-normal distribution.  There was also a consistent peak in 
residency near the air end of the tube; because this air peak appeared to be a rather 
stereotyped end effect these data were not included when assessing the goodness of 
the models. 
 The probability distribution function (PDF), that results from the DPP, 𝑃(𝑥) 
for the log-normal distribution was calculated for positions along the tube x = [0 ... L] 
as follows: 
 𝑃(𝑥) =    !!" !! ∙ 𝑒!(!"!!!)!!!    (5.8) 
 In order to find the best fit of the model to our experimental data, the PDF of 
DPP was calculated for 7 cm long tube (as it is conventionally used) and the 
parameters of the distribution were optimised in a sensible range of 𝜇 = [1.8 ... 3.4] 
and 𝜎 =  [0.02 … 0.2]. As we were more concerned with the positional preferences 
near the food end of the tube, the spike of the activity near the open end of the tube 
was not taken into account when evaluating the model and the last two bins of the 
tube length were excluded in the consequent analysis (so 46 bins instead of 48 bins 
for 7 cm long tube). To avoid the over-fitting of the model to the experimental data, 
the set of parameters for the model optimisation was limited to only two (mean and 
standard deviation for the PDF). In addition, PDF was normalized to unity, so that the 
probabilities values at each position along the tube will sum up to 1 and can be used 
to estimate the likelihood of the fly directional persistence. 
In our model, locomotion of the fly is governed by a few rules: 1) The fly 
starts each simulation in the middle of the tube; 2) at each iteration of the model 
simulation, each equivalent to 1 sec or real time, the probability that the fly will 
change direction is determined according to the PDF value for its previous position; 
3) at the end of either tube ends the fly reverses direction; 4) the fly walks with 
constant velocity. For each of the 300000 iterations that comprised a simulation 
experiment (comparable to the 3 day duration of the experiments: 1 step/sec x 60 sec 
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x 60 minutes x 24 hours x 3 days = 259200 steps) a random number (range 0-1) was 
drawn from a standard uniform distribution and compared with the DPP value for the 
previous position of the fly in the tube. The fly reversed its direction only if the drawn 
random number was higher than the probability derived from DPP. It was therefore 
necessary to adjust the boundary conditions of the DPP so that the lowest probability 
should be above 0 (to prevent being trapped by changing direction every iteration), 
and the highest probability value below 1 (so that there is always at least a small 
background chance of changing direction). The lower boundary was set to 0.05 and 
higher boundary to 0.99. The pseudocode describing the algorithms is presented 
below. 
Algorithm 2: Modelling the fly behaviour in constant darkness 
1:  Input: tube length L, PDF of experimental data for tube 7 cm long 
2: direction_space = [left, right]; tube_bounds = [0, L]; #position boundaries of the tube 
3:  for 𝜇=1.8 to 3.4 step 0.2 do 
4:         for 𝜎=0.02 to 0.2 step 0.02 do 
5:   n = 1 #simulation; direction(1)=right; x(1)=L/2 #initial position in a tube;  
6:   DPP = lognormal(𝜇,𝜎, 𝐿) 
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Figure 5.3 Normalized probability distribution function. The PDF was estimated for 
log-normal distribution with the desired set of parameters. 
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7:  while n<300000 do 
8:      random_number = random(0,1) #draw random number between  0 and 1  
9:      n = n+1; 
10:       if random_number<DPP(x(n-1)) do  #same direction of movement 
11:       direction(n)=direction(n-1);  
12:     else #change direction of movement 
13:   direction(n) = difference(direction(n-1), direction_space);  
14: update current position x(n) 
15: if x(n) exceed tube_bounds do #change direction 
16:   direction(n) = difference(direction(n-1), direction_space);  
In total, 8 simulations for each tube length were performed, replicating the 
experimental design. The time resolution of each simulation was binned into 5 
minutes intervals by summing up the occurrence of the fly at every position along the 
tube, and the average residency of modelled fly was calculated as described above. 
 
5.2.5 GOODNESS OF MODEL FIT 
The accuracy of this model was tested by calculating the mean-squared errors 
(MSE), that is the difference between the average positional preferences as estimated 
by the model and average positional preferences given by the experimental data: 
 𝑀𝑆𝐸 =    (!!!!!)!! , (5.9) 
where 𝑌!  – average positional preference at position 𝑖 ,  𝑌!  – predicted positional 
preference at position 𝑖, N – length of the tube. 
 
5.3 RESULTS 
 
To investigate the control system behind the positional preferences in fruit fly, 
a previously developed technique FLYGLOW, as described in chapter 4, was used to 
get the estimate of flies’ spatial location in capillary tubes of 4 different lengths. Two 
sets of data produced by FLYGLOW were used in the subsequent analysis: location 
of the fly along the tube was determined using the spatial distribution of the 
bioluminescence, and sleep/wake cycle was established with the help of sleep binary 
array. Furthermore, two models of fly behaviour were to see which better explained 
the role of olfactory and/or position cues in determining positional preferences in the 
absence of visual stimuli: model 1 hypothesised that fly uses olfactory stimuli to 
orient itself in complete darkness, whereas model 2 is based on the assumption that 
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the fly uses self-motion cues to estimate its position in the tube. Moreover, a 
stochastic model of fly behaviour in constant darkness was developed in order to 
simulate the persistence of fly movement towards the food. 
 
5.3.1 SPATIAL LOCATION OF THE FLIES 
 The bioluminescence intensity emitted by the flies gave an opportunity to 
identify the position of the fly in the tube, so this information was used to investigate 
the control mechanism behind the positional preferences in healthy population of 
flies. Considering the timeframes when the fly was in the awake state, the average 
position of the population of control flies in the tubes of different lengths was 
visualized using the heatmap approach (Figure 5.4). 
 As can be expected from the previous findings of animal positional 
preferences, the awake fly positions in the tubes distributed unevenly with seemingly 
two peaks of location preferences around both ends of the tube. Notably, the flies in 
tube of 7, 10.5 and 14 cm long all show similar pattern of positioning themselves 
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Figure 5.4 Heatmap of mean residency of control flies in the tube during the wake 
periods. Lighter color represents the higher probability of the residency within the tube. 
X-axis: time in hours, y-axis: position along the tube as a bin number. 
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within the tubes with the clear preference towards the air end of the tube. Moreover, 
the flies have demonstrated the periodic preference to stay near the food end of the 
tube, mostly just before falling asleep or in-between the sleep episodes. Consistent 
with multiple lines of evidence (Donelson, Kim et al. 2012, Faville, Kottler et al. 
2015), the flies showed the distinct preference to remain near the food end of the 
tubes when they enter into the sleep-like state (Figure 5.5). 
On the other hand, flies in 3.5 cm long tube have a slightly different positional 
distribution with rather chaotic movements when they are awake towards the end of 7 
days experiment. Indeed, it has been found that all of the flies in 3.5 cm long tubes 
died on day 5. 
Interestingly, it may be observed from the relative brightness of the top panel 
in Figure 5.5 that on average flies in shorter tubes have greater numbers of sleep-like 
episodes than those in longer tubes, particularly in case of 3.5 cm tubes. In order to 
determine whether the mean amount of sleep is significantly different in tubes of 
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Figure 5.5 Heatmap of mean residency of control flies in the tube during the sleep 
periods. Lighter color represents the higher probability of the residency within the 
tube. X-axis: time in hours, y-axis: position along the tube as a bin number. 
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different lengths, a one-way analysis of variance (ANOVA) test was performed. For 
each fly, the mean duration of sleep was determined as the sum of the number of sleep 
episodes starting from day 2 (the data from first day was omitted in the assumption 
that flies need to accommodate to the new environment) and until day 4 so that the 
arrhythmic behaviour of the flies just before their death is excluded. The null 
hypothesis was that the flies sleep the same amount in tubes of different lengths. 
Using this analysis, it is apparent that flies in shortest tubes (3.5 cm) sleep for 67% of 
the time which is significantly longer than flies in other tubes (Figure 5.6 A). 
Furthermore, the flies in longer than conventionally-used tubes, that is 10.5 and 14 cm 
tubes, showed significantly lower amount of sleep on average, specifically around 
30% of the time during the three day window. Accordingly, the average amount of 
both activity and rest for flies in 3.5 cm long tubes are significantly different from 
longer tubes, and the same is true for flies in 7 cm long tubes (Figure 5.6 B). On the 
other hand, the flies in both 10.5 and 14 cm long tubes did not show any significant 
difference in either of sleep, activity or rest amounts between two populations. 
The visual inspection of the positioning of Aβ42-expressing flies within the 
tubes of different lengths in timeframes when they were identified as being in a sleep 
state have shown a slightly different pattern of positional preferences as compared to 
control flies. In particular, the location of Aβ42-expressing flies are more scattered 
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Figure 5.6 Comparing the sleep amount for control flies in tubes of different lengths. 
A) Average amount of sleep was calculated for the population of flies and presented 
as a percentage (with 100% means that a fly was sleeping all the time during the 3 
days of the experiment). B) Distribution of the proportion of each behavioural 
parameter in tubes of different length. 
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along the tubes, which is most noticeable in 10.5 cm long tubes where the flies fall 
asleep near either air and food ends of the tubes in the equal proportions (Figure 5.7, 
third heatmap). Similarly to the control population of flies, it has been found that 
Aβ42-expressing flies in shortest tubes (3.5 cm long) sleep significantly longer than in 
any other tubes, while Aβ42-expressing flies in longer tubes (10.5 and 14 cm) did not 
showed any difference in the average amount of sleep. Consistent with our previous 
finding in 4.3.3, the average proportion of sleep, activity and rest of Aβ42-expressing 
flies in tubes of different lengths have the same distribution as the one for the control 
flies.   
  
5.3.2 MODEL OF FLY BEHAVIOUR WHILE AWAKE IN CONSTANT 
DARKNESS 
In order to experimentally test the two models of fly location preference, the 
average residency along the tubes was established for awake flies in complete 
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Figure 5.7 Positional preferences of Aβ42-expressing flies during sleep. The heatmap 
shows the mean residency of the flies in the tube during the sleep periods. Lighter 
color represents the higher probability of the residency within the tube. X-axis: time 
in hours, y-axis: position along the tube as a bin number. 
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darkness, as shown in Figure 5.8. The averaged positional preferences of the control 
group of flies during the three days period (black traces in Figure 5.8) in 7, 10.5 and 
14 cm long tubes have exhibits the similar distribution with the highest peak of 
residency near the air end (right hand side of the plots in Figure 5.8) and the second 
highest point of preferred position for flies was at some distance away from the food. 
However, the control flies in 3.5 cm long tubes have rather inverted pattern: the peaks 
of preferred residency is equally distributed between either being some distance away 
from the food or from the fresh air.  
 The averaged positional preferences of Aβ42-expressing flies are characterized 
by higher degree of variability between individuals (multicolour traces in Figure 5.8), 
which is particularly pronounced for flies in 10.5 long tubes. In contrast to control 
flies, Aβ42-expressing flies in 3.5 cm long tubes demonstrated the bias to stay in the 
middle section of the tubes. 
The average positional preferences for the control populations of flies were 
used to test the two models of their response to olfactory and/or spatial cues. When 
the position data is plotted against the relative distance along the tubes, that is 
consistent with control by an olfactory gradient, the peak in residency occurs at 
between 14% and 35% of the way along the tube (Figure 5.9, top panel, inverted 
triangles). By contrast when the data is plotted as absolute distance from the food, that 
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 Figure 5.8 The average residency of flies along the tubes of different lengths. Black 
traces represent the mean value for the population of flies. 
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is consistent with control by internal motion cues, the peak is observed in a narrower 
range, 10-18 mm, from the food.  This initial analysis indicated that model 2 is more 
likely to explain the position preferences of the flies, relying on self-motion cues 
rather than olfactory cues (Figure 5.9). Indeed, apart from flies in 3.5 cm long tubes, 
control flies have demonstrated the distinct desire to stay on average 16 bins away 
from the food source as if they have spatial awareness in constant darkness (triangles, 
Figure 5.9). By contrast, according to model 1 it would be expected than if flies use 
smell of food to orient themselves within the tube then they will stay at same fraction 
of the tube length away from the food, which was not the case as shown in Figure 5.9. 
 
 
5.3.3 SIMULATION OF FLY PERSISTENT BEHAVIOUR IN CONSTANT 
DARKNESS 
 To understand the underlying control system that governs the flies locomotion 
behaviour and persistence of movement toward the target, the stochastic model was 
Figure 5.9 Two models of fly response to the cues available in constant darkness. 
Model 1 (top) assumed that the fly response to the olfactory gradient while model 2 
(bottom) hypothesized that the fly use self-motion cues in darkness. Y-axis represents 
the positional preferences of the flies within the tube, while x-axis represents either a 
percentage of the tube length (away from food at 0) or bins along the tube. 
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developed and tested by using the experimental data from conventionally used 7 cm 
long tubes.  The persistence of fly locomotion was simulated by assigning the 
directional positional probability to each position along the tube and comparing it 
with the random number drawn at every iteration of the simulations. The resulting 
simulations of fly walking behaviour within the tube were averaged into 5 min bins 
(Figure 5.10, top heatmap) to replicate the experimental conditions and converted into 
the average positional residency. The best fitting model was found with the following 
parameters of log-normal distribution: 𝜇=2.8, 𝜎=0.18 as shown in Figure 5.10 
(bottom plot, black traces – experimental data, red traces – DPP, green traces – 
average positional preferences of 8 simulations). 
 As can be seen, lognormal DPP distribution roughly replicates the distribution 
of the experimental positional preferences for flies in 7 cm long tube and the same is 
true for the averaged positional residency data from 8 individual runs of the 
simulation. Due to the random nature of the simulations, the resulting average 
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residency along the tube is not a simple conversion of the direction persistence 
probability but rather a reduction of simulated data dimensionality by averaging along 
the time frames. 
The flies’ behaviour was modelled in a similar way for tubes of different 
lengths using the same parameters as have been previously optimised for the 
simulation model in 7 cm long tube. Moreover, the two models of spatial orientation 
in constant darkness in the tubes of different lengths were evaluated by fitting the 
averaged simulated data to the experimental data captured for the control population 
of flies as shown in Figure 5.11 (black traces – experimental data, red traces – 
simulated data). And again model 2 demonstrated the better fit to the experimental 
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Figure 5.11 Testing two models of fly orientation using simulated data. Y-axis: 
averaged residency of control flies within the tubes for experimental data (black) and 
simulated data (red). X-axis: either a percentage of the tube length (model 1) or bins 
along the tube (model 2). Triangles represent the location of the residency peak. 
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data for all the flies in tubes of different lengths. In contrast, according to the model 1 
lengthening the tube have resulted the progressive divergence from the actual 
positional preferences as demonstrated by the experimental data. 
Accordingly, for model 2 the mean-squared errors (MSE) of fitting the 
simulated data to experimental data (control group of flies) is significantly lower than 
the MSE for model 1 (Figure 5.12, A). The linear regression line fitted to the 
distribution of MSE for model 2 showed the steady horizontal trend (black dashed 
line, Figure 5.12 A), meaning that on average the errors of model fit are on the same 
level when fitted to the experimental data from the tubes of different lengths. 
ANOVA test of distribution of MSE errors for tubes of different lengths have 
indicated that the mean and variance of MSEs for model 2 is significantly different 
from the MSEs for model 1. 
 As can be expected, fitting the simulated data to the average residency of 
Aβ42-expressing flies in tubes of different lengths have demonstrated a worse match 
to model 2 of fly spatial orientation as compared to the control population of flies 
(Figure 5.12 B), with mean values of MSE for model 2 is 0.11 versus 0.08 for control 
flies. However, in Aβ42-expressing flies a match to the model 1 was better than to 
model 2 and on a similar level as the match to model 2 in control flies, with the 
average values of MSE for model 1 is 0.08. In addition, according to the ANOVA test 
the distribution of MSEs for two models did not differ from each other.  
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Figure 5.12 Mean-squared errors of fit distribution for two models. MSEs of fitting 
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5.4 DISCUSSION 
 
 As it has been shown previously, in the early stage of Alzheimer’s disease 
neurodegeneration starts at the hippocampus and leads to the inability to set down 
new memories. In addition, the recent discovery of the “inner GPS”, or positioning 
system, to be situated in the hippocampus in mammals has shed a light on why a 
spatial orientation is affected on the early stage in patients with AD (O'Keefe and 
Dostrovsky 1971, Fyhn, Molden et al. 2004). However, the mechanisms underpinning 
the spatial memory loss are not yet understood. Using the model organisms of the 
disease can help us investigate this complex problem and gain valuable insights.  
Most motile organisms have the similar ability to navigate and orient 
themselves in the environment. For example, bacteria E. coli use the chemotactic 
approach to move towards the target and other organisms may use similar strategy. In 
particular, it has been demonstrated that Drosophila may use stereo chemosensation 
to locate the olfactory signal and use a “run-and-tumble” mechanism for locomotion. 
However, the sensorimotor pathways by which the fly integrates the input from 
different modalities, especially in the constant darkness, is unknown. 
In this project we proposed to use the FLYGLOW system to investigate the 
flies’ behaviour in the absence of visual cues to guide their positional preferences 
within their tubes. Two models of fly response to the available stimuli were 
developed with the underlying assumptions that fly can estimate its position by either 
olfactory gradient, which results in estimating the relative distance from the food, or 
self-motion cues, as if the fly counts the number of steps it has taken away from the 
food source. These two models were tested for the flies in tubes of different lengths 
for both control and Aβ42-expressing flies. Moreover, two stochastic models of fly 
movement in constant darkness was developed and evaluated against the experimental 
data.  
Consistently with the previous findings (Donelson, Kim et al. 2012, Faville, 
Kottler et al. 2015), it was found that control flies indeed have positional preferences 
within the tubes with the clear bias to stay near the air end of the tubes in the awake 
state and near the food source when they falling asleep. In contrast to the previous 
statement (Kim 2012) that the flies prefer to stay quarter of the tube closest to the 
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food suggesting the ability of the flies to judge the relative distance within the tubes, 
it was discovered, that irrespective of the tube length, the flies stay approximately 16 
bins away from the food source (equivalent to 2 cm in real distance). In contrast, aβ42-
expressing flies have demonstrated more dispersed and chaotic location preferences, 
especially during the sleep periods when they sometimes to prefer to fall asleep near 
the air end of the tubes. 
The interesting observation was that flies in shortest tubes have a quite distinct 
pattern of positional preferences in both sleep or awake states. One explanation could 
be that being in the close proximity to the food source might determine their sleep-
wake behaviour. In contrast to the commonly held belief that circadian rhythms 
determine the fly’s sleep onset, and prior to falling asleep the fly prefers to be near the 
food, it may be that an alternative explanation is valid. Indeed, we saw clearly that a 
fly’s preferred location for sleep was about 2 cm away from the food, which can be 
defined as the sleep region. It appears that when the flies were confined to the sleep 
region (shortest tubes 3.5 cm long have in fact have effective length around 2.5 cm) 
the time spent sleeping was more than double than in the longest tubes. This implies 
that the widely-accepted causation may be reversed, so that circadian rhythms govern 
locomotor behaviour and hence the particular patterns of residency within the tube; I 
propose that it is the behavioural localisation of flies within that sleep zone that 
induces sleep behaviour.  Furthermore, it is well known, although not widely 
reported, in the field that the optimal tube length for observing clear circadian 
behaviour in the fly is 7 cm. Other tube lengths, particularly shorter, have resulted in 
deterioration in circadian sleep-wake behaviour. I propose that forced proximity to the 
food source in shorter tubes drives flies to sleep even in the absence of a circadian 
clock. 
 With regards to the models of behavioural control in constant darkness, it was 
revealed that the flies use self-motion cues to estimate their location within the tube, 
meaning that the fly has an absolute spatial awareness in constant darkness. Indeed, 
using the stochastic model of fly walking behaviour, where the persistence of 
movement varied according to where the fly is in the tube, I have demonstrated that in 
tubes of different lengths flies navigate by judging the absolute distance away from 
the food source rather finding an optimal position along an olfactory gradient. 
Notably, aβ42-expressing flies are characterized by the higher inter-individual 
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differences underpinning the averaged positional data. Indeed, the Aβ42 fly behaviour 
approximates to random behaviour. The mean-squared errors for the simulated data 
for Aβ42-expressing flies are similar for both control models. This suggests that the 
control function that allows control flies to maintain their position according to the 
absolute distance from the food is degraded in Aβ42-expressing flies. 
The more precise confirmation of these findings could be acquired in the 
future by repeating the similar experiment with the mutant flies, that lack odorant 
receptors, to formally exclude the possibility of influence of the olfactory stimuli on 
the fly’s behaviour.  
  
5.5 CONCLUSION 
 
In this chapter, the spatial orientation of the flies was investigated by examining the 
fly spatial distribution within the custom made capillary tubes of different lengths 
using the FLYGLOW system. It was concluded that the flies use self-motion cues in 
order to estimate their position within the tube and it seems that in Aβ42-expressing 
flies this underlying controlling mechanism is disrupted. Moreover, it was proposed 
that confinement of the flies in a defined sleep region result in the increased amount 
of sleep and disruption of normal sleep-wake cycles. 
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CONCLUSION 
 
 In this work the analysis of Alzheimer’s disease was focused on the 
pathological role of the aggregation and accumulation of Aβ peptide. In the thesis I 
have aimed to investigate the different aspects of Aβ toxicity and so dissect the 
pathways of disease pathogenesis. The main outcomes of this work are as follows: 
 
Using a worm model of Aβ  toxicity to derive more information from human 
GWAS in Alzheimer’s disease.  
The role of Aβ toxicity in sporadic AD was evaluated by using the results of 
previously performed knockdown screen in C. elegans model system that finds the 
genes that modify the Aβ-induced paralysis phenotype. Comparing the human 
orthologues of genes identified by this worm modifier screen with the genes 
implicated by GWAS in sporadic AD I have demonstrated no identity between the 
two lists of genes, suggesting that mechanisms of Aβ toxicity, at least in worm model, 
are not equivalent to sporadic AD. However, further analysis of the direct physical 
interactors of those genes has revealed 7 worm genes that have a non-random overlap 
with GWAS. Four of those worm genes had larger than expected by chance overlap 
with interactors of GWAS genes, with three of them forming TRiC/CCT chaperone 
complex and fourth being a major substrate of the same chaperone complex. At the 
present time, the exact role of TRiC/CCT in the pathogenesis of sporadic AD is 
unclear, but the fact that RNAi knockdown of those genes in worm model rescues 
Aβ-induced paralysis phenotype might implicate that this chaperone complex in some 
way promotes Aβ toxicity. In conclusion, it has been shown that using the animal 
model of Aβ toxicity can provide the means to extract further information from 
human GWAS in AD and find the potential candidate genes.  
  
Study of circadian disruptions in Alzheimer’s disease using Drosophila as a 
model organism.  
The involvement of Aβ toxicity in the circadian disruptions, associated with 
AD, has been evaluated by developing the new recording system to simultaneously 
observe the oscillations of peripheral clocks and behavioural rhythms in Drosophila. 
Careful examination of the results has revealed that in Aβ-expressing flies the normal 
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consolidated structure of the sleep is disrupted, leading to the fragmented sleep 
architecture. Taking advantage of simultaneous recording and comparing the rhythms 
robustness has demonstrated that oscillations of behavioural rhythms and peripheral 
clocks are independent of each other, suggesting that Aβ toxicity damages the 
communication pathways between molecular clock and circadian behaviour. In 
conclusion, the developed system has provided the opportunity to dissect the 
relationship between molecular and behavioural rhythms in Drosophila model of Aβ 
toxicity. 
 
Study of positional preference in Drosophila and how this is degraded in a model 
of Alzheimer’s disease.  
The control mechanism of spatial orientation has been studied by examining the 
positional preferences of fruit flies within the tubes of different length. It has been 
established that in absence of visual stimuli, wild-type flies use self-moving cues to 
orientate themselves in the tubes and in the presence of Aβ toxicity the underlying 
control function of spatial navigation is disrupted. Moreover, it has been observed that 
the flies confined to the sleep region in the shortest tubes slept significantly more than 
flies in longer tubes, suggesting that the forced proximity to the food source induces 
the sleep behaviour. 
 
Future Perspectives 
The further evaluation of the genes forming the TRiC/CCT chaperone complex can 
shed the light on its involvement in the pathogenesis of sporadic AD and provide 
additional insights into the mechanisms of Aβ toxicity. The similar procedure can be 
applied to uncover additional information from the findings of GWAS in many 
complex neurodegenerative diseases. 
The method developed in chapter 4 (FLYGLOW) can be applied to more broadly 
based behavioural, genetic and drug-based screens. For example, evaluating the 
circadian disruptions in mutant flies with the expression of sleep-regulation 
transgenes can provide the insight into the role of those particular genes in the sleep 
homeostasis. Another possibility would be to initiate the genetic screen to identify 
genes involved in the circadian disruption mechanism. 
CONCLUSION 
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In order to validate the control mechanism of spatial orientation in flies, the 
experiment described in chapter 5 can be performed for the mutant flies lacking the 
odorant receptor in order to exclude the presence of olfactory stimuli.  
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A.1 Suppressors of the Aβ-paralysis phenotype (Khabirova, Moloney et al. 2014) 
 The list consists of the human orthologues of worm genes that, when targeted by 
RNAi, suppress the paralysis phenotype in Aβ-expressing worms (n=78 genes).  
C. elegans 
gene symbol 
Human gene name Human gene 
symbol 
Accession 
number 
F46E10.1 Long chain fatty acid acyl-CoA 
ligase 
ACSF2 NM_001028767 
T04C12.6 Actin and related proteins ACTB NM_073416 
T25C8.2 Actin and related proteins ACTG1 NM_067408 
K07C5.1 Actin-related protein Arp2/3 
complex, subunit Arp2 
ACTR2 NM_073256 
F55A12.7 AP-1 complex subunit mu-1 AP1M1 NM_059171 
F29G9.3 Clathrin adaptor complex, small 
subunit 
AP1S2 NM_072158 
C13B9.3 Medium subunit of clathrin 
adaptor complex 
ARCN1 NM_066062 
C34E10.6 F0F1-type ATP synthase, beta 
subunit 
ATP5B NM_065710 
R10E11.8 Vacuolar H+-ATPase V0 sector, 
subunits c/c' 
ATP6V0C NM_066764 
Y49A3A.2 Vacuolar H+-ATPase V1 sector, 
subunit A 
ATP6V1A NM_074158 
F20B6.2 Vacuolar H+-ATPase V1 sector, 
subunit B 
ATP6V1B2 NM_076310 
Y55F3AR.3 Chaperonin complex component, 
TCP-1 theta subunit (CCT8) 
CCT8 NM_067634 
F09G2.4 mRNA cleavage and 
polyadenylation factor II complex, 
subunit CFT2 (CPSF subunit) 
CPSF2 NM_072421 
M03F8.3 Cell cycle control protein (crooked 
neck) 
CRNKL1 NM_001129507 
B0464.1 Aspartyl-tRNA synthetase DARS NM_066688 
C55B6.2 dsRNA-activated protein kinase 
inhibitor P58, contains TPR and 
DnaJ domains 
DNAJC3 NM_076808 
D2085.3 Translation initiation factor 2B, 
epsilon subunit (eIF-
2Bepsilon/GCD6) 
EIF2B5 NM_063440 
F22B5.2 Translation initiation factor 3, EIF3G NM_001276737 
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subunit g (eIF-3g) 
C40H1.4 Elongation of very long chain fatty 
acids protein 3 
ELOVL3 NM_066655 
H19N07.1 Eukaryotic Peptide Chain Release 
Factor 
GSPT2 NM_001269363 
T10C6.11 Histone H2B HIST1H2BA NM_074630 
F26D10.3 Molecular chaperones 
HSP70/HSC70, HSP70 
superfamily 
HSPA8 NM_070667 
C49F5.1 S-adenosylmethionine synthetase MAT1A NM_077601 
C30A5.3 MOB-Like Protein Phocein MOB4 NM_066397 
Y57G11C.12 NADH:ubiquinone 
oxidoreductase, NDUFA6/B14 
subunit 
NDUFA6 NM_070389 
K07C5.4 Ribosome biogenesis protein - 
Nop56p/Sik1p 
NOP56 NM_073259 
T22B11.5 2-oxoglutarate dehydrogenase, E1 
subunit 
OGDHL NM_068216 
D1054.15 Isoform 1 of Pleiotropic regulator 
1 
PLRG1 NM_001269330 
F36A4.7 RNA polymerase II, large subunit POLR2A NM_068122 
K02B12.3 Prolactin regulatory element 
binding 
PREB NM_059904 
R07E4.6 CAMP-dependent protein kinase 
type I-Alpha, regulatory subunit 
PRKAR1A NM_076598 
C50C3.6 U5 snRNP spliceosome subunit PRPF8 NM_066384 
CD4.6 20S proteasome, regulatory 
subunit alpha type PSMA1/PRE5 
PSMA1 NM_072071 
Y38A8.2 20S proteasome, regulatory 
subunit beta type PSMB3/PUP3 
PSMB3 NM_062512 
C52E4.4 26S proteasome regulatory 
complex, ATPase RPT1 
PSMC2 NM_073604 
Y49E10.1 26S proteasome regulatory 
complex, ATPase RPT6 
PSMC5 NM_067208 
C23G10.4 26S proteasome regulatory 
complex, subunit RPN2/PSMD1 
PSMD1 NM_065946 
C39F7.4 GTPase Rab1/YPT1, small G 
protein superfamily, and related 
GTP-binding proteins 
RAB1A NM_070996 
F10B5.1 60s ribosomal protein L10 RPL10L NM_063306 
T22F3.4 60S ribosomal protein L11 RPL11 NM_071607 
C27A2.2 60S ribosomal protein L22 RPL22 NM_062531 
C09H10.2 60S ribosomal protein L44 RPL36AL NM_063974 
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B0250.1 60s ribosomal protein L2/L8 RPL8 NM_075539 
R13A5.8 60S ribosomal protein L9 RPL9 NM_066259 
F54E7.2 40S ribosomal protein S12 RPS12 NM_065820 
C16A3.9 40S ribosomal protein S13 RPS13 NM_065992 
T01C3.6 40S ribosomal protein S16 RPS16 NM_074289 
T05F1.3 40S ribosomal protein S19 RPS19 NM_060154 
C23G10.3 40S ribosomal protein S3 RPS3 NM_065948 
B0393.1 40S ribosomal protein SA 
(P40)/Laminin receptor 1 
RPSA NM_065577 
F53E10.6 RRP15-like protein RRP15 NM_071312 
VZK822L.1 Fatty acid desaturase SCD NM_001268666 
F43D9.3 Sec1 family domain-containing 
protein 1 
SCFD1 NM_001129225 
Y113G7A.3 Vesicle coat complex COPII, 
subunit SEC23 
SEC23B NM_075476 
Y57E12AL.1 Tumor differentially expressed 
(TDE) protein 
SERINC1 NM_171479 
T08A11.2 Splicing factor 3b, subunit 1 SF3B1 NM_065452 
Y116A8C.42 Small nuclear ribonucleoprotein 
Sm D3 
SNRPD3 NM_070626 
ZK652.1 Small Nuclear Ribonucleoprotein 
Polypeptide F 
SNRPF NM_066307 
T27F2.1 SNW domain-containing protein 1 SNW1 NM_073549 
F55A11.2 SNARE protein SED5/Syntaxin 5 STX5 NM_073567 
T05C12.7 Chaperonin complex component, 
TCP-1 alpha subunit (CCT1) 
TCP1 NM_063321 
Y116A8C.35 U2 small nuclear RNA auxillary 
factor 1 isoform b 
U2AF1 NM_070635 
C47E12.5 Ubiquitin-like modifier activating 
enzyme 6 
UBA6 NM_001268520 
*C46G7.1 - - NM_068504 
*F28C6.7a - - NM_063422 
*Y105E8C.e - - N/A 
*K04E7.2 - - NM_076686 
*F58G6.7 - - NM_069313 
*ZK858.1 - - NM_060045 
*Y41D4B.19 - - NM_067703 
*F42D1.3 - - NM_078054 
*F55C5.4 - - NM_073679 
*F17C8.5 - - NM_065572 
*C41C4.7a - - NM_063303 
*W09B6.1 - - NM_001267098 
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*D2024.1 - - NM_068750 
*W06H8.8 - - NM_001029030 
*F25B5.4 - - NM_171139 
 
A.2 Gene ontology enrichment for worm screen hits (Khabirova, Moloney et al. 
2014) 
The worm screen hits were analysed for enrichment in molecular function, cellular 
component and biological process ontology labels. 
Molecular function 
Proton transporting ATP synthase activity, rotational mechanism 
Proton transporting ATPase activity, rotational mechanism 
 
Cellular component 
Cytosolic small ribosomal subunit 
Eukaryotic translation initiation factor 3 complex 
Chaperonin-containing T-complex 
 
Biological process 
Protein binding 
Structural constituent of ribosome 
Purine nucleotide binding 
 
 
A.3 The 63 human genes in the AD GWAS white+grey zones (Khabirova, 
Moloney et al. 2014) 
1 ABCA1 
2 ABCA7 
3 ADCY8 
4 AEN 
5 ANK1 
6 APOC1 
7 APOE 
8 BIN1 
9 CCDC134 
10 CCDC76 
11 CD2AP 
12 CD33 
13 CLU 
14 CLVS1 
15 CNTNAP2 
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16 CR1 
17 CUBN 
18 CYP7B1 
19 DBT 
20 DCHS2 
21 DIAPH3 
22 DIP2C 
23 DISC1 
24 DNAH11 
25 EML1 
26 ENSAP3 
27 F13A1 
28 FARP1 
29 GAB2 
30 GFRA2 
31 GRIN2B 
32 LRRC39 
33 MGST3 
34 MPP7 
35 MS4A6A 
36 MTHFD1L 
37 NCAM1 
38 NCR2 
39 NDP 
40 NEDD9 
41 NHSL1 
42 ODZ4 
43 PAK2 
44 PCDH11X 
45 PITPNC1 
46 POLN 
47 PVRL2 
48 RBFOX1 
49 RORA 
50 RYR2 
51 SLC28A1 
52 SLC4A1AP 
53 SLC44A5 
54 ST3GAL1 
55 STK11 
56 STK24 
57 TOMM40 
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58 TXNDC6 
59 UTS2D 
60 VSNL1 
61 WBSCR17 
62 ZNF292 
63 ZNF320 
 
 
A.4 Overlap between the +1 interactome for the products of genes in the GWAS 
white+grey zone and those of genes in the +1 interactome of the worm RNAi 
screen (Khabirova, Moloney et al. 2014) 
The human AD GWAS white+grey zone genes, and their +1 interactors, overlap with 
the human orthologues of worm-screen hits, and their +1 interactors. Worm screen 
genes that have human orthologues with a significantly non-random +1 interactome 
overlap with the GWAS list are shown in bold. Worm screen genes that have human 
orthologues that interact directly with GWAS genes are marked with an asterisk. 
Gene p-value 
+1 interactome overlap 
[experimental vs MC] 
MOB4 0.003 larger * 
PSMA1 0.014 smaller 
TCP1 0.014 larger * 
NOP56 0.014 smaller 
CCT8 0.015 larger * 
ACTB 0.018 larger 
RPL10L 0.033 smaller 
RPL9 0.058 smaller 
ATP6V1B2 0.064 smaller 
HSPA8 0.065 larger 
RPL22 0.087 smaller 
PSMB3 0.089 smaller 
RPL11 0.097 smaller 
RPS13 0.12 smaller 
PSMC2 0.131 smaller 
PSMD1 0.137 smaller 
PRPF8 0.141 smaller * 
ACTR2 0.153 larger 
ACTG1 0.159 larger * 
PLRG1 0.168 smaller 
SCFD1 0.189 smaller 
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AP1M1 0.196 smaller 
RRP15 0.199 larger 
U2AF1 0.199 smaller 
RPS12 0.233 smaller 
SNW1 0.253 larger 
RPSA 0.272 smaller 
ARCN1 0.289 smaller 
SCD 0.289 larger 
ATP5B 0.299 larger 
RPS19 0.31 smaller 
RPS16 0.313 smaller 
DARS 0.314 smaller 
RPL8 0.322 smaller 
STX5 0.33 smaller 
POLR2A 0.331 smaller 
GSPT2 0.333 larger 
EIF3G 0.334 larger 
DNAJC3 0.343 smaller 
PSMC5 0.346 smaller * 
CPSF2 0.362 smaller 
SEC23B 0.371 larger 
RAB1A 0.382 smaller 
SF3B1 0.421 smaller 
PRKAR1A 0.435 smaller 
RPS3 0.437 smaller 
OGDHL 0.449 larger 
SNRPD3 0.458 smaller 
ACSF2 0.467 larger 
NDUFA6 0.486 larger 
UBA6 0.515 larger 
CRNKL1 0.535 larger 
MAT1A 0.539 smaller 
RPL36AL 0.55 larger 
ATP6V1A 0.557 larger 
SERINC1 0.577 larger 
EIF2B5 0.58 smaller 
HIST1H2BA 0.58 smaller 
AP1S2 0.655 smaller 
ATP6V0C 0.759 larger 
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